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Abstract
The expression of eukaryotic genes is controlled by non-coding regulatory elements
such as promoters and enhancers, which bind sequence-specic DNA-binding pro-
teins (transcription factors). In multicellular organisms, the characterisation of
these elements is required in order to understand how a single genome is utilised
to generate a multitude of cell types, and how aberrant regulation of transcription
contributes to disease processes. This involves the identication of transcription
factor binding sites within regulatory elements that are occupied in a dened reg-
ulatory context. Digestion with DNase I and the subsequent analysis of regions
protected from digestion followed by high-throughput sequencing (DNase-seq foot-
printing), allows for the quantication of genome-wide transcription factor bind-
ing. However, the handful of methods for analysing DNase-seq data has not been
extensively validated or benchmarked. This thesis describes a novel footprinting al-
gorithm, Wellington, which is presented in the context of a comprehensive compar-
ison of several other DNase-seq footprinting algorithms on a multitude of datasets.
Wellington outperforms other methods in almost all situations. An open-source
software package, pyDNase, that facilitates interacting with DNase-seq data and
provides many tools for DNase-seq analysis is also presented. Wellington is used
to perform footprinting on clinical samples to validate cell lines as a model system,
and to identify the binding partners of the RUNX1/ETO fusion protein in t(8;21)
AML. By expanding the Wellington method, dierential footprinting is shown to
be able to link dierences in transcription factor binding at promoters to changes
in gene expression. Applying this methodology to a range of haematopoietic cell
types illustrates the ability for dierential footprinting to identify key regulators
in the haematopoietic lineage. These results represent advances in the methods
available to analyse DNase-seq data (all of which have been released as free, open-
source software) and demonstrate the power of integrating DNase-seq footprinting
with other functional genomic assays to study transcriptional regulation.
v
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Chapter 1
Introduction
1.1 Motivation
Understanding the information encoded in the genome requires the study of how
transcription factors can recognise DNA sequences in order to coordinate gene ex-
pression. The motivation behind the work presented in this thesis stems from the
need for a high-throughput assay to identify occupied transcription factor bind-
ing sites without the use of antibodies, as used in chromatin immunoprecipitation
(ChIP) experiments, which are currently considered the `gold standard' for iden-
tifying protein-DNA interactions. In this thesis, I will introduce digital DNase
I footprinting, and illustrate how it can be used as a complementary method to
genome-wide ChIP experiments (ChIP-seq) for the global identication of occu-
pied transcription factor binding sites. At the onset of this PhD project, digital
footprinting after DNase-seq1 was a novel technique, having only been described
two years earlier [1]. Due to the unique challenges presented by the data, there
were only a handful of laboratories performing DNase-seq and even fewer with the
necessary experience to analyse the data. Here I sought to develop software to
facilitate the analysis of high-read depth DNase-seq data with the aim to iden-
tify DNA-sequences occupied by transcription factors, and evaluate the extent to
which DNase-seq is an accurate assay for determining transcription factor binding
sites by benchmarking current analysis methods and other transcription factor
binding assays alongside these novel analyses.
1Not to be confused with DNA-seq (DNA Sequencing).
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1.2 Overview
This thesis is presented in the format of a thesis based on publications, with a brief
introduction and discussion. Each results chapter is composed of novel research
that has either been submitted or accepted for publication in a peer-reviewed jour-
nal. Each of these chapters are prefaced with a statement outlining the motivation
for, and overview of, the research, and personal contributions towards the work
performed.
The Introduction provides the motivation for the work conducted and concisely
introduces methodological aspects of the thesis that are used extensively but not
described in subsequent chapters: classical methods for identifying transcription
factor binding sites, chromatin immunoprecipitation, DNase footprinting, and mo-
tif nding.
The rst paper [2], referred to as theWellington paper, extends the introduction
by providing a comprehensive overview and critical analysis of current methods of
analysing DNase-seq data. Here, a novel method to identify transcription factor
binding sites from DNase-seq data, called Wellington, is described. Wellington
is objectively benchmarked against both ChIP-seq and previous algorithms de-
signed for the analysis of DNase-seq data, showing that Wellington outperforms
previously described methods across almost all performance metrics. Alongside
Wellington, pyDNase, a software package to facilitate the analysis of DNase-seq
data, is also described.
The second paper, referred to as the dierential footprinting paper, advances
the Wellington method developed in theWellington paper to allow the comparison
of two datasets in order to identify dierentially occupied protein binding sites be-
tween two DNase-seq datasets. A comparative analysis of DNase-seq experiments
with cells from healthy donors over a range of cell types illustrates the possibility
of using dierential footprinting to inform gene expression prediction models. This
paper also describes several improvements to the underlying pyDNase software li-
brary, including increases in speed, new analysis scripts, the ability to correct for
DNase I cutting bias when visualising data, and a DNase-seq analysis tutorial for
those new to DNase-seq analysis and footprinting.
A summary of the work alongside an outlook on DNase-seq footprinting and
conclusions of the thesis are present in the Discussion.
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1.3 Background
1.3.1 Transcriptional regulation
Transcriptional regulation is one of the many underlying mechanisms by which the
cellular state can be modulated. In single-celled organisms, genes are switched on
and o in response to changing levels of nutrients and other intra- and extracellular
cues. While the same is true for multicellular organisms, transcriptional regulation
is also pivotal to the ability to utilise a single genome in order to generate a multi-
tude of cell types. This cellular dierentiation is driven by tissue-specic patterns
of gene expression that are guided by spatial, temporal, and environmental cues
throughout development during the lifetime of an organism [3].Although it may
be biologically feasible for protein levels to be completely regulated at the post-
translational level, this is not the case, and transcriptional regulation underpins
genetics and is fundamental to all life.
The correct tissue-specic and temporal function of the genome is tightly con-
trolled by transcription factors, proteins that bind specic DNA sequences in order
to regulate gene expression. Upon binding, transcription factors can recruit other
proteins to modulate gene expression or alter chromatin architecture. In the most
basic example, a transcription factor binds directly adjacent to the transcriptional
start site (TSS) of a gene (the promoter), recruiting the transcription pre-initiation
complex (PIC), which is responsible for the positioning of RNA polymerase II
at the TSS, leading to the transcription of the gene into RNA, thus promoting
gene expression [4, 5]. Conversely, transcriptional repressors can down-regulate
transcription by various mechanisms such as inhibiting the assembly of PIC, or
preventing other promoting transcription factors from binding [6].
1.3.2 The chromatin landscape
The ability for a transcription factor to promote gene expression is conditional on
the ability of the transcription factor to physically contact (bind) the DNA. In
eukaryotes, the majority of nuclear DNA is bound to histone proteins and as a
consequence is transcriptionally silent [7, 8]. Heterooctameric histone complexes
are encircled by 147bp of DNA, resembling a thread around a spool | a complex
known as a `nucleosome.' Nucleosomes form interactions with scaolding proteins
(the most abundant of which is histone H1) in order to form compact chromatin
bres [9] (Figure 1.1).
Chromatin serves two functions: it allows the vast amounts of DNA present in
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Figure 1.1: The role of nucleosomes in chromatin packing. A diagram-
matic representation of naked genomic DNA, a single nucleosome, loosely packed
euchromatin, and a densely packed 30nm heterochromatin bre. Adapted from
[10].
the nucleus of each cell to t within the connes of the nucleus, and provides an ad-
ditional layer of genetic regulation. Chromatin is often described of as being in two
states | `open` and `closed` (or `accessible' and `inaccessible' to transcription fac-
tors). Consistency or alteration of covalent modications of the N-terminal histone
protein tails leads to the maintenance of the current chromatin state, or a remod-
elling cascade that can lead to nucleosome repositioning or removal (depletion)
by chromatin remodelling complexes [11]. These histone modications themselves
can be driven by transcription factors that indirectly promote the opening of chro-
matin (pioneering factors) [12], close the chromatin (repressors), or maintain the
current chromatin state. The ability of a transcription factor to bind a consensus
sequence and promote gene expression is therefore often limited by the accessi-
bility of the DNA to the transcription factor due to chromatin packing | in any
given sample of human cells, roughly 90% of the genome is `closed chromatin.' A
good review of chromatin architecture in the context of DNase Hypersensitivity is
provided in [13].
1.3.3 Regulation from a distance
In eukaryotes, the transcription of genes is not only regulated via their promoter,
but by distal enhancers as well. Enhancers are regulatory regions of DNA that reg-
ulate gene transcription from a distance (i.e. more than 2kb from a gene's TSS) via
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interactions with one or many gene promoters, as discovered in some cases [14, 15].
Conservative estimates place the number of enhancers in the human genome at
> 100; 000 [16]. Liberal estimates place this as high as 2; 900; 000, which vastly
outnumbers the ca. 25; 000 protein coding genes in the human genome. Enhancer
activity is highly cell type specic [17], with only around 200; 000 enhancers being
active at any one time [18]. Enhancers, like promoters, are also bound by transcrip-
tion factors. They function via the induction of chromatin looping, making contact
with and activating one or several distal promoters [19]. Conversely, enhancers can
also be bound by silencing factors that can inhibit the transcription of genes by
various mechanisms. Neuron-Restrictive Silencer Factor (NRSF), for example, in-
hibits the expression of neuronal specic genes in non-neuronal tissues by binding
to enhancers with the Neuron-Restrictive Silencer Element (NRSE) sequence, re-
cruiting histone deacetylases (HDACs) that lead to histone hypomethylation and
inducing chromatin packing, silencing the enhancer [20]. The most abundant tran-
scriptional repressor, CTC-binding factor (CTCF), however, inhibits the action
of transcription factors via a dierent mechanism, inhibiting chromatin looping
preventing the contact of nearby enhancers to their target promoters [21]. This
illustrates the complex many-to-one relationship of enhancer eects on gene ex-
pression, whereby gene promoters integrate the signals from many gene-promoting
and gene-repressing enhancers, themselves only active in specic contexts, in order
to regulate gene expression.
1.3.4 Characterising regulatory elements
The publication of the nished sequence by the human Genome Project in 2004
[22] was a milestone in genomics, however, much work was still required to identify
all the functional elements of the genome such as protein coding and non-protein
code genes, alongside regulatory elements (also known as functional non-coding
regions) such as promoters and enhancers. The US National Human Genome
Research Institute (NHGRI) launched the Encyclopedia of DNA Elements (EN-
CODE) project consortium with the aim of annotating functional elements in the
human genome over multiple cell lines 2. The results from the pilot study on
just 30Mb (1%) yielded a wealth of results, which not only recapitulated known
methods of genetic regulation that had not previously been characterised on a
systems level, but also revealed novel information [23]. One example is the nding
2The biggest criticism of the ENCODE project is its decision to use cell lines and not healthy
samples in the majority of their assays.
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that specic transcription factors previously thought to only bind gene promoters
were found to bind to enhancers, and regulatory elements previously annotated as
enhancers were discovered to be novel promoters for unannotated transcripts.
Discovering promoters is a relatively simple task achieved by identifying the
region directly adjacent to a transcriptional start site. Unlike protein coding genes,
there are no sequence-specic elements that accurately predict the presence of an
enhancer although some sequence features, like increased CG content and sequence
conservation are highly correlative. As part of the full ENCODE project, the EN-
CODE project consortium employed several high-throughput genomic techniques
in an attempt to identify and characterise regulatory elements, including the iden-
tication of transcripts through CAGE-seq [24] and RNA-seq [25], transcription
factor binding sites via ChIP-seq and DNase-seq, and the determination of chro-
matin structure via ChIP-seq, MNase-seq [26], FAIRE-seq [27], and DNase-seq.
Whilst these assays have helped identify putative enhancers and distal regula-
tory elements, the knowledge of their existence by themselves does not provide
characterise the action of these regulatory elements.
The data and analyses from the ENCODE project has been pivotal in fa-
cilitating our understanding of the genome, in particular, provided a wealth of
information characterising the location of the non-coding regulatory elements in
the human genome. However, the characterisation of these regulatory elements in
the human genome has proven to be challenging. Given the approximately 1500
transcription factors, and the large number of enhancers that are estimated to be
active in any one cell type at any given time [28], the functional characterisation of
all of these elements is a monumental task that will require many dierent assays
and analyses, and ENCODE has only scratched the surface.
Even with the knowledge of the location and the known transcription factor
binding sites in an enhancer, it remains dicult to predict the genes are under the
control of a specic transcription factor. There are, however, certain histone mod-
ications (H3K27ac and H3K4me1) that are associated with active and inactive
enhancers, along with specic co-activators (p300) that have been found to bind
to active enhancers. It is thought that by understanding the specic combinations
of transcription factors that bind regulatory elements, an `enhancer grammar' can
be inferred that enables the prediction of enhancers in silico.
The ENCODE project has provided a wealth of data about regulatory elements
that have illustrated the importance of enhancers in evolution. It has been known
that GWAS SNPs are enriched in non-coding regions, and with the characterisa-
tion of regulatory elements through ENCODE, it has subsequently been shown
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that these SNPs are enriched in regulatory elements, or are in linkage disequi-
librium with those elements [29, 30]. Moreover, evidence suggests that evolution
is accelerated at non-coding regulatory elements [31]. Regulatory elements oer
ecient ways to make phenotypic changes to an organism through only a small
number of nucleotide polymorphisms which change the regulatory phenotype of a
gene. In one such example of evolution through regulatory elements, Single Nu-
cleotide Polymorphisms (SNPs) were identied via quantitative trait loci (QTL)
analysis that were associated with the absence of pelvic ns in a specic sub-
population of sticklebacks lost through divergent selection; Transfecting embryos
with an edited enhancer led to the reestablishment of pelvic ns [32], reinstating
phenotypes that had been lost through selection. Individual SNPs in enhancers
that are sucient to disrupt a single transcription factor binding site have been
shown to alter chromatin structure, causing the chromatin to close and prevent
activation of the enhancer [33].
However, the types of assays performed by the ENCODE project that charac-
terise the location, and in some cases, the transcription factor binding sites, do not
identify where in the genome an enhancer is acting. Whilst expression quantita-
tive trait loci (eQTL) is able to correlate changes in gene expression to regulatory
elements these studies require very large samples in order to gain statistical power
and it is impossible to show correlation vs causation. In addition, eQTL studies
have been shown to be highly cell-type specic, which is probably due to the cell
type specicity of enhancers leading to variants in regulatory regions only aect-
ing those cell-types in which the enhancer is active [34]. Beyond computational
and statistical methods, there are several high-throughput biological methods for
identifying long-range interactions in a genome such as contact between enhancers
and promoters. These methods rely on cross-linking cells with formaldehyde in
order to freeze the cell in time. The DNA is then digested with a restriction en-
zyme in order to generate globules of cross-linked protein with strands of DNA
intertwined. A variety of dierent techniques are then used to ligate DNA that
were spatially near to each other in the cell, which can then be sequenced in order
to determine the chromatin interaction landscape (Figure 1.2).
These `3C' based techniques include chromosome conformation capture (3C)
[36], circularised chromosome conformation capture (4C) [37], chromosome con-
formation carbon copy capture (5C) [38], Hi-C [39], and chromatin interaction
analysis by paired-end tag sequencing (ChIA-PET) [40]. Whilst these tools give
an idea of the long-range interactions of enhancers and promoters, they do not help
elucidate the precise transcription factors that are ultimately the driving forces
7
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Figure 1.2: Methods for identifying higher-order chromatin interactions.
Various methods exist for identifying long-range chromatin interactions. These
`3C' based techniques cross-link chromatin with formaldehyde in order to isolate
regions of DNA that are co-located in physical space. These regions are then
circularised and sequenced, where each half of the sequencing read originates from
one genomics location in contact with the other half. Image adapted from [35].
behind the enhancer/promoter contact. In order to piece together a system-wide
view of gene regulation | the identication of active enhancers and characteri-
sation of how these enhancers function in order to regulate their target gene(s)
| a multitude of assays must be integrated. Information on transcription factor
binding sites, long-range chromatin interactions, gene expression, histone modi-
cations, mutation, genetic variants, amongst others, need to be analysed in concert
in order to construct a complete model of transcriptional regulation in the human
genome.
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1.4 Identifying transcription factor binding sites
1.4.1 Chromatin immunoprecipitation
Currently, the gold-standard high-throughput method for identifying transcrip-
tion factor binding sites is ChIP-seq. Almost all methods that aim to predict
transcription factor binding sites have used ChIP-seq recapitulation as the vali-
dation metric. Both of the results chapters in this thesis will refer to ChIP-seq
data, so a brief overview of the protocol, along with comments on the benets and
limitations, are outlined here.
The rst stage in a ChIP-seq experiment is the cross-linking stage. Formalde-
hyde is added to live cells, reacting with the protein in the cell and resulting in
neighbouring proteins becoming cross-linked through the formation of methylene
bridges. DNA becomes trapped in this matrix of cross-linked proteins, providing
a snapshot of the protein-DNA interactions in a population of cells. Cells are
lysed, and the protein-DNA matrix is extracted and sonicated in order split the
mixture into protein-bound fragments of DNA between 100 and 300 base pairs in
length. An antibody for a protein of interest is then used together with a solid
matrix to which it binds to enrich fragments of DNA bound by the target pro-
tein. The cross-linking process can be easily reversed by heating in water, yielding
fragments of DNA that were bound to the protein of interest, either directly or
indirectly. These fragments are then analysed by high-throughput sequencing,
and are mapped to reference genome of the organism being studied in order to
determine the genome-wide binding sites of the protein of interest [41] (Figure
1.3).
Analysing ChIP-seq data allows for the identication of putative binding sites
with a resolution in the range of 400|2000bp. Because of this, it can extremely
dicult to identify whether the protein of interest is directly or indirectly binding a
given region unless further experiments are carried out, and results from ChIP-seq
experiments can yield numerous false positives. Therefore, ChIP-seq experiments
are often required to be validated through other experimental means. One such
method to address this issue is ChIP-exo [43] (Figure 1.4). An exonuclease is used
to trim the overhanging fragments surrounding a transcription factor complex.
This method has not yet gained widespread adoption, with only a handful of
publicly available datasets (43 as of 13th December 2014 contrasted with 11,443
ChIP-seq datasets) in the Gene Expression Omnibus [44, 45].
The greatest limitation of ChIP-seq (and therefore ChIP-exo) stems from the
9
Figure 1.3: Chromatin Immunoprecipitation. Cells are cross-linked using
formaldehyde, lysed, and sonicated. An antibody against a protein of interest is
subsequently used in order to isolate regions of DNA associated with a specic
protein. Next, the cross-linking is reversed so that the DNA associated with the
protein-DNA interaction can be sequenced and aligned to the genome in order to
identify transcription factor binding sites. Image courtesy [42].
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Figure 1.4: Chip-exo. A standard ChIP protocol is followed, however, before
elution, the 50 end of the bound DNA fragment is trimmed using lambda exonu-
clease, so the 50 end of the DNA anks the protein-DNA interaction. These 50
ends can then be targeted for sequencing using LM-PCR. Image courtesy [46].
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requirement that a highly specic, high-anity antibody must be raised against
the protein of interest. This limits experiments to one protein per sequencing run,
as well as to proteins that are already of interest and known. The inability to
distinguish between direct and indirect binding to the DNA is another major lim-
itation of ChIP-seq. The absence of the target transcription factors corresponding
to DNA binding motifs provides evidence of indirect binding, however the mere
presence of a motif is not a good indicator that the protein is directly bound. In
addition, epitope masking can occur, in which the antibody used in the immuno-
precipitation is unable to recognise the target protein. Solutions such as epitope
tagging with an accessory protein (e.g. GFP) can be utilised to mitigate this prob-
lem. Epitope tagging can also allow the study of proteins for which no antibody is
available, but this could interfere with the cellular function of the epitope tagged
protein (a review highlighting the technical considerations for ChIP-seq can be
found [47]).
1.4.2 DNase I footprinting
The identication of protein-DNA interactions via DNase I began with the obser-
vation that upon ultraviolet irradiation, the breakage of DNA of the E. coli lac
operator was diminished at specic sites by the presence of the lac repressor [48],
and similarly, the ability of dimethylsulfate (DMS) to methylate purines (preferen-
tially guanines) was also inhibited by the presence of a bound protein interacting
with these bases [49]. The ability of a DNA binding protein to shield the DNA
from damage was harnessed in a technique called deoxyribonculease I (DNase I
3) footprinting [50]. DNase is a eukaryotic endonuclease that cleaves the DNA
phosphodiester backbone adjacent to pyrimidic bases on one strand at a time i.e.
introduces `nicks'. It has an observable sequence specicity [51{54], where the
phosphodiester bonds adjacent to specic sequences are hydrolysed with prefer-
ence over several orders of magnitude. However, even though this bias exists, it is
unlike a bacterial restriction enzyme in that it does not have a recognition site.
In the original DNase footprinting protocol, by subjecting a protein-DNA com-
plex to DNase I cleavage, a southern blot was be used to visualise where the DNA
is bound by a protein. DNase is unable to cleave DNA where protein is bound,
but is able to cleave directly adjacent (as much as steric hindrance allows) to the
protein-DNA complex and anywhere else where the DNA is not bound to a pro-
3Interestingly, DNase was originally referred to as `DNAase'[50] and has at at some point lost
the superuous `a.'
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Figure 1.5: DNase I footprinting via southern blotting. Protein-DNA in-
teractions can be identied in vitro using DNase I footprinting. A protein-DNA
complex is subject to digestion by DNase I. The DNA fragments generated by this
process are subject electrophoretic separation, where a `footprint' is left by the
protein contacting the DNA and preventing DNase I digestion. Image courtesy
[55].
tein. This method was coupled with DNA sequencing (at the time of discovery,
Maxam-Gilbert sequencing) in order to identify the sequence of the protein-DNA
binding site. DNase footprinting provided conclusive evidence that transcription
factors bind specic DNA sites based on their sequence (Figure 1.5).
DNase footprinting was quickly adapted for in vivo use via ligation-mediated
PCR (LM-PCR) [56]. Whether whole cells or isolated nuclei are subjected to
DNase digestion, and regions of interest are amplied via single-stranded PCR
using primers anking the region of interest. As nicks introduced by DNase will
prevent elongation by DNA polymerase, the PCR fragments will abruptly ter-
minate in regions where DNase is able to cleave the phosphodiester backbone.
In regions where a protein is bound, fewer nicks will be present and the PCR
reaction will rarely terminate in these regions. Linkers are then ligated to the
single-stranded DNA fragments and primers against these linkers utilised to re-
constitute the complementary strand of DNA. This ability to characterise the
activity of transcription factors in their native environment is critical to under-
standing genetic regulation. DNase footprinting methodology remained largely
unchanged as a single locus assay for 30 years, and was restricted to the study of
limited numbers of proteins and sequences at once due to the laborious nature of
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the assay. During this time, in terms of the number of experiments submitted to
the main online data repositories, the Gene Expression Omnibus (GEO) and the
Sequence Read Archive (SRA), ChIP-seq remained the most popular assay for the
determination of transcription factor binding sites.
High-throughput DNase I assays
In 2004, two member groups [57, 58] of the ENCODE consortium developed re-
newed interest in DNase as a tool to identify regulatory regions by using the
cleavage activity of DNase to map thousands of so-called DNase Hypersensitive
Sites (DHSs). In order for regulatory regions to function, nucleosomes are dis-
placed, revealing regions of `open' chromatin whereby the DNA becomes accessi-
ble to transcription factors. These regions, often 200-2000bp in length, are much
more sensitive to cleavage by DNase than `closed' chromatin i.e. DNA that is
bound to nucleosomes. The authors showed that short fragments of DNA isolated
from DNase cleavage reactions aligned to known regulatory regions in the human
genome, namely known enhancers and promoters .
Shortly afterward, the use of DNA microarrays was employed [60] in order
to provide the rst high-throughput screen for DHSs, and with the increased af-
fordability of next-generation high-throughput sequencing technologies, DNase di-
gestion was coupled with high-throughput sequencing (DNase-seq), providing the
rst unbiased assay for identifying active regulatory regions [1, 60]. The specic
method used for library preparation was introduced as the `single hit' method,
Figure 1.6, with the slight disadvantage that sequence fragments generated by
the single-hit method are limited to 20bp, which although theoretically mappable,
is at the lower limit of acceptable read length to be able to align to the human
genome.
1.4.3 DNase-seq for identifying transcription factor bind-
ing sites
Unlike the work undertaken by Galas and Schmitz [50], the sequencing depth of
these assays was insucient to distinguish areas of protection from DNase cleavage
by bound proteins, but the method identied potential regulatory elements in the
human genome. It was not long, however, before this method was adapted as a
high-throughput method to identify DNase I footprints in vivo. High-throughput
sequencing platforms typically sequence 20-72bp of a ca. 300bp fragment in the 50
to 30 direction. When aligning the sequenced fragment to the reference genome,
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Figure 1.6: The `single-hit' DNase-seq method. After DNase digestion, frag-
ments are ligated to a linker which contains a MmeI restriction site. The sample is
treated with MmeI, which will cut 20bp downstream from the recognition site, and
nally ligate this fragment to another linker to `pad` the fragment to be suciently
long enough to be sequenced. Adapted from [59].
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Figure 1.7: The `double-hit' DNase-seq method. Cells are subjected to
DNase I digestion in vivo, where DNase I is only able to digest DNA in regions of
open chromatin where the DNA is unbound by protein. Fragments generated by
this process that pass a size-selection threshold are isolated and then sequenced.
Adapted from [62].
the 50 end of the aligned sequence corresponds to where the DNA has been cut
by the DNase, and the 30 end corresponds to the sequence length limit of the
sequencer. By aligning reads to the genome and identifying the location of all the
50 ends of the sequenced fragments, the genomic position where DNase has cut
DNA can be established.
Yeast was chosen as the rst organism for this assay, which the authors named
`digital genomic footprinting' [61] for two main reasons. Yeast's small genome
(12Mb) yields 400 the sequencing depth compared to the same number of se-
quencing reads on a human sample, and the transcription factor binding sites
within the yeast genome are well classied, providing a simple method of vali-
dating the results from this novel technique. Although these experiments did not
provide much in the way of elucidating any novel biological results, they provided
proof of principle that DNase digestion followed by high-throughput sequencing
could identify transcription factor binding sites in vivo.
Further developments drastically simplied the DNase-seq protocol. In the
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Figure 1.8: DNase-seq Footprinting. Classical DNase I footprinting can be
adapted into a whole-genome study by using the 50 end of aligned sequence tags
as a measure of DNase I cutting. By subjecting cells to digestion by DNase I and
isolating sub-nucleosomal fragments (<150bp), the 50 most end of aligned sequence
tags will occur in protein-DNA binding sites less often than of neighbouring regions
due to protection of the DNA from DNase I cleavage.
`double-hit' protocol [63], the ligation of MmeI linkers and digestion was replaced
by a simple size selection step (Figure 1.7). Regions of open chromatin are digested
with DNase I at the correct concentration that provides two `cuts' per DNase
hypersensitive site. The fragments that span the protein-DNA binding sites are
isolated using size selection on an agarose gel or via ultracentrifugation using a
sucrose column. These data can can be analysed in order to detect protein-DNA
binding events (footprints) (Figure 1.8).
The assay is extremely sensitive to the precise distribution of fragment sizes,
with fragments less than 50bp resulting in fragments that span the protein-DNA
binding site, which is best suited for footprinting [52]. Fragments larger than
150bp often span entire nucleosomes, and these larger fragments are not suitable
for identifying transcription-factor binding sites. Using either a combination of
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size-selection, or in silico size selection following paired-end sequencing, DNase-seq
can be used not only to nd transcription-factor binding sites, but also nucleosome
positions [64]. Over 90% of DNase-seq data in the public domain (almost all of
which is part of the ENCODE project) have been generated with this simpler
`double-hit' method, with only the very early experiments using the older single-
hit method.
1.5 Analysing transcription factor binding data
1.5.1 Peak calling
The basic analysis of both ChIP-seq and DNase-seq data is to identify where in
the genome the protein of interest is binding ,or in the case of DNase-seq, the
identication of DHSs. The aligned sequence tags are analysed to nd regions
of the genome where the number of reads that have been aligned is statistically
signicantly higher compared to a background model, whereby the exact statistical
methods used vary between the tools used to identify the peaks. These binary
predictions partition the genome into regions where the protein is bound to the
DNA (peaks) and regions where it is not.4 When analysing ChIP-seq data, the
scores assigned to these regions are often used as evidence of the `strength' of
binding. However, as there is no easy method of determining the heterogeneity
of transcription factor binding in the population of cells used in the assay, it is
not possible to dierentiate between a protein binding weakly in all cells in the
population, or binding strongly in a subpopulation. A wide variety of tools have
been developed to full the purpose of peak calling, and the sophistication of these
methods ranges from using a simple sliding window to calculate the sum of reads
in an area, to methods that consider the signal on a single base-pair resolution,
Hidden Markov Model based approaches, and those that correct biases in the
underlying library preparation protocols and sequencing methods used to generate
the data. Much could be said about the approaches taken to analyse ChIP-seq
data, with dierent ChIP-seq peak callers yielding peaks that drastically alter
the biological interpretations of the downstream analyses (reviewed extensively in
[65]).
4There is much to be said about such a binary view on the protein-DNA landscape, whereby
near to this threshold, the dierence of one aligned read can determine the dierence between
`bound' and `unbound'.
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1.5.2 Digital genomic footprinting
For ChIP-seq analyses, identifying regions of enrichment (peaks) followed by motif
searching (outlined in Section 1.5.3) is the preferred analysis in order to identify the
transcription factor binding sites. Similar analyses can be performed on DNase-
seq data through the identication of motifs in DHSs, but there can be between
2|100 the number of DHSs in a DNase-seq experiment compared to a ChIP-seq
experiment, with the number of DHSs per cell line ranging between 84; 201 for
Th1, 142; 986 for K562, and 266; 618 H7-hESC [66], whereas the number of ChIP-
seq peaks ranging between 1; 902 for NRF1 and for 45; 732 CTCF in K562 cells
[2]. Because of the large numbers of DHSs detected, the number of transcription
factor binding DNA motifs present in these regions will far outnumber the number
of transcription factors that are actually bound, so this analysis can yield many
false positives. The power of DNase-seq is the ability to analyse the data in order
to demarcate transcription factor binding sites within DHSs (i.e. footprinting).
This can performed computationally by identifying short (< 50bp) regions where
the number of 50 sequence tags aligning to the genome is diminished due to a
protein-DNA interaction blocking digestion of the DNA by DNase. This process,
originally referred to as `digital genomic footprinting' was rst described using
data generated on the single-hit data in yeast, by searching for regions of depleted
50 sequence tags in the data using a binomial test [61].
The rst DNase-seq footprinting eorts on the human genome were performed
using the early `single-hit' data generated by the ENCODE project [67, 68]. These
methods used fundamentally dierent statistical analyses such as a Bayesian Hi-
erarchical Model and a Hidden Markov Model, respectively, to identify footprints.
DNase-seq data from 41 cell lines generated as part of the ENCODE project pro-
vided the rst comprehensive overview of transcription factor footprints in the
human genome [66]. The authors also described their approach a novel algorithm
(named Ambrose) for discovering footprints without motif information, along with
a set of footprints for 41 cell lines with ChIP-seq validation for a select few tran-
scription factors in K562 cancer cell line (discussed further in Chapter 2).
In contrast to ChIP-seq, DNase-seq footprinting provides a holistic approach
to identifying transcription factor binding sites. DNase-seq reveals that a specic
10-30bp fragment of DNA is bound, without identifying which protein is bound.
ChIP-seq determines which protein is binding a certain region, but not where it is
bound, and whether it is binding directly or indirectly. Because of this, ChIP-seq
and DNase-seq have complementary roles, and the combination of ChIP-seq and
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DNase-seq can be used to dierentiate primary from secondary binding [66]. Sev-
eral studies have shown that transcription factor footprints are able to recapitulate
the binding of almost all transcription factors, as well as the identication of novel
transcription factors. Several studies have commented on the false positive rate
of these analyses, commenting on both the lack of evolutionary conservation of
so-called `novel' transcription factor binding sites [2, 69], and the possibility that
these false positives arise from unaccounted bias in DNase I cutting [52].
A thorough introduction to DNase-seq footprinting methodology is presented
in Chapter 2.
1.5.3 Identifying DNA binding motifs
After peak (or footprint) detection, the most fundamental downstream analysis of
transcription factor binding sites as determined by ChIP-seq is the identication
of the DNA sequence that a transcription factor binds to by analysing the set of
sequences identied by the peak calling process. Knowledge of the DNA sequences
that are preferentially bound by individual transcription factors (binding motifs)
allows the prediction of transcription factor binding sites within the genome, and
supplements other genomic assays by being able to predict bound transcription
factors based on DNA sequence (e.g. the determination of binding partners or the
identication of common DNA motifs in gene promoters that may suggest com-
mon regulatory mechanisms). As most transcription factors exhibit degeneracy in
their ability to recognise DNA sequences, to represent the complete repertoire of
sequences that a transcription factor binds to, the position weight matrix (PWM),
also known as a position-specic scoring matrix (PSSM)[70] is frequently used.
For a set S of N sequences of length l that a transcription factor is known to
bind to, the elements of the PWM P are calculated as follows.
Pk;j =
1
N
NX
i=1
I(Si;j; k) (1.1)
where i 2 (1; :::N), j 2 (1; :::; l), k 2 fA;C;G; Tg, and the identity function
I(a; k) =
8<:1 if a = k0 if a 6= k
PWMs are more intuitively visualised (Figure 1.9), where it is easily observed
that families of transcription factors often have extremely similar PWMs (Figure
1.9d-f), reecting the fact they share a common DNA binding domains. The use
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Figure 1.9: Position Weight Matrices (PWM) can be represented graph-
ically to compare and contrast the binding characteristics of transcrip-
tion factors. A graphical representation of the PWMs for three transcription
factors containing dierent DNA binding domains highlights the dierence DNA
sequences bound (a,b,c), whereas three dierent transcription factors from the Ets
family that that share similar binding domains have very similar PWMs (d,e,f)
The height of the letters indicates the bits of information that the specic letter
carries.
of the PWM to represent a protein's DNA binding anity makes the assumption
that the eects of a nucleotide on the binding anity of a protein are independent
of all other positions in the PWM, and is a simplistic method of representing a
complex biophysical interaction. Several more complex models for representing
DNA binding sites have been developed, most have not managed to signicantly
improve on the PWM, which also had the added benet that is simple to interpret
visually. There have been developments in the area of tting the `best' PWM for a
transcription factor, identifying the short 8-10bp sequences out of the 200|1000bp
ChIP-seq that the transcription factor recognises, and these various methods rely
on a number of statistical frameworks, comprehensively reviewed in [71].
The identication of the enriched set of motifs in a ChIP-seq dataset often
reveals more than the sequence that the immunoprecipitated transcription fac-
tor binds. As transcription factors do not bind on their own, but interact with
other factors, secondary motifs found in ChIP-seq peaks provide insight into the
co-operative transcription factor binding partners of the protein of interest, and
therefore the protein-protein interactions of the target protein. The total number
of known human DNA binding motifs currently numbers in the thousands, and sev-
eral databases exist such as TRANSFAC [72], JASPAR [73] which have catalogued
them and which are constantly updated as a result of substantial high-throughput
screening studies. The amount of redundancy is large, as many transcription fac-
tors share common DNA binding domains, resulting in families of transcription
factors, with often diverse functions, that recognise similar DNA binding motifs
(Figure 1.9). One extreme example is the ETS factor family of transcription fac-
tors, with 27 members in the human genome that all bind the relatively simple
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core motif of TTCC [74]. Coupled with the degeneracy of DNA binding proteins,
this many-to-many relationship where a single DNA binding site can be bound by
a myriad of transcription factors, and conversely a single transcription factor can
bind many dierent sequences with varying specicities illustrates the extremely
complex nature of the transcription factor landscape within the cell.
Because of the large number of DNA binding motifs, almost any given region
of the genome will contain scores of known DNA binding motifs.
1.6 Introduction to the thesis
DNase-seq is a high-throughput adaptation of a the classical DNase I Footprinting
assay [50] that can identify regions of open (active) chromatin. Through the use
of more sophisticated analyses, DNase-seq footprinting is able to demarcate tran-
scription factor binding sites with an accuracy of < 30bp resolution [61]. DNase-
seq data continues to be generated by public functional genomics consortia such
as the ENCODE and NIH Roadmap Epigenomics projects, and the application of
DNase-seq on mice [75], Drosophila [76], Arabidopsis [77], Rhesus monkeys, and
Chimpanzee [78] illustrate the versatility of the method. The DNase-seq method is
of great utility in organisms where little is known about transcriptional regulation.
In these cases, the power gained from DNase-seq footprinting is not recapitulating
results, but being able to study multiple transcription factors in one assay without
the requirement to either specify a protein of interest or obtain antibodies as used
in ChIP.
Despite this growing adoption of the method, prior to the work described in
this thesis, the options available for analysing DNase-seq data were sparse. Several
tools designed for peak calling in ChIP-seq data have been coaxed into this role,
with tools such as MACS, FindPeaks, and HOMER being used to locate regions
of open chromatin, along with several DNase-seq specic peak callers specically
for DNase-seq data, reviewed in [79]. For more ne-grained footprinting analyses,
even though a number of papers had been published either describing or utilising
footprinting analyses of DNase-seq data, there was no software available for per-
forming footprinting, the exception being CENTIPEDE which is not a de novo
footprinting method as it requires prior knowledge of genomic DNA binding motifs
for a transcription factor of interest (discussed further in Section 4.4).
The aim of this thesis is to build on the pioneering work performed on devel-
oping the DNase-seq protocol, and the early attempts at footprinting DNase-seq
data. Chapter 2 reviews the methods available for identifying transcription factor
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binding sites in DNase-seq data and identies several shortcomings in the meth-
ods being used to validate these attempts. Here, Wellington, a novel algorithm
for identifying transcription factor binding sites is introduced, and benchmarked
against ChIP-seq data and the results of other algorithms. The strand imbalance
inherent in the DNase-seq library preparation protocol is shown to increase the
predictive power of transcription factor binding site predictions. pyDNase is also
introduced alongside Wellington, providing an easy to use and ecient applica-
tion programming interface (API) for interacting with DNase-seq data, along with
several convenient scripts for performing common analyses.
Chapter 3 builds on the methodological and analytical work performed in the
previous chapter. An extension to the Wellington algorithm is presented that
allows for the ability to identify dierential transcription factor binding in com-
mon DNase hypersensitive sites, along with signicant computational performance
gains to the original method brought about by major refactoring of the code base.
The analysis of a number of samples from primary cell lines using this extension
identies transcription factors that convey cell identity across the haematopoi-
etic lineage, and is able to illustrate how transcriptomic data can be linked to
transcription factors that aect gene expression in these cells.
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Chapter 2
Footprinting analysis of
DNase-seq data
2.1 Motivation
At the beginning of this project, several approaches to identifying footprints in
DNase-seq data had been described. One such method outlined the footprinting
analysis of yeast DNase-seq data generated using the single-hit method, with the
authors providing a software implementation as a collection of scripts in MATLAB,
Python, and Bash [61]. Another approach developed on single-hit DNase-seq
data, but on human data, was CENTIPEDE [67] (which requires the locations of
DNA binding motifs in the genome a priori), implemented in R. Neither of these
tools were intuitive to use, requiring the DNase-seq data in non-standardised le
formats to produce footprint predictions. The authors of these studies provided
descriptions of these le formats and example les, but software to prepare these
les from the sequencing data was not provided. Two further methods existed for
which there was no software implementation available [66, 68], but the results of
the analyses on several cell lines had been published.
Here, a comprehensive evaluation of the performance of these approaches to
identifying protein-DNA interactions in DNase-seq data on identical datasets was
performed, the rst objective assessment of these dierent methods. As part of
this eort, a software library for interacting with the raw DNase-seq alignment
data called pyDNase was developed, in order to allow for the fast and ecient
generation of the non-standardised data formats required by CENTIPEDE [67]
and the Hesselberth Method [61].
Using pyDNase, a novel footprinting algorithm, Wellington, has been intro-
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duced, that utilises a previously undescribed feature in the `double-hit' DNase-
seq protocol in order to increase the predictive power of DNase-seq footprinting.
Wellington was validated against ChIP-seq data, motif content, and phylogenetic
conservation scores across several cell types and between the two prevailing library
preparation protocols. Where data are available, Wellington was benchmarked
against other methods.
Here, a comprehensive suite of benchmarks over several criteria is presented
that illustrate the power of Wellington to accurately identify protein-DNA interac-
tions from DNase-seq data. In almost all circumstances, Wellington outperforms
previously described methods across almost all performance metrics. Wellington
is provided as part of the pyDNase package, a free, open source, and easy-to-install
Python library. pyDNase was designed using modern software development prac-
tises such as unit tests, extensive documentation, and continuous integration in
order to maintain quality assurance throughout development of the tools.
2.2 Contributions
For this paper, I was responsible for the design of the study and the entirety of the
design, development, and implementation of the underlying Wellington algorithm
and pyDNase software, the data analysis, gure generation, and the preparation
of the manuscript, with the following exceptions.
Markus Elze provided statistical consultation, aiding the renement of an ear-
lier model for footprint detection. Markus Elze also signicantly contributed to
the writing of Supplementary Sections 1.4, 1.6|10, and 1.13. Pierre Cauchy pro-
vided ongoing computational and analytical support and provided the rightmost
panel of Figure S6 and the lower three panels of Figure S7. Peter N. Cockerill
contributed the gure and gure legend for Figure S3 and along with Constanze
Bonifer and Sascha Ott, provided ongoing general guidance. All authors provided
comments and amendments to the manuscript during preparation and the peer
review process.
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ABSTRACT
The expression of eukaryotic genes is regulated by
cis-regulatory elements such as promoters and
enhancers, which bind sequence-specific DNA-
binding proteins. One of the great challenges in
the gene regulation field is to characterise these
elements. This involves the identification of tran-
scription factor (TF) binding sites within regulatory
elements that are occupied in a defined regulatory
context. Digestion with DNase and the subsequent
analysis of regions protected from cleavage (DNase
footprinting) has for many years been used to
identify specific binding sites occupied by TFs at
individual cis-elements with high resolution. This
methodology has recently been adapted for high-
throughput sequencing (DNase-seq). In this study,
we describe an imbalance in the DNA strand-
specific alignment information of DNase-seq data
surrounding protein–DNA interactions that allows
accurate prediction of occupied TF binding sites.
Our study introduces a novel algorithm,
Wellington, which considers the imbalance in this
strand-specific information to efficiently identify
DNA footprints. This algorithm significantly
enhances specificity by reducing the proportion
of false positives and requires significantly fewer
predictions than previously reported methods to
recapitulate an equal amount of ChIP-seq data. We
also provide an open-source software package,
pyDNase, which implements the Wellington
algorithm to interface with DNase-seq data and
expedite analyses.
INTRODUCTION
The correct tissue-specific and temporal function of the
genome is tightly controlled by transcription factors
(TFs) that recognise specific DNA sequences and
regulate the expression of specific genes. However, they
do not act as single molecules but interact with each
other to form large multi-protein assemblies that act as
platforms for the recruitment of members of the epigenetic
regulatory machinery (1,2). One of the significant chal-
lenges facing gene regulation studies is the identification
of sites where TFs are bound to specific genes in a specific
regulatory context. Although previous studies have shown
a direct link between the sequence as well as tissue speci-
ficity of a number of TFs and gene expression patterns
(3,4), the mechanisms behind how defined DNA sequences
and the assembly of TF complexes translate into global
gene expression patterns remains to be fully understood.
Characterising TF binding sites (TFBSs) across the
entire genome is a monumental task. It is estimated that
the total number of TFs in the human genome number
!1500, where several hundred of these may be active in
a given cell type at any one time (5). Currently, the ‘gold
standard’ for identifying occupied TFBSs in a given
context uses chromatin immunoprecipitation paired with
high-throughput sequencing (ChIP-seq) (6), which
requires either a high-quality antibody or high cell
numbers or alternatively epitope tagging. Although
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ChIP-seq has proven to be extremely powerful, it is not
without limitations: It is only possible to characterise one
TF per experiment, it cannot be used alone to differentiate
between primary and secondary binding (7), and the
protein binding regions of the genome identified by
ChIP-seq are in the order of several hundred base pairs.
Progress has been made in this respect with the advent of
ChIP-exo (8), which increases resolution of ChIP-seq data
to below 50 bp, but this method has yet to see widespread
adoption.
Another widely used approach in gene regulation
studies uses DNase I as a tool to identify DNase I
Hypersensitive Sites (DHSs) within chromatin (1). DHSs
represent open chromatin regions that are normally only
accessible at sites of active regulatory elements such as
transcriptional enhancers. The recent development of
DNase-seq has allowed more comprehensive mapping of
the active chromatin landscape than is possible with ChIP-
seq (9). The specific patterns of DNase I cleavage within
DHSs also provide additional information about regions
of DNA that are bound by proteins and are thereby
protected from DNase I digestion, a feature that has
been exploited for many years to obtain information
about DNA–protein interactions at specific genes
(10,11). However, the genome-wide data gained from
this method are not trivial to analyse. DHSs can occupy
hundreds of base pairs, and the entire complement of such
sites contains an intrinsically high number of different
specific TFBSs (9).
Although analyses of DNase-seq data were originally
confined to identifying DHSs by peak detection, there
have recently been several advances in the analysis of
the raw tag counts that correspond to DNase activity at
base pair resolution. The first of these digital genomic
footprinting (DGF) methods were developed in yeast,
where tag counts were processed with a rank transform-
ation and tested for depletions in reads corresponding to
occupied TFBSs using a binomial test (12). Subsequently,
the first DGF studies in mammalian cells used a machine-
learning approach where the tag counts were truncated,
smoothed and differentiated, followed by the supervised
training of a Hidden Markov Model on the known TFBSs
in the FMR1 promoter. Viterbi decoding was then
performed to provide binary classifications (bound or
unbound) for every base in the genome (13). Although
several sets of footprints for various cell types as well as
the model parameters were published, a software imple-
mentation was not made available. Another machine-
learning approach, CENTIPEDE, trains an unsupervised
Bayesian mixture model on the raw tag counts surround-
ing all genomic occurrences of a specified motif of interest
to predict the binding states of each motif occurrence (14);
however, unlike the previous methods, it cannot make
predictions at arbitrary genomic loci. A software imple-
mentation of the CENTIPEDE algorithm is available
but requires data to be pre-processed by the user into
non-standard formats. The ENCODE project (15) has
produced the most comprehensive set of DGFs in
human cells by performing high-sequencing depth
DNase-seq experiments on a multitude of cell types,
adapting their previous footprinting methodology (12)
to human data through the use of a metric that calculates
the ratio of DNase-seq tags within a binding site to those
directly outside (the Footprint Occupancy Score) (7).
Using publically available DNase-seq data from the
ENCODE project, we describe how the alignment direc-
tion of DNA fragments relative to the reference strand
exhibits a characteristic strand imbalance in the patterns
surrounding known protein–DNA binding sites. We
introduce Wellington, a novel footprinting algorithm
that uses this knowledge to identify protein–DNA inter-
actions in DNase-seq data with increased performance
over previous methods, by reducing the number of false
positives in our predictions. Alongside this, we provide the
pyDNase software package to interface with DNase-seq
data to run the Wellington algorithm and accelerate
development of further analysis methods for these data.
pyDNase and Wellington form a complete tool chain
that can be used to identify protein–DNA interactions
in any DNase-seq experiment performed according to
the ‘double-hit’ protocol (16). Finally, we compared
the performance of the different footprinting methods
on a single data set, which we hope will be useful to the
community in their decision of how to approach DGF
tasks.
MATERIALS AND METHODS
Data
Aligned double-hit DNase-seq data and genomic co-ordin-
ates of DHSs (K562: wgEncodeUwDgfK562, HepG2:
wgEncodeUwDgfHepg2, A549: wgEncodeUwDgfA549,
SkMC: wgEncodeUwDgfSkmcAln) and PhyloP conserva-
tion (Vertebrate phyloP46way) scores were downloaded
from the UCSC genome browser (17). K562 data corres-
ponding to the original single-hit DNase-seq library prep-
aration method (9) were downloaded from the Sequence
Read Archive (accession SRS131306) and aligned to hg19
using bowtie 1.0.0 (18) with the command line parameters
‘-a -best -strata -v 2 -m 1’. ChIP-seq data were downloaded
as peaks from the ENCODE project’s ChIP-seq studies
(19); for track names, see Supplementary Table S1.
The Wellington algorithm
To detect protein–DNA binding sites, we must
characterise the activity of DNase I and define what we
consider to be a footprint. It is known that the activity of
DNase I is lower in regions of inaccessible chromatin
owing to protection of cleavage by histones or protein–
DNA interactions. DNase I activity is therefore higher in
regions of open chromatin without a bound protein.
Protein–DNA binding sites can be detected by searching
for a characteristic depletion of DNase I cuts compared
with a large number of cuts in the surrounding region of
open chromatin that do not harbour bound proteins.
To formalise our hypothesis test, we use the notation
introduced in Figure 1. We will call the region surround-
ing the possible footprint the shoulder region. Let lFP be
the length (in base pairs) of the possible footprint and lSH
be the length (in base pairs) of the shoulder on each side of
the possible footprint. We consider counts of cuts in these
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regions where ‘cuts’ refers to 50 ends of the aligned
sequencing tags. We consider four cut counts: the total
number of cuts on the forward reference strand inside
the possible footprint (FP+), the cut count in the
upstream shoulder region on the forward reference
strand (SH+), the cut count on the backward reference
strand inside the possible footprint (FP") and the cut
count in the downstream shoulder region on the
backward reference strand (SH").
We now test the null hypothesis that the number of
reads is proportional to the region length by using
a binomial test. As the number of reads can depend on
the strand, e.g. because the protein structure might be such
that it only inhibits DNase I activity on one strand, we test
both strands separately. We consider these tests to be in-
dependent, as each !200 bp fragment will at most produce
either one forward or one backward read close to the
footprint site under investigation. With F(k, n, p) being
the binomial cumulative distribution function, i.e. the
probability of achieving at least k out of n successes
with the probability of each success being p, we calculate
a p-value using the formula p-value={1-F[FP+,
FP++SH+, lFP/(lFP+lSH)]} # {1-F[FP", FP"+SH", lFP/
(lFP+lSH)]}. This p-value is for a given possible foot-
print of length lFP with surrounding shoulder regions of
length lSH.
We can calculate p-values for different possible foot-
print and shoulder lengths lFP and lSH. We can then
choose which regions we wish to consider footprints by
selecting an appropriate threshold for the p-values and
subsequently using a greedy selection strategy for foot-
print identification. The parameters lFP and lSH are indi-
vidually determined for each footprint using maximum
likelihood estimation. The default values for lFP are
bound between 11 and 26 base pairs, whereas lSH is
fixed at 35 base pairs. Both of these parameters can be
user-settable at run time with either ranges or fixed
values. Further details are provided in the supplementary
material.
Validation of predicted binding sites
We downloaded peaks determined by ENCODE’s peak
calling algorithm (specifically, ENCODE’s ‘optimal’,
high confidence set of peaks) for ChIP-seq experiments
corresponding to a range of TFs. ChIP-seq confirmed
binding sites were defined as motif instances falling
within these peaks for each TF, and unbound motif
locations were defined as motif instances falling outside
ChIP-seq peaks.
To calculate ChIP-seq recapitulation, we used
Wellington to calculate footprint p-values for each base
pair in all DHSs and compared footprints with ChIP-seq
positive motif instances. A ChIP-seq confirmed binding site
is said to be successfully recapitulated by DNase-seq data if
either at least 70% of the footprint is contained within the
binding site or vice versa. This criterion is necessary as
protection from DNase I is not always centred perfectly
on a DNA motif. The same method was used when
analysing Hesselberth et al. (12) footprints, Neph et al.
(7) footprints and DHSs.
Average conservation scores were calculated using
Vertebrate phyloP46way, and motif content was calcu-
lated using the genomic locations of 214 curated ChIP-
seq verified position weight matrices published as part of
the HOMER suite (20). For full details, see supplementary
material.
RESULTS
Strand imbalance information increases the predictive
power of footprinting algorithms
Strand-specific information in the context of DNase-seq
data has been used primarily to describe TF-specific
Figure 1. Wellington: a novel strand sensitive algorithm for the identification of protein–DNA binding sites from DNase-seq data. (A) The
Wellington algorithm calculates p-values for every base pair in all DNase hypersensitive sites in a given DNase-seq data set, where the s-value is
assigned to the base pair at the centre of the footprint. For each base pair, Wellington tests the hypothesis that there are significantly more reads
aligning to the forward reference strand in the upstream shoulder region (SH+) with respect to the+ve strand footprint region (FP+) and significantly
more reads aligning to the reverse reference strand in the downstream shoulder region (SH–) with respect to the "ve strand footprint region (FP–).
(B) Example output of the Wellington algorithm. The corresponding footprint prediction recapitulates the ChIP-seq confirmed CTCF-binding site.
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cleavage patterns in reference to the orientation of a
known DNA motif (13,14). Previous efforts at predicting
DGFs have been strand-agnostic, ignoring alignment
strand information and considering DNase I cleavage
activity as absolute, without regard to the orientation of
the sequenced fragment relative to the cut site. However, if
one considers that the DNA fragments generated by
DNase cutting are likely to originate predominantly
from within DHSs, with a high probability of spanning
occupied binding sites, then the strand to which the
sequence tags align is likely to be highly informative
with regard to the relative position of TFBSs. This is
because the upstream end of a DHS fragment will be
aligned as a+ve strand sequence tag, whereas the down-
stream end will be aligned as a "ve strand sequence tag, as
illustrated in Supplementary Figure S3. Hence, for DNA
fragments that span DHSs, and encompass DNase I foot-
prints, the DNase I cuts identified from+ve strand align-
ments will be concentrated to the left, and those from "ve
strand alignments will be concentrated to the right.
Chromatin structure influences the digestion pattern, as
there is a lower probability of sequencing DNA fragments
that extend away from the DHS. This is caused by the fact
that these fragments will be of lower abundance due to
the lower probability of generating a second DNase I
cleavage within flanking regions occupied by nucleosomes.
Such fragments will thus likely be discarded during the ne-
cessary process of size selection before or during library
preparation.
We tested the aforementioned predictions by consider-
ing the alignment strand when visualising DNase I
cleavage sites in the vicinity of known motifs using pub-
lished DNase-seq data at ChIP-seq verified binding sites
from K562 cells that are available from ENCODE
(Figure 2A and B). Similar to the imbalance of sequencing
reads observed in ChIP-seq and DHS mapping (21), we
noted that DNase-seq data surrounding binding sites
often exhibit an abundance of sequencing reads aligning
to the+ve reference strand upstream of the binding site,
and reads aligning to the "ve reference strand down-
stream of the binding site, consistent with these tags
representing opposite ends of DNA fragments spanning
protected regions. This was particularly evident when
DNase I cuts at binding motifs for specific factors across
the genome were collapsed into a heat map (Figure 2B).
When investigating a diverse set of TFs, we noticed that
the imbalance varies in strength, with some binding sites
having diminished strand imbalance, and others showing
almost none. However, we never observe a ‘reverse’ im-
balance of sequencing reads aligning to the "ve reference
strand upstream of the binding site, and reads aligning to
the +ve reference strand downstream of the binding site
(Supplementary Figure S4). Although this imbalance is
prominent in the data generated using the newer double-
hit protocol used for all recent ENCODE DNase-seq data,
the pattern is less pronounced in older data generated by
the single-hit DNase-seq library preparation protocol (9)
(Supplementary Figure S5).
It is also evident that more DNase I cut sites are
detected immediately adjacent to the DNase I footprints,
perhaps because the non-protected regions of a DHS are
cleaved multiple times, with the smaller fragments being
lost from the analysis. Overall, the number of reads
aligning to the positive and negative strands in each
DHS is roughly equal (Supplementary Figure S1) and so
does not account for this imbalance. For some but not
all motifs, additional information can be gained by re-
orienting the DNase-seq data according to the orientation
of the specific motif (Supplementary Figure S6). In the
case of CTCF, a region of DNase I hypersensitivity
exists on the "ve strand in a region that separates the
major CTCF consensus motif from a secondary CTCF-
binding site reported by others (13,22,23) When the
motifs are aligned in the same orientation, this second
site appears as a separate distinct protected region in
Supplementary Figure S6. Here, we also show that CTCF
motif scores are inversely correlated with Footprint
Occupancy Scores, revealing that poorer motifs are less
likely to generate clear footprints, as they are more suscep-
tible to DNase I cleavage within the binding sites.
To assess whether the consideration of strand imbalance
in DNase-seq data surrounding protein–DNA binding
sites has an equally significant impact on the accuracy of
DGF, we developed Wellington, a novel algorithm that
performs DGF on DNase-seq data without the need for
any prior knowledge, such as position weight matrices for
the motifs that are likely to be annotated as a footprint.
Wellington makes use of the sequence tag strand imbal-
ance and searches DHSs for footprints that have a statis-
tical enrichment of reads aligning to the +ve and "ve
reference strand upstream and downstream of the
binding site, respectively, with a depletion of reads on
both strands in the region of the binding site. Figure 1
shows an example of such a footprint at a binding site
for the TF CTCF containing a CTCF binding motif in
the K562 data. This example demonstrates that
Wellington footprints can accurately recapitulate the
presence of a bound protein at a known TFBS.
To ensure that we were not missing genuine protein–
DNA binding sites by excluding footprints that exhibited
strand imbalance in the opposite direction, we again
applied the Wellington algorithm to the ENCODE K562
DNase-seq data, but simultaneously applied it in a
‘reverse’ mode. This detected features exhibiting strand
imbalance in the opposite direction to that which we
demonstrated in Figure 2, (i.e. reads aligning to the "ve
reference strand upstream of the binding site, and reads
aligning to the +ve reference strand downstream of the
binding site). Using the reverse Wellington method, we
made footprinting predictions and compared them with
those made by Wellington at the same p-value threshold
of 1$ 10"30 (Figure 3A). All footprints identified possess
the typical depletion in DNase I signal at the centre of the
footprint (Figure 3B and D). As it is known that sequence
conservation is correlated with the strength of TF binding
(5,7,12–14), we investigated PhyloP (24) conservation
scores surrounding footprints identified by both
Wellington and reverse Wellington. We discovered that
footprints only identified by Wellington showed an enrich-
ment in sequence conservation at the centre of the
footprint. This also held true for the footprints identified
by both algorithms (due to there being sufficient reads on
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both strands for both methods to detect a footprint).
However, ‘reverse footprints’ identified by reverse
Wellington only, did not show any evidence of enrichment
in conservation score (Figure 3C), suggesting they are
artefacts. To exclude the possibility that this result was
only associated with the specific significance threshold
chosen, we ran this analysis over a range of significance
thresholds, but the main outcome of the analysis did not
change (Figure 3E). Another indicator of the quality of
footprint predictions, motif content (7,12–14), was also
investigated. We found that motifs were enriched at the
centre of footprint predictions (Supplementary Figure S7)
and that over a range of significance thresholds, the
pattern in the average motif content was the same as the
average conservation score, with Wellington outperform-
ing reverse Wellington (Figure 3F). Based on the fact that
‘reverse footprints’ with reverse strand imbalance patterns
had very low motif content and very low average conser-
vation scores, we consider these to be largely false posi-
tives. The majority of these are found adjacent to (5041,
54%), or in between (2734, 29%) footprints identified by
Wellington (Supplementary Figure S8), with the minority
(1607, 17%) having no neighbouring footprint within
50 bp. This indicates that these false positives are ‘ghost’
sites identified between or next to the shoulder regions of
true footprints. To a strand-agnostic algorithm, these will
appear to be depletions in DNase I activity associated with
protein–DNA binding events. It is only by considering the
strand information that it becomes possible to identify and
discard them as artefacts in the data.
We next visualised footprints identified by Wellington
at regions with known protein–DNA interactions that
have previously been characterised by manual footprint-
ing approaches, including the FMR1 promoter (25), the
IL-3 gene+4.9 kb CTCF site (26) and the b-globin LCR
HS2 DHS (27). Figure 4 and Supplementary Figure S7
demonstrate the high precision with which Wellington
infers regions of protein–DNA interaction.
Wellington is highly accurate at inferring protein–DNA
interactions from DNase-seq data
To further assess the performance of the Wellington algo-
rithm at identifying protein–DNA interactions compared
with other methods, we used a range of different valid-
ation techniques, again using DNase-seq, footprinting and
ChIP-seq data published by ENCODE. We also con-
sidered an implementation of Wellington that ignores
strand information in the data, ‘Wellington 1D’ (see sup-
plementary material for details), to assess the impact of
the strand information on footprinting performance inde-
pendently of the footprinting method. In the first instance,
we compared our footprinting predictions for the K562
Figure 2. DNase I cleavage patterns surrounding known protein–DNA interactions as identified by ChIP-seq exhibit a strand imbalance, regardless
of the strand where the binding motif is located. (A) Individual representative regions of DNase-seq data flanking NRF1, Sp1 and CTCF binding
sites illustrate large numbers of sequencing fragments aligning to the positive reference strand upstream of the protein–DNA binding site and to the
negative reference strand downstream of the protein–DNA binding site. These patterns exist independent of the direction in which the binding motif
is located. (B) Heat maps show that the DNase-seq strand imbalance surrounding NRF1, Sp1 and CTCF binding sites identified by ChIP-seq exists
on a genomic scale relative to the reference strand, irrespective of motif orientation (heat maps relative to motif orientation are shown in
Supplementary Figure S4). Red indicates an excess of positive strand cuts over negative strand cuts per nucleotide position, and green indicates
an excess of negative strand cuts. Binding sites are sorted from top to bottom in order of decreasing Footprint Occupancy Score (7).
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Figure 3. Strand imbalance information is crucial for the identification of true protein–DNA interactions. (A) The Wellington algorithm was run on
K562 DNase-seq data in parallel with a modified version of the Wellington algorithm (reverse Wellington) designed to identify strand imbalance in
the opposite direction than expected, i.e. reads aligning to the negative reference strand upstream of the binding site, and reads aligning to the
positive reference strand downstream of the binding site. (B, C) Although footprints identified only by reverse Wellington harbour the characteristic
depletion of DNase I cleavage, we find that they do not exhibit the increase of conservation typical of known protein–DNA interactions (7,12–14).
(D) Heat maps of the DNase I signal surrounding the reverse Wellington footprints support the hypothesis that false-positive footprint signals
primarily arise from junctions in between adjacent protein–DNA binding sites. (E) The observation of low conservation scores of footprints detected
by reverse Wellington is maintained when comparing Wellington and reverse Wellington footprints at a range of significance levels. (F) Footprints
detected by reverse Wellington contain fewer TF-binding motifs.
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DNase-seq data with K562 ChIP-seq data for a range
of TFs (ATF3, c-Myc, CTCF, JunD, Max, NFE2,
NRF1, NRSF, PU.1, Sp1 and USF1). We investigated
the ChIP-seq recapitulation performance of our method
by searching for motifs within footprints using a range
of decreasing stringencies for the footprint p-value
(Figure 5A). Over all stringencies, Wellington performed
the best, meaning that the efficiency of Wellington at
recapitulating ChIP-seq data per base pair of prediction
was higher than that of other methods. For example, it
required approximately 60% fewer predictions compared
with Neph et al.’s footprint analysis to recapitulate an
equal amount of ChIP-seq data for these 11 TFs.
Although this analysis clearly showed the increased
coverage gained by Wellington, it did not take the
number of false positives or false negatives made by
these predictions into account. To address this, we
calculated the Average Nucleotide Performance
Coefficients (28) for the 11 ChIP-seq experiments as a
function of total genomic footprint predictions, which
revealed a consistently higher correlation between the
ChIP-seq confirmed binding sites and the Wellington foot-
prints across all sensitivities compared with other methods
(Figure 5B).
A validation method commonly used in classification
experiments, the Receiver Operator Characteristic
(ROC), assesses the performance of a binary classifier
over a range of significance thresholds (see supplemental
material for details). Wellington yielded an area under the
ROC curve higher than 0.80 in the ability to recapitulate
all 11 TFs in K562 cells (Figure 5C), indicating that
Wellington is an excellent predictor of TF binding (29).
ROC analysis was also performed on HepG2 and A549
DNase-seq data (Supplementary Figures S10 and S11),
yielding similar performance. Although this method has
been used in the validation of previous footprinting
methods, it should be noted that due to the relatively
small number of true positives (bound motif instances)
and large number of true negatives (unbound motif
instances) in the genome for most TFs (Supplementary
Table S1), this statistic is skewed towards assessing the
ability of an algorithm to correctly predict unbound
locations.
CENTIPEDE (14) is based on known binding motif
locations and learns one footprint model for each individ-
ual motif. It is therefore capable of using features of foot-
prints that are specific to one or few motifs. In contrast,
Wellington is a generic footprinting method for the detec-
tion of a wide range of binding sites. It does not depend on
previous knowledge of motifs and does not learn models
for individual motifs. We therefore considered the possi-
bility that CENTIPEDE might outperform Wellington.
However, we found that Wellington still outperformed
CENTIPEDE when comparing the Positive Predictive
Figure 4. Wellington footprints recapitulate known protein–DNA interactions at (A) the FMR1 promoter (25), (B) the IL3+4.9 kb insulator (26)
and (C) the b-globin HS2 hypersensitive site (27) and refine previous footprinting predictions at these loci (7).
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Figure 5. Wellington outperforms other methods with respect to ChIP-seq recapitulation performance, sequence conservation and motif content
within footprints. (A) Wellington is able to recapitulate a given amount of ChIP-seq data with approximately half the number of genomic predictions
compared with Neph et al. (7). The horizontal axis shows the total number of base pairs in the genome that are covered by footprints at a given
stringency, the vertical axis shows the average performance of these footprints in recapitulating binding sites found from ChIP-seq data for 11 TFs in
K562 cells. DHSs: using DNase hypersensitive sites to recapitulate ChIP-seq binding sites. (B) The nucleotide performance coefficients for these
predictions (28) take numbers of false positives and false negatives into account and show a consistent finding compared to (A). (C) ROC curves for
Wellington binding site predictions of 11 genomic TFs. The dashed line shows the expected performance of a random classifier. AUC: Area under
curve. (D) Using the NFE2 ChIP-seq data as an example, we illustrate that the positive predictive value (the proportion of binding site predictions
that are correct) of Wellington is either equal to or exceeding other footprinting techniques. (E, F) Wellington footprints have consistently the highest
PhyloP conservation scores and motif content.
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Value (the fraction of predicted binding sites that are con-
firmed in ChIP-seq data, PPV) as a function of the ChIP-
seq coverage (Figure 5D), implying that Wellington can be
specifically used for the purpose of determining in vivo
occupancy of a given motif. The method by Neph et al.
and Wellington performed comparably when the location
of a binding motif was known, but CENTIPEDE’s
Positive Predictive Value was lower at lower sensitivities.
Comparable results were observed for the other 10 TFs
(Supplementary Figure S9). However, it is worth noting
that when performing analyses that require the presence of
a motif in the footprint, a high number of motif-less foot-
prints are masked and unknown motifs are not found.
Moreover, the assumption that a given TF generates
a uniform digestion pattern limits the predictive power
of the algorithm, for example, it has been shown that
multiple clusters of DNase I cleavage patterns exist for
CTCF (13). In addition, the dynamic binding behaviour
of a specific TF can be modulated by interaction with
other factors binding within the DHS (30). The extent of
this has not yet been investigated, and other TFs could
also generate differing DNase I cleavage patterns depend-
ent on differing binding dynamics at individual sites across
the genome.
All of the aforementioned analyses rely on ChIP-seq
data as a gold standard, and therefore false positives in
ChIP-seq analyses can appear as false negatives in foot-
printing assays and vice versa. Other metrics that do not
rely on ChIP-seq data, such as conservation scores and
motif enrichment, which are also highly correlated with
TF binding and regulatory activity (31), can be used to
assess footprinting performance. We therefore calculated
the average PhyloP conservation score and the average
motif content of footprints across a range of thresholds
on footprint p-values. To calculate motif content, we used
a library of 214 ChIP-seq derived DNA motifs. Across all
sensitivities, Wellington footprints yielded higher conser-
vation scores and motif content per base pair (Figure 5E
and F) than other methods, further demonstrating
Wellington’s ability to identify footprints enriched for
regulatory elements with high conservation scores and
protein binding potential. This notion is exemplified in
Supplementary Figure S12, which depicts the DHS at
the FMR1 promoter demonstrating the precise overlap
of regions with high footprinting p-values and high con-
servation scores. The ability for Wellington to outperform
Wellington 1D in these metrics confirms that the consid-
eration of the strand information in DNase-seq data
assists in reducing the number of low conservation
scoring false-positive ‘reverse’ footprints in the genome
without affecting predictive power. When considering
data generated with the original single-hit protocol,
however, we found that Wellington did not improve
over Wellington 1D (Supplementary Figures S14–S16).
This is likely due to the fact that the single-hit data
have less pronounced strand imbalance patterns
(Supplementary Figure S5), which Wellington is specific-
ally designed to detect.
In summary, Wellington efficiently increases the speci-
ficity of footprint detection by avoiding artefacts, which
only become apparent when considering the
alignment strand of DNase I cuts in DNase-seq data
(Supplementary Figure S13). It therefore maintains excel-
lent ChIP-seq recapitulation performance whilst signifi-
cantly reducing the total number of predicted footprints
in the genome.
pyDNase: a Python package for analysing DNase-seq
data
At present, no free open source software package is avail-
able that would allow the analysis of DNase-seq data with
the aim of performing digital footprinting without specify-
ing any prior parameters, such as motif of interest. DGF
presents unique challenges in data handling due to the
large (>500 million) number of reads, and the necessity
to interact directly with raw alignment data to perform
complex analyses. With ChIP-seq, this step is unnecessary
after basic peak calling and generation of extended read
densities. We therefore developed pyDNase as the first
open source DNase-seq analysis software package.
pyDNase complements other common bioinformatics
tools to establish the first functional DNase-seq footprint-
ing pipeline. It is written in Python for higher-level func-
tions and C for lower-level performance-critical functions.
The analysis pipeline using pyDNase is outlined in
Figure 6, whereby pyDNase serves a conduit between
the raw alignment data and DNase-seq analysis algorithms
such as Wellington. The most basic usage, a footprinting
analysis with the default parameters can be performed by
running the wellington_footprints.py script with
the sequencing reads in BAM format, a list of DHSs in
the data set, and an output location for the results (e.g.
$ python Footprint.py reads.bam dhs.bed !/
results/), which will then output the footprint scores
as a wig file, and footprints at various p-value cutoffs.
The behaviour of this script is highly configurable
through command line arguments. pyDNase allows
Wellington footprinting of all DHSs in a 600 million read
DNase-seq experiment in !4 –10h on a desktop computer
with 1Gb of RAM and a 2.3GHz Intel Core i5 processor.
This will simplify and expedite data analyses as well as
method development for future studies. pyDNase and the
Wellington algorithm are available as a Python package,
along with sample data sets, a step-by-step tutorial, and
documentation of every method and class at http://jpiper.
github.com/pyDNase and is freely released under the GNU
GPLv3 open source software license.
DISCUSSION
By designing the Wellington algorithm to identify foot-
prints using the knowledge that strand imbalance
surrounds known protein–DNA interactions, we have
increased our ability to perform DGF by reducing the
number of motif-depleted non-conserved false positives.
Footprints identified by Wellington show consistently
higher average conservation scores, motif content and
ChIP-seq recapitulation per base pair than other methods.
Considering that the ChIP-seq recapitulation performance
was the justification behind the previous claim of 0.4 to 2.3
million genomic footprints (dependent on the cell type) (7),
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Figure 6. The pyDNase Python package forms a complete toolchain for the rapid analysis and footprinting of DNase-seq data. Using mapped
DNase-seq reads as a BAM file, pyDNase not only has scripts to perform common analyses (heat maps, footprinting, average profiles) but also
exposes an API to allow the easy development of further DNase-seq analysis tools.
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the results presented here suggest that much less of the
genome may be involved in protein-binding events than
previously predicted. Wellington required approximately
60% fewer predictions compared with Neph et al.’s foot-
print analysis to recapitulate an equal amount of ChIP-seq
data for 11 TFs. This is due to the large number of motif-
less false positives in the Neph et al. set of predictions that
do not impact on the chosen validation metrics. However, it
remains difficult to determine exactly how many binding
sites there may actually be as human DGF is still limited
by sequencing depth (7) (Supplementary Figure S2).
We hypothesise that the strand imbalance is a natural
consequence of the size selection step of the ‘double-hit’
protocol, which purifies !50–200 base pair DNA frag-
ments produced by DNase I digestion (Supplementary
Figure S3). This is strengthened by the result that consid-
eration of strand information does not contribute any
predictive power to data generated by the single-hit
DNase-seq method, which does not use size selection in
the library preparation (9) and has detectable but less
pronounced strand imbalance patterns (Supplementary
Figures S5, S14–S16). In the double-hit protocol,
eliminating the smallest digestion products and excluding
larger chromatin fragments creates a bias towards
sequencing DNA fragments that actually span the
DNase I footprints where TFs are bound. Because
the +ve and "ve strand sequence tags simply represent
the opposite ends of the same sets of DNA fragments,
this is a straightforward predictor of the location of a
footprint relative to the 50 end of the sequence tag.
Giving due consideration to the introduction of strand
imbalance surrounding sites protected by protein–DNA
interactions in the double-hit DNase-seq data allows the
development of analyses that reduce the number of false
positives in footprint predictions.
This increased footprinting precision as well as the
ability of Wellington to be used on a priori defined
motifs opens the door to higher-order analyses, such as
de novo identification of occupied cis-regulatory modules,
as well as the elucidation of direct or indirect TF inter-
action in a given complex via determination of specific
motif distances. Furthermore, the strand-specific cleavage
patterns surrounding motifs bound by different TF
families seemingly constitute unique, individual signa-
tures, which may permit motif identification based solely
on DNase-seq data.
The identification of TFBSs bound in a cell-type and
cell-stage specific fashion is a key stage in gaining an
understanding of differential gene expression underlying
all cell differentiation processes. Using techniques such as
DNase-seq, ChIP-seq, and algorithms such as Wellington,
we can begin to document the TF-binding events that
confer cell identity, developmental processes or which
underpin aberrant regulation in diseases such as cancer.
By significantly reducing the number of false-positive pre-
dictions, we decrease the need for multiple technical and
biological replicates, which can be difficult to obtain for
primary tissues such as patient samples. This opens up the
possibility of performing analyses on disease-specific tran-
scription regulation mechanisms, which have previously
only been possible using data combined from multiple ex-
periments over large numbers of cell lines (7,13).
It remains to be seen how footprinting algorithms can
be further enhanced. Even though it is known that the
pattern of the DNase-seq signal surrounding protein–
DNA binding events is TF dependent, we found
Wellington to perform well using a single model to
search for all possible TF-binding events in a DNase-seq
data set. The use of more complex mixture models could
yield even better performance, which at some stage may
even allow the incorporation of an analysis of the chro-
matin landscape. The speed at which new computational
analyses of DNase-seq data are being developed is greatly
surpassed by the rate at which new DNase-seq data are
being generated (32). To encourage further investigations,
we have released pyDNase and Wellington as a Python
package for the fast and easy analysis of DNase-seq data.
We hope that accelerates both the analysis of DNase-seq
data and the development of advanced footprinting
algorithms.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online,
including [33].
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1 Development of the Wellington Algorithm
1.1 Goals and underlying assumptions
The goal of Wellington is to statistically identify footprints from DNase I cut
data. We define a footprint as a region where the number of DNase I cuts per
base pair is significantly lower than in the surrounding area. Specifically, we
compare the number of DNase I cuts per base pair inside the possible footprint
region on the forward reference strand with cuts per base pair the upstream
region on the forward reference strand and the number of DNase I cuts per base
pair inside the possible footprint region on the backward reference strand with
cuts per base pair the downstream region on the backward reference strand.
As stated in the Methods, we assume that the number of DNase I cuts is
much lower (depleted) in regions of closed chromatin or of open chromatin with
a bound protein than in regions of open chromatin without a bound protein,
which is well established by the literature (Sabo et al., 2006; Boyle et al., 2008;
Hesselberth et al., 2009; Cockerill, 2011; Neph et al., 2012). Thus, protein-DNA
binding sites can be detected by finding a characteristic depletion of DNase I
cuts compared to the surrounding region of open chromatin without bound
proteins. Furthermore, we assume that the number of DNase I cuts in open
chromatin without bound proteins is roughly proportional to the length of the
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region. Thus, we can test if a region has a significantly lower than expected
number of cuts to identify footprints or putative protein-DNA binding sites.
1.2 Rationale
It has been previously established that DNase I cuts are not distributed uni-
formly across the open chromatin, but that the probability is dependent on
the DNA sequence around and at the cleavage site. This problem could theo-
retically be compensated by appropriate pre-processing, such as adjusting the
observed number of reads by the DNase I cutting rates for the surrounding
base doublet (Koohy et al., 2013). However, in practice, we and others have
found that diﬀerences in cutting preferences are suﬃciently small to not have
an undue impact on the footprint identification. The diﬀerence in DNase I
accessibility within and outside DHS in chromatin by far exceeds sequence
dependent diﬀerences in the digestion frequency of naked DNA (Neph et al.,
2012; Hesselberth et al., 2009).
Due to the methodology employed, DNase-seq typically only includes DNA
fragments of a certain size range. Any fragments smaller than about 50bp
or larger than about 250bp are discarded. Thus, DNase I needs to cut the
DNA twice in reasonably close proximity for the fragment to be included in
the analysis. This means that regions with multiple bound proteins in close
proximity to each other or regions with bound proteins close to nucleosomal
chromatin might be hard to identify. In order to avoid this problem as much
as possible, we only consider cuts arising from fragments that span across the
footprint site, i.e. those upstream of the footprint site on the forward strand
and those downstream of the possible footprint site on the reverse strand. In
principle, other bound proteins very close to the possible footprint site might
still be a problem even with this step. However, this was not observed in
practice.
The DNA fragment may be further shortened by additional DNase I cuts.
This means that we typically expect to observe more shorter DNA fragments
than longer DNA fragments. This can lead to an increased number of cuts
just outside of footprints upstream on the forward strand and downstream
on the reverse strand. Wellington currently does not explicitly utilise this
phenomenon, as we did not observe it for all footprints.
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1.3 Data preprocessing
Diﬀerent DNase-seq techniques can produce sequencing artefacts, e.g. in the
form of read spikes at single base pairs. If possible, appropriate preprocess-
ing should be used in order to reduce the impact of sequencing artefacts and
other undesirable phenomena mentioned above. Which preprocessing method
is appropriate depends on the precise experimental method. Some authors have
suggested to allow a maximum number of reads per base pair to reduce the im-
pact of spikes. Whilst the provided software implementation of the Wellington
algorithm oﬀers this feature, we do not generally recommend it, as a lot of data
may be needlessly discarded.. Rather, we encourage researchers either to iden-
tify and remove sequencing artefacts manually or to choose a suﬃciently high
p-value cutoﬀ and to check for problems by shuﬄing the data and searching for
footprints again (see below). Usually, the forward and the reverse strands will
have a similar number of cuts (Figure S1). Thus, finding many more cuts on
one strand than on the other in a region can be an indicator that a sequencing
artefact may be present.
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Figure S1: The numbers of cuts observed on the positive and on the negative strand
are of the same order of magnitude. Within each hypersensitive region
in K562 cells, the ratio of cuts on the positive strand to the total number
of cuts has a mean of 0.50 and a standard deviation of 0.10.
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1.4 Calculating a p-value for a given potential footprint
As described in the Methods, we use the following notation introduced in
Figure 1. We call the region surrounding the possible footprint the shoulder
region. Let lFP be the length of the possible footprint and lSH be the length
of the shoulder on each side of the possible footprint. For now, consider lFP ,
lSH , and the centre of the potential footprint as given. We can then calculate
the four DNase I cut counts that are relevant for the hypothesis test: the
total number (i.e. sum over all base pairs) of cuts on the forward reference
strand inside the possible footprint (FP+), the number of cuts in the upstream
shoulder region on the forward reference strand (SH+), the number of cuts on
the backward reference strand inside the possible footprint (FP−), and the
number of cuts in the downstream shoulder region on the backward reference
strand (SH−).
We test the null hypothesis that the number of cuts is proportional to the
region length by using a binomial test. Because the number of cuts might
depend on the strand, e.g. because the protein structure might be such that it
only inhibits DNase I activity on one strand, we test both strands separately.
With F (k, n, p) being the binomial cumulative distribution function (the prob-
ability of achieving at least k out of n successes for the probability of each
success being p), we calculate a p-value using the formula
p−value = F (FP+, FP++SH+, lFP
lFP + lSH
)∗F (FP−, FP−+SH−, lFP
lFP + lSH
)
This p-value is for a given possible footprint of size lFP with surrounding
shoulder regions of size lSH .
1.5 A strand agnostic Wellington
In order to investigate the impact of the strand information of Footprinting
results independently of footprinting methodology, we utilised a simplified ver-
sion of Wellington which uses data on both strands, Wellington 1D. We calcu-
late parameters in the model diﬀerently than above to account for this. Let the
total number of cuts on both strands inside the possible footprint (FP ), the
number of cuts in the upstream shoulder region on the both strands (SHu),
and the number of cuts in the downstream shoulder region on both strands
(SHd). We then calculate a p-value using the formula
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p− value = F (FP, FP + SHd + SHu, lFP
lFP + lSH
)
1.6 Selecting footprint and shoulder widths at a given
position
For a given centre position of a possible footprint, we can vary both the length
of the possible footprint lFP and the length of the shoulder lSH . This results
in a multitude of hypothesis tests, all of which may have diﬀerent p-values.
Typically, the researcher will specify a range of possible values for lFP and
lSH that are appropriate. If no hypothesis tests are significant at the chosen
significance threshold, there is clearly no evidence for this site being a footprint.
If only one hypothesis test is significant at the chosen significance threshold,
we consider this a footprint of length lFP belonging to the significant test.
Matters get slightly more complicated if more than one test is significant.
If more than one test is significant, we have successfully rejected multi-
ple slightly diﬀerent hypotheses. For practical purposes, we wish to have a
set footprint length lFP and shoulder length lSH instead of multiple possible
values. To achieve this, we choose the lFP and lSH that provide the most
evidence against the null hypothesis and result in the lowest p-value. From
a Bayesian perspective, this corresponds to putting a uniform prior over the
previously specified ranges of possible lFP and lSH . It is straightforward to
extend Wellington to allow arbitrary priors for lFP and lSH .
1.7 Greedy selection of footprints from all possible can-
didates
The previous section produced one p-value for each possible footprint centre
base pair along with corresponding footprint widths. If we only have one
significant p-value in a region, the corresponding possible footprint will be
considered our one true footprint. Multiple significant p-values in a region
may result in overlapping footprints and a decision has to be made how to deal
with this phenomenon.
While overlapping footprints can occur and we wish to allow this, we also
want to avoid artificially extending footprints simply for the reason that base
pairs slightly away from the centre of a protein binding site will often still suc-
ceed in rejecting the null hypothesis. Thus, we wish to require two overlapping
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footprints to overlap for less than a certain user-settable percentage, which
defaults to 50%. This requirement in no way restricts what footprint patterns
are possible. Lifting this requirement results in noticeably larger footprints,
which are often somewhat longer than the desired maximum length for a single
footprint.
To achieve this goal, we implement a greedy selection strategy. For a given
region, we start by choosing the footprint with the lowest p-value as our first
footprint, as this footprint oﬀers the strongest evidence against the null hy-
pothesis. After we have added this footprint to our list of identified footprints,
we then consider any base pairs contained in this footprint not to be eligible to
be the centre of additional footprints. For the next footprint, we continue in
the same fashion by choosing the footprint with the lowest p-value, adding it
to our list, and removing all base pairs contained in it from the list of possible
footprint centres. This process continues until no eligible base pairs remain
with a p-value below the significance threshold.
1.8 Choosing a significance threshold and assessing pos-
sible false positives
To choose a significance threshold, the fact that possibly billions of hypothesis
tests are performed needs to be considered. We decide to err on the side of
caution and perform a Bonferroni correction. To make the multiple testing
correction as simple as possible for the end user, we adjust all p-values in-
stead of just adjusting the significance threshold internally. More advanced
methods, such as a Bonferroni-Holm correction, are not used for the sake of
computational simplicity.
As, even with excellent preprocessing, the cut counts in open chromatin re-
gions without bound proteins will be neither uniformly nor independently dis-
tributed, we typically recommend being more conservative than the standard
p < 0.05 threshold (corresponding to 1.3 on the − log scale). For ENCODE
datasets, we found that thresholds of 1.3 − 20 work very well, depending on
the desired number of false positives.
Ultimately, when applying this method to a dataset, we wish to adjust
the p-value threshold we choose for calling footprints on a hypersensitive site-
wise basis to generate a single set of footprints for the dataset (and not set a
single p-value cutoﬀ for the entire dataset). In order to do this, Wellington
has a command line argument to employ an empirical method of estimating
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the False Discovery Rate (FDR) as described previously (Neph et al., 2012;
Hesselberth et al., 2009). Briefly, we shuﬄe the number of tags aligned to each
base pair within a hypersensitive site and recalculate the footprint scores on
this shuﬄed data 500 times, and then can determine a p-value threshold which
would only occur at most 1 in 100 times, corresponding to an FDR of 0.01.
1.9 Sequencing Depth
The number of footprints called will largely be determined by the sequenc-
ing depth of the dataset. A common question from experimentalists remains
‘How deep do I need to sequence my DNase-seq samples to perform digital
footprinting?’. In order to assess the aﬀect of sequencing depth on footprint
detection, using the ENCODE SkMC DNase-seq dataset (owing to its large
550 million read depth), we randomly subsampled reads to simulate the eﬀect
of diﬀering read depths. We then ran Wellington on these data, utilising an
FDR of 0.01 to select footprints at the varying read depths. In line with the
subsampling eﬀorts performed by ENCODE (Neph et al., 2012); footprint de-
tection of human DNase-seq data by these methods are currently limited by
the number of sequencing reads, with a positive correlation between sequencing
depth and number of footprints detected (Figure S2). The current answer to
this question, is therefore ‘as much as possible’, as we have not yet reached a
point where contributing more sequencing depth does not increase the number
of footprints detected.
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Figure S2: The number of footprints identified by Wellington in the SkMC DNase-
seq dataset is positively correlated with sequencing depth. DNase-seq
data were randomly subsampled in order to simulate diﬀerent read depths
of a single DNase-seq library, and the Wellington algorithm was used to
identify footprints (FDR: 0.01).
1.10 Interpretation of the footprinting results
As mentioned before, note that p-values only give an indication of the strength
of evidence against the null hypothesis, but do not provide a measure of foot-
print quality or strength. Further note that footprinting results depend on
both the choice of significance threshold and possible values for lFP and lSH .
We recommend trying Wellington with diﬀerent parameters and observing how
the choices influence the footprinting results as, in some situations, changing
these can cause individual footprints to change their length or move by several
base pairs. Therefore, when interpreting the footprinting results we need to be
mindful of not to over-interpret minor diﬀerences in the p-values. In particu-
lar, when comparing footprints to known motifs, we recommend not requiring
a 100% overlap between footprints and motifs, but some tolerance. As always,
sensitivity analyses should be performed to see how any inferences made from
the result depend on choices made.
1.11 Options to increase computational eﬃciency
There are several options to reduce computation time. The biggest gains can
be achieved by restricting the search for footprints to regions of interest, such
as DNase I hypersensitive sites (DHS). It has been established in the literature
46
that the vast majority of protein binding sites are in these regions (Cockerill,
2011). The pyDNase package can incorporate DHS coordinate information
and restrict the footprint search to these regions without needing to load data
from other parts of the genome. We have compared the footprinting results for
ENCODE datasets for the whole genome and for DHS only and the diﬀerences
in the results were small (data not shown). cl Computation time can also
be reduced by reducing the number of possible values for lFP and lSH . For
ENCODE datasets, we have found that restricting these to multiples of two
does not significantly change the results.
The pyDNase package oﬀer additional options which change how the al-
gorithm processes data to accommodate certain computer setups (e.g. low
amounts of RAM), but does not alter the algorithm nor impact the results.
These are explained in the documentation provided with the package.
1.12 Alignability of the genome
We note that previous methods have included the consideration of the alignabil-
ity of the target genome in their model (Hesselberth et al., 2009), whilst others
do not (Pique-Regi et al., 2011; Boyle et al., 2011). In particular, a short un-
alignable region in between two alignable regions might be falsely identified as
a footprint if the mappability of the genome is not taken into consideration.
We initially allowed for mappability correction using a previous method (Hes-
selberth et al., 2009) but the results did not yield an increase in performance
and increased compute time by a factor of 5-10x, extending analysis times
to several days. The negligible diﬀerence in performance was because this
hypothetical situation of short, unalignable regions in the genome is not par-
ticularly common, especially as read length increases beyond 36bp. Based on
this, we decided in our final model that mappability would not be considered.
We recommend that anyone wishing to perform mappability correction filters
footprints that are in unmappable regions using their criterion of choice after
footprint detection. This method has been utilized previously (Neph et al.,
2012), who note that less than 1% of their footprints satisfy this criterion.
1.13 Possible extensions to the Wellington method
The Wellington method can be easily extended in several directions. The cur-
rent binomial hypothesis test can be changed to a more complex null hypothe-
sis that takes sequencing artefacts (spikes) in the data into account. Priors on
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footprint lengths or even fully Bayesian approaches can easily be implemented
by simply changing how the p-values are calculated. Additional preprocess-
ing methods can also easily be added, e.g. to allow taking DNase I cutting
preferences into account.
It remains to be seen how digital genomic footprinting can be used to
compare multiple datasets covering diﬀering states (e.g. healthy vs. diseased).
The presence of a DHS in two cell types does not mean that the same event
is occurring, as diﬀerent transcription factors could be binding in a context
sensitive manner. More detailed analyses into the diﬀerences in DNase cuts in
DHSs between datasets would give an insight into the occupancy of promoters
and enhancers by diﬀerent transcription factors in diﬀering states.
2 pyDNase
We noticed the need for a simple tool to handle DNase-seq data from a stan-
dard format, and to be able to access the data in a random order, as 90% of the
genome is not hypersensitive and therefore processing these regions increases
computational time and resources tenfold. pyDNase solves these problems
by providing a simple Python interface to access cut information stored in
the Binary Standard Alignment/Map (BAM) file format produced by popu-
lar mapping tools such as Bowtie and BWA and adopted by the ENCODE
consortium as the preferred alignment file format.
pyDNase capitalises on the recent introduction of the SAM format to ran-
domly access cut information in any region in the genome without the need
to load the entire dataset at once. By using peak detection software such as
FindPeaks, HOMER, Maq, HotSpots, etc to locate DNase Hypersensitive sites,
footprinting algorithms can be performed solely on regions of interest, speeding
up computational time dramatically.
Briefly, pyDNase uses a key-value array read cache which can be enabled or
disabled at run time. If enabled, when DNase-seq cut data are requested from a
genomic location for the first time, the surrounding 1000bp (configurable) will
be automatically stored in memory for subsequent access. A key-value array is
used as a sparse vector to store this data, as most sequences in the genome are
not hypersensitive (and therefore have a data value of 0) so the use of spare
data storage significantly reduces the memory footprint. Around 4GB of RAM
is required to cache all the information in Human DNase I hypersensitive sites
at once.
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Full documentation and description of the features can be found at
http://jpiper.github.com/pyDNase
3 Validation of Footprints
3.1 ChIP-seq data
We used ‘optimal’ ChIP-seq peaks downloaded directly from the EBI ENCODE
analysis FTP server. Names of the files along with summary statistics for each
ChIP-seq experiment can be found in Table S1.
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3.2 CENTIPEDE and ENCODE data preparation
All motif instances in the genome were located using HOMER, and DNase-
seq cuts were exported into the custom data format required by CENTIPEDE
using pyDNase. We verified that our implementation was working using the
example data and results provided by the authors. CENTIPEDE was then run
on each transcription factor. ENCODE (Neph et al., 2012) footprinting data
were downloaded from the EBI ENCODE analysis FTP server, and sorted ac-
cording to the score assigned to each footprint. Their footprints were extended
7bp in each direction as per their processing instructions. We found that when
this step is omitted, the ENCODE (Neph et al., 2012) footprints are often too
small to overlap motif instances and the performance drops drastically.
3.3 Definition of performance characteristics
In order to calculate the Receiver Operator Characteristic (ROC), we must
define a gold standard set of bound and unbound motifs using each ChIP-seq
experiment. Using ChIP-seq derived matrices provided as part of the HOMER
suite (Heinz et al., 2010), we searched the entire genome for known binding
motif instances. Motifs which were found inside ChIP-seq peaks were said to
be bound by its corresponding factor family, and motifs falling outside the
ChIP-peaks, were considered to be unbound by its corresponding factor.
We then calculated the footprint predictions over a range of p-value thresh-
olds for Wellington, the full range (0 to 0.95) of Footprint occupancy scores for
ENCODE (Neph et al., 2012), and full range (0 to 1) Log-odds probabilities
for CENTIPEDE, limiting our analyses to the DHSs provided by ENCODE.
Using the same set of motif locations outlined above, we then used the Welling-
ton footprints to split all genomic instances of the motifs into ‘Predicted to be
Bound’ or ‘Not Predicted to be Bound’, if either 70% of the motif was con-
tained within the footprint, or vice versa. Thus, we end up with the following
classifications for ROC analysis.
• True Positives (TPs): Motif instances falling within ChIP-seq peaks that
are correctly predicted as being bound by Wellington.
• True Negatives (TNs): Motif instances falling outside of ChIP-seq peaks
that are correctly predicted as being unbound by Wellington.
• False Positives (FPs): Motif instances falling outside of ChIP-seq peaks
that are incorrectly predicted as being bound by Wellington.
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• False Negatives (FNs): Motif instances falling within ChIP-seq peaks
that are incorrectly predicted as being unbound by Wellington.
This can either be measured on a site-wise basis, or base pair basis. In prac-
tice, we found little diﬀerence between the statistics in the results presented,
but used the per base pair prediction statistic.
3.4 Performance statistics
Performance statistics were calculated as follows.
• Positive Predictive Value (PPV): TP/(TP + FP )
• Sensitivity (Coverage): TP/(TP + FN)
• False Positive Rate (FPR): FP/(FP + TN)
• Performance Coeﬃcient (Tompa et al., 2005) (PPC): TP/(TP + FN +
FP )
3.5 Conservation and motif content
Conservation was calculated by summing the Vertebrate phyloP46way values
for each co-ordinate in a set of footprints, and then dividing by the number
of basepairs to yield the average conservation per bp. Motif content was cal-
culated by searching for motifs (using HOMER’s ChIP-seq derived matrices)
and then counting the number of basepairs in the predicted footprints that are
overlapped by a motif (multiple overlapping motifs at one base pair do not
increase the score), and then dividing by the number of basepairs to yield the
average motifs per bp. de novo motif searching was performed using HOMER
(Heinz et al., 2010).
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4 Supplemental Figures
DNase I cut sites 
sequence 
tags 
+ strand tag 
DNase I cuts 
FP FP 
- strand tag 
DNase I cuts 
Figure S3: Chromatin structure based modelling of strand-specific DNase-seq data
arising from DHSs. DHSs are usually 200-250 bp across, and the DNA
sub-fragments of DHSs detected by DNase-seq are typically in the order
of 50 to 150 bp in length and are surrounded by nucleosomal DNA.
As depicted above, most of these fragments are expected to originate
from within the DHS, meaning that they are likely span the regions
of DNA protected by bound factors (indicated as ovals) that give rise
to DNase I footprints (FPs). This means that it is the cut site that
must be used to identify FPs, and not the entire sequence tag as is used
in most peak detection algorithms. Furthermore, because sequence tags
represent just one end of these fragments, upper strand +ve sequence data
(red arrows) should represent sequences starting upstream of these FPs,
while lower strand –ve sequence data (green arrows) should represent
sequences starting downstream of FPs. The Wellington program has
taken advantage of the fact that this strand information can be used to
greatly increase the power of FP detection algorithms by making use of
both the precise position of the cut site, and the predicted orientation of
these cuts relative to a bound factor. As represented below the model,
when the sum of the DNase I cuts in a DHS is depicted it is immediately
apparent that FPs will generate a concentration of upstream +ve strand
tags and a concentration of –ve strand downstream tags.
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Figure S6: Heat maps show transcription factor specific DNase-seq cleavage pat-
terns surrounding verified NRF1, Sp1, and CTCF binding sites. Here
the data are oriented relative to motif strand which is indicated in the
upper panels. Red indicates an excess of positive strand (with respect
to motif strand) cuts over negative strand (with respect to motif strand)
cuts per nucleotide position, and green indicates an excess of negative
strand (with respect to motif strand) cuts. Binding sites are sorted from
top to bottom in order of decreasing Footprint Occupancy Score (Neph
et al., 2012). Note that alignment of the CTCF motifs in the same orien-
tation reveals an additional region corresponding to a secondary motif for
CTCF binding (resembling CTGCAG; (Bowers et al., 2009; Boyle et al.,
2011)) that is also protected. For CTCF, the HOMER motif scores are
presented as a moving average on the right, highlighting the fact that de-
creasing footprint scores equate with decreasing motif scores. Additional
sub-patterns of DNase I cleavage can also be seen within motifs with lower
occupancy scores, perhaps reflecting ineﬃcient binding of some specific
individual DNA-binding domains when bound to sub-optimal motifs.
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Figure S7: Motif content and motif location of Wellington and reverse Wellington
footprints. Heatmaps of motif locations surrounding footprints identi-
fied by Wellington and reverse Wellington demonstrates the depletion of
motifs at the centre of reverse Wellington footprints.
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Figure S8: The majority of the 9,382 false positive footprints identified only by Re-
verse Wellington are located adjacent to or inbetween footprints identified
by Wellington. (A) The distribution of Wellington footprints surround-
ing the 9,382 Reverse Wellington footprints, shown as the percentage
of nucleotides at this position surrounding a Reverse Wellington Foot-
print which are found in a Wellington Footprint. (B) Heat map of foot-
prints identified by Wellington centred on those only identified by Reverse
wellington.
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Figure S10: ROC analysis for 11 genomic transcription factor binding site predic-
tions by Wellington using data from HepG2 cells
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Figure S11: ROC analysis for 11 genomic transcription factor binding site predic-
tions by Wellington using data from A549 cells
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Figure S12: Footprints at the FMR1 promoter overlap with regions of high sequence
conservation and improve over basic DNase-seq peak calling. Whilst
phastcons conservation and DNA motifs overlap with known binding
sites in this region, without footprinting, motif content alone is unable
to predict bound locations. After applying the Wellington algorithm
to the 1kb DNase hypersensitive site covering the FMR1 promoter, we
produce footprints that align with the known protein-DNA interactions
in this region without any oﬀ-target hits.
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Figure S13: Footprints only identified by ENCODE (Neph et al., 2012) do not ex-
hibit typical asymmetry. By comparing the 40,000 top scoring foot-
prints for K562 cells from the ENCODE and the Wellington set, we ob-
serve that ENCODE exclusive footprints do not exhibit typical strand
asymmetry identified in Figure 2 and have low average PhyloP conser-
vation scores. De novo motif finding results show that Wellington foot-
prints show more specific sequence logos, more enrichment over back-
ground, and more matches to known matrices.
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Figure S14: Wellington and Wellington 1D can also be used on DNase-seq data gen-
erated using the single-hit protocol. (A) Wellington is able to recapitu-
late a larger amount of ChIP-seq data than the predictions by Boyle et
al. and Hesselberth et al. The horizontal axis shows the total number
of base pairs in the genome that are covered by footprints at a given
footprinting stringency, the vertical axis shows the average performance
of these footprints in recapitulating binding sites found from ChIP-seq
data for 11 transcription factors in K562 cells. (B) The nucleotide per-
formance coeﬃcients for these predictions Tompa:2005gx take numbers
of false positives and false negatives into account and show a consistent
finding compared to (A). (C, D) Wellington and Wellington 1D foot-
prints have comparable conservation scores and motif content over a
range of sensitivities, and with the available implementation, are able
to detect more footprints than Hesselberth et al.
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Introduction Many people currently analyzing DNase-seq data are using tools designed for ChIP-seq work, but
may be inappropriate for DNase-seq data where one is less interested in the overlaps of sequenced fragments, but
the site at which the cut occurs (the 5’ most end of the aligned sequence fragment).
We have developed pyDNase to interface with a sorted and indexed BAM file from a DNase-seq experiment,
allowing efficient and easy random access of DNase-seq cut data from any genomic location, e.g.
>>> import pyDNase
>>> reads = pyDNase.BAMHandler(pyDNase.example_reads())
>>> reads["chr6,170863500,170863532,+"]
{’+’: array([0,0,0,1,0,0,1,1,2,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0,1]),
’-’: array([0,10,1,0,1,0,4,9,0,1,0,2,1,0,0,0,0,0,3,0,6,3,0,0,0,1,1,1,3,0,3,6])}
Querying the BAMHandler object returns a dictionary containing numpy arrays with DNase cut counts on the
positive reference strand (+), and cuts on the negative reference strand (-). pyDNase efficiently caches the cut data
queried, so that multiple requests from the same genomic locations do not require repeated lookups from the BAM
file (this can be disabled).
pyDNase comes with several analysis scripts covering several common use cases of DNase-seq analysis, and also
an implementation of the Wellington and Wellington 1D footprinting algorithms.
to install pyDNase, ensure NumPy is installed, and run:
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$ pip install pyDNase
for full documentation go to: http://pythonhosted.org/pyDNase/
Support If you’re having any troubles, please send an email to j.piper@warwick.ac.uk and I’ll do my best to help
you out. If you notice any bugs, then please raise an issue over at the github repo.
Contributions I highly encourage contributions! This is my first software development project - send any pull
requests this way. I’m particularly interested in cool analysis scripts that anyone has written.
Reference
Note: If you use pyDNase or the Wellington algorithm in your work, please cite the following paper.
Piper et al. 2013. Wellington: A novel method for the accurate identification of digital genomic footprints from
DNase-seq data, Nucleic Acids Research 2013; doi: 10.1093/nar/gkt850
License Copyright (C) 2013 Jason Piper. This work is licensed under the GNU GPLv3 license, see
LICENCE.TXT for details.
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1 Installation
1.1 Supported systems
Hardware 1GB of RAM and a 64-bit operating system. RAM usage heavily depends on what you’re
doing, but 1GB is the bare minimum if you disable caching.
Software Tested on OS X 10.8 and on Ubuntu 11.10, but should run fine on any other *NIX flavour
as long as the prerequisites are fulfilled.
Note: Windows is not supported.
1.2 Pre-installation requirements
In order to install pyDNase, the following software is required. Most people will already have most of these on
their system. I have attempted to list them in the order that you need to install them in.
1. A compiler suite You can check by opening up the terminal and typing
$ clang --version
or
$ gcc --version
As long as you get a response from one of these, you’re good to go. Failing that...
• On OS X < 10.7.3: Install “Xcode” from https://developer.apple.com/downloads/
• On OS X >= 10.7.3: Install “Command Line Tools for Xcode” from
https://developer.apple.com/downloads/
(you can also install Xcode, but this is overkill) * On Ubuntu: Install with sudo apt-get
install build-essentials * If you’re using some other *NIX distro, I assume you know
what you’re doing.
2. Python >= 2.6 (including Python 3!)
• This will come installed with OS X or any respectable *NIX distro.
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3. pip: Used for automated installation of Python packages. If you don’t already have pip installed, you can
use the following command to install it
$ curl https://raw.github.com/pypa/pip/master/contrib/get-pip.py | python
4. Cython
• Provided you installed pip, you should be able to simply run
$ pip install Cython
5. samtools
• On OS X the simplest way to install samtools is using the homebrew command brew tap
homebrew/science
followed by brew install homebrew/science/samtools.
• On Ubuntu you can use sudo apt-get install samtools
6. NumPy
• Provided you installed pip, you should be able to simply run
$ pip install numpy
1.3 Installing pyDNase
To install, simply
$ pip install pyDNase
This will attempt to download, compile, and install the python dependencies (clint, numpy, scipy, pysam,
and matplotlib) automatically. However, due to a myriad of reasons it might not work. If this is the case, go
and install these manually in said order, then try pip install pyDNase once more.
2 Getting DNase-seq cut data from BAM files
At the heart of the pyDNase package is the BAMHandler class, which provides an interfact to the cut data in a
BAM file corresponding to a DNase-seq dataset. The interface is extremely simple:
>>> import pyDNase
>>> reads = pyDNase.BAMHandler("pyDNase/test/data/example.bam")
>>> reads["chr6,170863500,170863532,+"]
{’+’: array([0,0,0,0,1,0,0,1,1,2,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,1,0,0,0]),
’-’: array([0,10,1,0,1,0,4,9,0,1,0,2,1,0,0,0,0,0,3,0,6,3,0,0,0,1,1,1,3,0,3,6])}
As you can see, querying the BAMHandler object returns a dictionary containing numpy arrays with cut count
on the positive reference strand (+), and cuts on the negative reference strand (-). If you wanted to look at the cuts
with reference to something on the opposite strand, you can rotate the data 180 degrees by passing a “-” flag,
>>> reads["chr6,170863500,170863532,-"]
{’+’: array([6,3,0,3,1,1,1,0,0,0,3,6,0,3,0,0,0,0,0,1,2,0,1,0,9,4,0,1,0,1,10,0]),
’-’: array([0,0,0,1,1,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,0,2,1,1,0,0,1,0,0,0,0])}
By default, the BAMHandler caches lookups in 1000bp chunks. You can alter this behaviour at instanstiation. The
BAMHandler also gives an interface to the Footprint Occupancy Score (FOS).
class pyDNase.BAMHandler(filePath, caching=True, chunkSize=1000)
The object that provides the interface to DNase-seq data help in a BAM file
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FOS(interval, bgsize=35)
Calculates the Footprint Occupancy Score (FOS) for a Genomicinterval. See Neph et al. 2012 (Nature)
for full details.
Args: interval (GenomicInterval): The interval that you want the FOS for
Kwargs: bgsize (int): The size of the flanking region to use when calcuating the FOS (default: 35)
Returns: A float with the FOS - returns 10000 if it can’t calculate it
__getitem__(vals)
Return a dictionary with the cut counts. Can be used in two different ways:
You can either use a string or a GenomicInterval to query for cuts. Returns reads dict with “+” corre-
sponding to the +ve strand and “-” has the data with the -ve strand (rotated 180 degrees)
Args: vals: either a string with the format “chr18,500:600,+” or a GenomicInterval object
>>> BAMHandler(example_reads())["chr6,170863142,170863150,+"]
{’+’: array([ 1, 0, 0, 0, 1, 11, 1, 0]), ’-’: array([0, 1, 0, 0, 1, 0, 0, 1])}
>>> BAMHandler(example_reads())["chr6,170863142,170863150,-"]
{’+’: array([1, 0, 0, 1, 0, 0, 1, 0]), ’-’: array([ 0, 1, 11, 1, 0, 0, 0, 1])}
__init__(filePath, caching=True, chunkSize=1000)
Initializes the BAMHandler with a BAM file
Args: filePath (str): the path of a sorted, indexed BAM file from a DNase-seq experiment
Kwargs: chunkSize (int): and int of the size of the regions to load if caching (default: 1000) caching
(bool): enables or disables read caching (default: True)
Raises: IOError
3 Handling Genomic Intervals
3.1 GenomicInterval
The GenomicInterval is effectively pyDNase’s way of storing a BED interval. There are three mandantory
fields when creating a new GenomicInterval:
>>> import pyDNase
>>> interval = pyDNase.GenomicInterval("chr1",100,200)
>>> print interval
chr1 100 200 Unnamed1 0.0 +
class pyDNase.GenomicInterval(chrom, start, stop, label=0, score=0, strand=’+’)
Basic Object which describes reads region of the genome
__init__(chrom, start, stop, label=0, score=0, strand=’+’)
Initialization routine
Args: chrom (str): the chromosome
start (int): the start of the interval
stop (int): the end of the interval
Kwargs: label: The name of the interval (will be given an automatic name if none entered)
score (float): the score of the interval (default: 0)
strand (str): the strand the interval is on (default: “+”)
You might be wondering why this by itself is helpful. It isn’t, until you consider that you can use collections of
multiple GenomicInterval instances in a GenomicIntervalSet
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3.2 GenomicIntervalSet
Often, one may be interested in querying cut information for large numbers of regions in the genome (all the
DHSs, for example). We provide a basic way to organise BED files using a GenomicIntervalSet object.
>>> import pyDNase
>>> regions = pyDNase.GenomicIntervalSet("pyDNase/test/data/example.bed")
>>> print len(regions) # How many regions are in the BED file?
1
>>> print regions
chr6 170863142 170863532 0 0.0 +
Iterating/indexing the GenomicIntervalSet object returns GenomicInterval objects, which are sorted by their order
of creation (so the order of the BED file if importing a BED file). You can sort by any of the other attributes that
the GenomicInterval has, for example, to iterate by score,
>>> for i in sorted(regions,key=lambda x: x.score):
print i
The key here, is that as well as querying the BAMHandler for cuts using a string, we can also query using a
GenomicInterval object
>>> reads = pyDNase.BAMHandler("pyDNase/test/data/example.bam")
>>> reads[regions[0]] #Note: I’ve truncated this output
{’+’: array([1,0,0,0,1,11,1,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,2, ...]),
’-’: array([0,1,0,0,1,0 ,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,5,0,0, ...])}
For example, one could use this to efficiently calculate the total number of cuts in a DNase-seq dataset using the
intervals in a BED file
>>> readcount = 0
>>> for interval in regions:
readcount += reads[interval]["+"].sum() + reads[interval]["-"].sum()
>>> print readcount
3119
We have overloaded the + operator you can directly add other GenomicIntervalSet or GenomicInterval
objects, and you can delete intervals using the del keyword thus:
>>> print regions
chr6 170863142 170863532 0 0.0 +
>>> regions += pyDNase.GenomicInterval("chr10","100000000","200000000", "0", 10, "-")
>>> print regions
chr6 170863142 170863532 0 0.0 +
chr10 100000000 200000000 0 10.0 -
>>> del regions[0]
>>> print regions
chr10 100000000 200000000 0 10.0 -
class pyDNase.GenomicIntervalSet(filename=None)
Container class which stores and allow manipulations of large numbers of GenomicInterval objects. Essen-
tially a way of storing and sorting BED files.
__init__(filename=None)
Inits GenomicIntervalSet. You can also specify a BED file path to load the intervals from
Kwargs: filename (str): the path to a BED file to initialize the intervals with
If no filename provided, then the set will be empty
loadBEDFile(filename)
Adds all the intervals in a BED file to this GenomicIntervalSet. We’re quite naughty here and allow
some non-standard BED formats (along with the official one):
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chrom chromStart chromEnd chrom chromStart chromEnd strand chrom chromStart chromEnd name
score strand
Any whitespace (tabs or spaces) will be considered separators, so spaces in names cause a problem!
Note: If you don’t supply a strand, we infer that it’s +ve.
Args: filename: the path to a BED file to load
Raises: IOError
resizeRegions(toSize)
Resized all GenomicIntervals to a specific size
Args: toSize: an int of the size to resize all intervals to
4 Footprinting DNase-seq data
Note: We provide wellington_footprints.py as a script, which will automate footprinting for end users. This
below information only necessary if you want to do something fancy. You might want to read the documentation
in the source for more information.
We provide a simple interface for footprinting in the pyDNase.footprinting module. There are two foot-
printers, pyDNase.footprinting.wellington and pyDNase.footprinting.wellington1D,
which inherits from wellington and overrides the calculate method with a 1D version.
If you want to footprint, we provide an easy method to do so. One can import the Wellington object, and get the
Wellington footprints for an interval given the reads from a specific experiment.
>>> import pyDNase
>>> import pyDNAse.footprinting as fp
>>> regions = pyDNase.GenomicIntervalSet("pyDNase/test/data/example.bed")
>>> reads = pyDNase.BAMHandler("pyDNase/test/data/example.bam")
>>> footprinter = fp.wellington(regions[0],reads)
>>> footprints = footprinter.footprints(withCutoff=-30)
print footprints
chr6 170863264 170863306 Unnamed4 -150.07397301 +
chr6 170863338 170863383 Unnamed5 -47.9227745068 +
chr6 170863404 170863454 Unnamed6 -164.119817804 +
These can easily be written to a BED file, for example by
>>> with open("output.bed","w") as bedout:
>>> bedout.write(str(footprints))
If you want, you can also extract the raw footprint score.
>>> print footprinter.scores
[ 0.00000000e+00 0.00000000e+00 0.00000000e+00 0.00000000e+00
0.00000000e+00 0.00000000e+00 0.00000000e+00 0.00000000e+00
0.00000000e+00 0.00000000e+00 0.00000000e+00 0.00000000e+00 ...
So you can write the raw footprinting scores to a WIG file if you want to using something like
>>> print "fixedStep\tchrom=" + str(footprinter.interval.chromosome) + "\t start="+ str(footprinter.interval.startbp) +"\tstep=1"
fixedStep chrom=chr6 start=170863142 step=1
>>> for i in footprinter.scores:
... print i
0.0
0.0
0.0
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(you’d need to redirect these print statements to a file object to write the actualy WIG file)
5 Scripts
pyDNase installs several scripts which also serve as examples of how to use the pyDNAse API. Please have a
rummage through the source - it’s all documented (and hopefully understandable!)
5.1 example_footprint_scores.py
This script tests that everything has been installed and will run correctly. Upon running it, you should see the
following window
If so, congratulations! Everything has installed properly. The red and blue bars correspond to cuts on the positive
and negative strand, respectively, and the black line represents the raw Wellington footprint scores.
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5.2 dnase_average_profile.py
Average profile of DNase I activity surrounding ChIP-seq confirmed CTCF sites in K562 data.
Average profile plots illustrating DNase activity surrounding a set of regions are frequently used in papers. Here,
we provide a simple way to generate one
usage: dnase_average_profile.py [-h] [-w WINDOW_SIZE] [-i]
regions reads output
Plots average profile of DNase activity surrounding a list of regions in a BED
file
positional arguments:
regions BED file of the regions you want to generate the
average profile for
reads The BAM file containing the DNase-seq data
output filename to write the output to
optional arguments:
-h, --help show this help message and exit
-w WINDOW_SIZE, --window_size WINDOW_SIZE
Size of flanking area around centre of the regions to
plot (default: 200)
-i Ignores any strand information in BED file and plots
data relative to reference strand
Hopefully this is self-explanatory. This script uses matplotlib to generate the output, so it will write a filetype
based on the file extension provided (e.g. out.png or output.pdf).
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5.3 dnase_wig_tracks.py
Often, we want to visualise the raw cut data (just the 5’ most ends of the cuts) from a DNase-seq experiment, as
visualising the pileups isn’t helpful here. Here’s the FMR1 promoter viewed as a BAM file in IGV
and here’s the corresponding cut locations.
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We provide dnase_wig_tracks.py that generates a WIG file (we recommend you convert it to a BigWIG
file using UCSC’s wigToBigWig) based on a BAM file a list of regions of interest
usage: dnase_wig_tracks.py [-h] [-r] regions reads fw_output rev_output
Writes two WIG files with the cut information based on the regions in reads
BED file and the reads in reads BAM file
positional arguments:
regions BED file of the regions you want to write wig tracks for
reads The BAM file containing the read data
fw_output Path to write the forward reads wig track to
rev_output Path to write the reverse reads wig track to
optional arguments:
-h, --help show this help message and exit
-r, --real Report cuts on the negative strand as positive numbers instead
of negative (default: 100)
Note that by default, cuts on the reverse strand will be reported as negative numbers (for visualisation). If you
want to be using this data for something else, you can pass the -r flag, which will use the real number of cuts.
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5.4 dnase_to_javatreeview.py
Want to make a heatmap? Love JavaTreeView? So do we! This script will generate a CSV file that you can put
straight into JavaTreeView to visualize your data.
The options to be aware of here are -i and -a
usage: dnase_to_javatreeview.py [-h] [-w WINDOW_SIZE] [-i] [-o] [-a]
regions reads output
Writes a JavaTreeView file based on the regions in reads BED file and the
reads in reads BAM file
positional arguments:
regions BED file of the regions you want to generate the
heatmap for
reads The BAM file containing the read data
output filename to write the CSV output to
optional arguments:
-h, --help show this help message and exit
-w WINDOW_SIZE, --window_size WINDOW_SIZE
Size of flanking area around centre of the regions to
plot (default: 100)
-i Ignores strand information in BED file
-o Orders output the same as the input (default: orders
by FOS)
-a Write absolute cut counts instead strand imbalanced
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counts
5.5 wellington_footprints.py
So you want to get footprints from your data? No problem. We provide a handy script that will do this for you.
There’s lots of options here, so please read through them carefully. The most basic usage of the script uses the
default parameters described in our original paper. If anything goes wrong at any point, then there should be useful
error messages telling you exactly what went wrong.
usage: wellington_footprints.py [-h] [-b] [-sh SHOULDER_SIZES]
[-fp FOOTPRINT_SIZES] [-d] [-fdr FDR_CUTOFF]
[-fdriter FDR_ITERATIONS]
[-fdrlimit FDR_LIMIT] [-pv PV_CUTOFFS] [-dm]
[-o OUTPUT_PREFIX]
regions reads outputdir
Footprint the DHSs in a DNase-seq experiment using the Wellington Algorithm.
positional arguments:
regions BED file of the regions you want to footprint
reads The BAM file containing the DNase-seq reads
outputdir A writeable directory to write the results to
optional arguments:
-h, --help show this help message and exit
-b, --bonferroni Performs a bonferroni correction (default: False)
-sh SHOULDER_SIZES, --shoulder-sizes SHOULDER_SIZES
Range of shoulder sizes to try in format
"from,to,step" (default: 35,36,1)
-fp FOOTPRINT_SIZES, --footprint-sizes FOOTPRINT_SIZES
Range of footprint sizes to try in format
"from,to,step" (default: 11,26,2)
-d, --one-dimension Use Wellington 1D instead of Wellington (default:
False)
-fdr FDR_CUTOFF, --FDR_cutoff FDR_CUTOFF
Write footprints using the FDR selection method at a
specific FDR (default: 0.01)
-fdriter FDR_ITERATIONS, --FDR-iterations FDR_ITERATIONS
How many randomisations to use when performing FDR
calculations (default: 100)
-fdrlimit FDR_LIMIT, --FDR-limit FDR_LIMIT
Minimum p-value to be considered significant for FDR
calculation (default: -20)
-pv PV_CUTOFFS, --pv_cutoffs PV_CUTOFFS
Select footprints using a range of pvalue cutoffs
(default: -10,-20,-30,-40,-50,-75,-100,-300,-500,-700
-dm, --dont-merge-footprints
Disables merging of overlapping footprints (Default:
False)
-o OUTPUT_PREFIX, --output_prefix OUTPUT_PREFIX
The prefix for results files (default:
<reads.regions>)
6 Frequently Asked Questions
Here are common questions we get. If there are any questions about pyDNase or general DNase-seq analysis,
either raise an issue on GitHub or email me on j.piper@warwick.ac.uk
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6.1 How can I identify hypersensitive sites in DNase-seq data?
To identify DNase I hypersensitive sites in DNase-seq data, we recommend using HOMER‘s findPeaks with
the parameters: findPeaks -region -size 500 -minDist 50 -o auto -tbp 0, converting the
HOMER peaks to a BED file using pos2bed.pl and then merging the overlapping regions with:
$ bedtools sort -i <input.bed> | bedtools merge -i > <output.bed>
We find the results are almost exactly the same as the HOTSPOTmethod employed by ENCODE. See the HOMER
documentation for detailed information on how to carry out this procedure.
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Corrigendum
Wellington: a novel method for the accurate
identification of digital genomic footprints from
DNase-seq data
Jason Piper, Markus C. Elze, Pierre Cauchy, Peter N. Cockerill, Constanze Bonifer
and Sascha Ott
Nucl. Acids Res. (2013) 41 (21): e201. doi: 10.1093/nar/gkt850
It has come to the authors’ attention that several presentation errors exist in this article that incorrectly describe the
Wellington method.
The formula on page 3 that reads
p-value = {1 − F[FP+,FP+ + SH+, lFP/(lFP + lSH)]} · {1 − F[FP−,FP− + SH−, lFP/(lFP + lSH)] ]
should read as follows
p-value = {F[FP+,FP+ + SH+, lFP/(lFP + lSH)]} · {F[FP−,FP− + SH−, lFP/(lFP + lSH)] ]
We also present the following update to Figure 1, as the original did not specify a logarithmic y-axis, and to clarify the figure
legend.
These errors are purely typographical and do not affect the underlying methods, results or conclusions of the manuscript.
We apologise for any confusion caused.
Figure 1. Wellington: a novel strand sensitive algorithm for the identification of protein–DNA binding sites from DNase-seq data. (A) The Wellington
algorithm calculates P-values for every base pair in all DNase hypersensitive sites in a given DNase-seq data set, where the P-value is assigned to the
base pair at the centre of the footprint. For each base pair, Wellington tests the hypothesis that there are significantly fewer reads aligning to the forward
reference strand footprint region (FP+) than to the forward reference strand in the upstream shoulder region (SH+) and significantly fewer reads aligning
to the reverse reference strand footprint region (FP−) than to the reverse reference strand in the downstream shoulder region (SH−). (B) Example output
of the Wellington algorithm. The corresponding footprint prediction recapitulates the ChIP-seq confirmed CTCF-binding site.
C© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any
medium, provided the original work is properly cited.
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Chapter 3
Dierential DNase-seq
footprinting
3.1 Motivation
After the development of Wellington [2], it was realised that Wellington and pyD-
Nase could be expanded in order to interrogate the data in a more complex fashion.
A natural extension to footprinting is the ability to identify footprints that dier
between two datasets (termed `dierential' footprints). Whilst it is possible to
identify dierential footprints using the Wellington algorithm on two datasets and
then identifying the complement between the sets of footprints, this approach does
not provide a similarity metric of footprint structure between two datasets.
Here, the work performed in Chapter 2 is continued by developing an extension
to Wellington called Wellington-bootstrap. This extension of the method scores
footprints based on their similarity between two DNase-seq datasets and can be
used to identify dierential footprints. The power of this analysis is demonstrated
by the ability for the dierential footprints identied in gene promoters to be
attributes to changes in gene expression independent of changes in overall levels of
DNase sensitivity. Multiple DNase-seq datasets generated from clinical samples by
the NIH Roadmap Epigenomics project were analysed using Wellington-bootstrap.
An important result from this study is the nding that the analysis of motif
enrichment in dierential footprints reveals transcriptional regulators known to be
key drivers of cellular identity in these cell populations.
Improvements to pyDNase were also introduced in this paper: pyDNase was
extensively benchmarked and portions of code were rewritten in C and the over-
all method reimplemented to take advantage of parallel computation. This had
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a dramatic eect on computation time, as the computation time of footprinting
studies scales quasi-linearly with the number of processors. With the recent avail-
ability of DNase-seq data on `naked' genomic DNA, correction for the DNase-seq
cutting bias when visualising DNase-seq data was also introduced, providing evi-
dence against the theory that transcription factor binding induces hypersensitivity
at specic base pairs due to conformational changes to the DNA [61, 66]. In ad-
dition, further documentation was added to the pyDNase-seq library in the form
of a `footprinting tutorial.'
3.2 Contributions
For this paper, I designed the study, developed and implemented the Wellington-
bootstrap method, performed the DNase-seq and RNA-seq data analyses, wrote
the manuscript, and generated all the gures apart from Figure 2. Salam Assi
and Pierre Cauchy designed and implemented the motif clustering analysis used
in Figure 2, and also designed the gure. Christophe Ladroue contributed Supple-
mentary Figure 4. Pierre Cauchy, Constanze Bonifer, and Peter Cockerill assisted
with the biological interpretation of the dierential footprinting results. All au-
thors contributed towards the preparation of the manuscript.
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Abstract*The!analysis!of!differential!gene!expression!is!a!fundamental!tool!to!relate!gene!regulation!with!specific!biological!processes.!In!order!to!link!expression!changes!with! changes! in! transcription! factor! (TF)! binding!we! introduce! the! concept! of!differential! footprinting! alongside! a! computational! tool.! We! demonstrate! that!differential! footprinting! is!associated!with!differential!gene!expression!and!can!be!used!to!define!cell!types!by!their!specific!TF!occupancy!patterns.!!!
Main*text*Digital!DNaseI! footprinting! is! a! high! throughput! adaptation!of! classical!DNaseI!footprinting1.!By!subjecting!nuclei!to!digestion!by!DNaseI,!nucleosomeYdepleted!genomic! regions! (accessible! chromatin)! that! are! sensitive! to! cleavage! can! be!identified! as!DNase!Hypersensitive! Sites! (DHSs)2,3.! Analyses! of! the! patterns! by!which!DNase! I!cuts!within!DHSs!enables! the! identification!of! regions!protected!from!digestion!or! “footprints”,!which!accurately!demarcate! transcription! factor!binding!sites! (TFBSs)!at! subY30bp!resolution4,5,6,7,8,9,10,11.!However,!all! currently!available! footprinting! tools! are!designed! for! the!analysis!of! a! single!DNaseYseq!data!set!at!a!time!and!thus!will!indiscriminately!identify!TFBSs!that!are!part!of!a!variety! of! different! gene! regulatory! networks,! limiting! the! ability! to! link!regulatory! events! to! cellY! and! tissueYspecific! processes,! such! as! changes! in! cell!fate!or!response!to!extracellular!signals.!For!gene!expression!studies,!a!plethora!of! computational!methods!have!been!developed! in!order! to! identify!genes! that!are! differentially! expressed! in! different! conditions,! thereby! linking! gene!expression! to! changes! in! cellular! status.! However,! a! similar!methodology! that!identifies! differential! transcription! factor! occupancy! has! so! far! been! lacking.!Here! we! describe! the! development! of! a! novel! computational! tool! to! identify!differential! footprints! (DFPs).! We! show! that! this! tool! can! be! used! to! link!differential! TF! occupancy! with! differential! gene! expression! and! to! identify!closely!related!cell!types!by!virtue!of!their!TF!occupancy!patterns.!!Building! on! the!Wellington! footprinting!method! for! single! data! sets8,! we! have!developed! a! conceptually! simple,! computationally! efficient! extension,!
Wellington)bootstrap,! for! pairwise! analysis! of! DNaseYseq! data! sets.! Briefly,!footprints!in!data!set!A!are!detected!and!at!each!footprint!locus!a!statistical!test!is!performed!testing!whether!pooling!the!data!of!data!set!B!with!A!contributes!to!the!footprint!pattern!or!not.!This!yields!a!set!of!sites!that!are!overYfootprinted!in!
A! (underYfootprinted! in! B)! and! associated! DFP! scores.! Repeating! the! analysis!with! reversed! roles! for! A! and! B! yields! overYfootprinted! sites! in! B! (underYfootprinted! in!A).!We! chose! the! approach! of! pooling! data! at! individual! loci! in!order! to! avoid! biases! that! may! be! brought! about! by! variations! in! sequencing!depth.!Applying!WellingtonYbootstrap! to!publically!available!DNaseYseq!data! for!CD8+!and!CD19+!cells!we!find!37,488!sites!with!evidence!for!DFPs.!Furthermore,! the!WellingtonYbootstrap! score! provides! a! way! to! order! DFPs! by! the! extent! of!
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footprint!differences!(Supplementary*Fig.*1).!We!found!similar!results!making!pairwise! comparisons! for! all! DNaseYseq! data! sets! for! seven! cell! types! from!clinical! tissue!samples.!A! large!proportion!(up! to!98.5!percent,!43.9!percent!on!average)! of! DFPs! are! found! in! DHSs! that! are! shared! between! cell! types,! in!particular!in!closely!related!cell!types,!indicating!that!these!differences!would!be!missed! by! restricting! analyses! to! the! presence! or! absence! of! DHSs!(Supplementary*Table*1).!Using! spine! and! CD4+! cells! as! example! we! tested! the! ability! of! DFPs! to! reYdiscover!known!regulatory!links!and!predict!gene!expression.!In!CD4+!cells,!the!T!cell!specific!TF!TYbet!binds!TYbox!motifs!and!enhances!target!gene!expression!as!part!of!the!Th1Ydifferentiation!programme12.!In!spine,!the!TF!MAZ!is!known!to!be! involved! in!neuronal!development13.!Among!the!set!of!all!DFPs! located!near!transcriptional! start! sites! and! overYfootprinted! in! CD4+! cells!we! identified! the!sites! containing! a!match! for! the! TYbox!motif.!We! found! that! the! expression! of!nearby! genes! differed! significantly,! with! the! DNaseYseq! data! providing! strong!evidence! for! the! presence! of! protein! binding! in! CD4+! cells! and! absence! of!binding! in!spine!(Fig.* 1a,b).!Similarly,!we!found!that!a! link!between!binding!to!MAZ! motifs! and! gene! expression! was! evident! (Supplementary* Fig.* 2a,b),!demonstrating!the!ability!of!the!DFP!approach!to!isolate!the!effect!of!individual!TFs!from!their!genomic!context.!Previously,! comparisons! of! total! read! numbers! in! DHSs! have! been! used! as! a!means!of!analysing!pairs!of!DNaseYseq!data!sets14.!We!identified!the!set!of!TYbox!motifYcontaining! DHSs! in! gene! promoters! with! the! highest! increase! in! read!numbers! in! CD4+! cells! compared! to! spine.! While! these! showed! differential!expression!of!nearby!genes,!no!evidence!for!differences!in!binding!was!revealed!using! this! approach! (Fig.* 1c,d).! Similarly,! this! approach! did! not! reveal! the!regulatory! link! between! MAZ! binding! and! target! gene! expression!(Supplementary* Fig.* 2c,d).! The! cleavage! profiles! shown! in! Fig.* 1b,d! and!
Supplementary* Fig.* 2b,d! have! been! corrected! for! the! known! sequence!preference! of! the! DNaseI! enzyme.! Supplementary* Fig.* 3* compares! cleavage!profiles!with!and!without!this!correction.!Overall,!this!suggests!that!unlike!DFPs,!motif! analysis! of! DHSs! is! insufficient! to! link! a! given! TF! to! changes! in! gene!expression,!making!the!use!of!DFPs!a!valuable!tool!for!this!purpose.!We! sought! to! further! explore! the! potential! of! the! DFP! approach! to! reveal! cell!typeYspecific! regulatory! mechanisms.! Using! differential! footprints! amongst! all!pairs! of! DNaseYseq! data! sets! of! seven! primary! cell! types,! we! determined! the!relative!frequency!of!motif!occurrences!for!a!set!of!known!TF!binding!motifs!and!used! this! data! to! cluster! the! set! of! pairs! of! cell! lines! as! well! as! the! set! of! TF!binding! motifs! (Fig.* 2).! This! analysis! generated! a! number! of! striking! results.!Firstly,!our!DFP!methodology!combined!with!clustering!recovered!the!different!cell!types!as!they!formed!separate!clusters.!Moreover,!it!was!able!to!distinguish!related!cell!types!such!as!CD19+!B!cells,!T!cells!and!CD14+!monocytic!cells!all!of!which!belong!to!the!hematopoietic!lineage.!In!addition,!this!analysis!was!capable!
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of!differentiating!between!subYtypes!of! cells!of! the! same! lineage,! such!as!CD4+!helper!and!CD8+!cytotoxic!T!cells.!Secondly,!the!analysis!gave!interesting!insights!into! the! relative! role! of! individual! TF! families! within! a! given! cell! type.! For!example,! high! differential! C/EBP! motif! occupancy! was! a! classifier! for! CD14+!monocytes!as!well!as!fibroblasts,!both!of!which!express!C/EBPa,!but!the!relative!motif! frequency! was! lower! in! fibroblasts! which! agrees! with! the! fact! that! this!factor! is! absolutely! essential! for!monocyte! but! not! fibroblast! development15,16.!Another! interesting! finding!was! that! increased!occupancy!of!PU.1!motifs!was!a!classifier! for!both!B!cells!and!CD14+!monocytic!cells!where!this! factor!plays!an!important!role17,!but!a!significant!number!of!sites!were!occupied!also!in!T!cells.!PU.1! is!not! expressed! in!T! cells! and! its! overexpression! is!detrimental! for! their!development18! indicating! that! PU.1! motifs! originally! bound! in! hematopoietic!stem!cells!are!now!occupied!by!a!different!factor!of!the!Ets!family.!!To!facilitate!the!wideYspread!use!of!our!method,!we!provide!an!implementation!of! WellingtonYbootstrap! alongside! a! substantial! update! of! pyDNase,! including!increased!performance!and!parallelised!computations.!This! is! released!as!open!source! under! the! GPLv3! license! at! http://jpiper.github.io/pyDNase/! (upon!publication).!In! conclusion,! we! introduce! a! fundamental! and! useful! method! for! differential!footprints,!provide!a! tool! for! the!detection!of!DFPs,! and! reveal! the!potential!of!this! approach! to!map! regulators! to! contextYspecific! gene! expression.! Applying!this!methodology!will!be!highly!relevant!for!classifying!closely!related!cell!types,!both! in! the! normal,! but! also! the! diseased! state! and! to! assess! the! relative!importance! of! specific! TF! families! for! each! state.! WellingtonYbootstrap! is!applicable! to! any! pair! of! DNaseYseq! data! sets! obtained! with! comparable!experimental! protocols! including! perturbation! and! time! course! experiments,!making! it! a!widely! applicable! approach! for! the! identification!of! transcriptional!regulatory!hierarchies.!!
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Cell$
type$A$
Cell$
type$B$
DHSs$
in$A$
DHSs$$
in$B$
DHSs$shared$
between$A$
and$B$
Sites$over8
footprinted$
in$A$
Sites$in$
common$
DHSs$over8
footprinted$in$
A$
Sites$over8
footprinted$
in$B$
Sites$in$
common$
DHSs$over8
footprinted$
in$B$CD4! CD8! 84,830! 60,890! 49,365! 14,772! 10,600!(71.8)! 3,874! 3,584!(92.5)!CD4! CD14! 84,830! 109,647! 47,887! 14,819! 6,219!(42)! 17,932! 7,663!(42.7)!CD4! CD19! 84,830! 89,660! 43,282! 18,525! 10,423!(56.3)! 19,439! 13,018!(67)!CD4! CD56! 84,830! 69,966! 54,739! 17,745! 14,611!(82.3)! 2,616! 2,526!(96.6)!CD4! Spine! 84,830! 197,751! 34,812! 24,652! 9,158!(37.1)! 93,152! 10,233!(11)!CD4! Fibroblasts! 84,830! 193,546! 40,240! 21,473! 7,087!(33)! 118,265! 11,741!(9.9)!CD8! CD14! 60,890! 109,647! 32,185! 11,602! 6,529!(56.3)! 55,650! 12,546!(22.5)!CD8! CD19! 60,890! 89,660! 32,350! 8,780! 5,520!(62.9)! 28,708! 15,549!(54.2)!CD8! CD56! 60,890! 69,966! 51,965! 1,458! 1,428!(97.9)! 335! 330!(98.5)!CD8! Spine! 60,890! 197,751! 27,631! 13,128! 5,444!(41.5)! 110,950! 11,330!(10.2)!CD8! Fibroblasts! 60,890! 193,546! 30,237! 13,734! 5,894!(42.9)! 156,418! 15,573!(10)!CD14! CD19! 109,647! 89,660! 36,349! 48,031! 15,909!(33.1)! 27,111! 18,140!(66.9)!CD14! CD56! 109,647! 69,966! 33,900! 54,850! 17,845!(32.5)! 7,842! 5,357!(68.3)!CD14! Spine! 109,647! 197,751! 33,141! 53,731! 13,584!(25.3)! 96,856! 13,563!(14)!CD14! Fibroblasts! 109,647! 193,546! 45,179! 37,641! 8,383!(22.3)! 108,482! 12,677!(11.7)!CD19! CD56! 89,660! 69,966! 35,766! 31,561! 19,315!(61.2)! 5,553! 4,130!(74.4)!CD19! Spine! 89,660! 197,751! 31,858! 28,993! 13,118!(45.2)! 97,388! 14,826!(15.2)!CD19! Fibroblasts! 89,660! 193,546! 30,831! 32,531! 13,760!(42.3)! 138,301! 20,224!(14.6)!CD56! Spine! 69,966! 197,751! 28,731! 8,633! 4,404!(51)! 110,996! 13,892!(12.5)!CD56! Fibroblasts! 69,966! 193,546! 31,469! 9,237! 4,769!(51.6)! 154,923! 20,024!(12.9)!Spine! Fibroblasts! 197,751! 193,546! 64,733! 24,756! 5,497!(22.2)! 35,202! 9,461!(26.9)!!
Supplementary$Table$1.!A$large$proportion$of$differential$ footprints$occurs$in$shared$DHSs.$Number!of!DHSs!and!shared!DHSs,!number!of!overGfootprinted!sites,!and!number!of!overGfootprinted!sites!located!in!the!overlap!of!shared!DHSs!are!shown!for!pairs!of!cell!types.! For! closely! related! cell! types! most! differential! footprints! tend! to! be! found! in! common! DHSs! (e.g.! CD4+! vs.! CD56+).!Developmentally!distant!cell!types,!however,!often!have!a!large!number!of!DHSs!that!are!cell!type!specific,!and!therefore!the!majority!of!differential!footprints!are!in!cellGtype!specific!DHSs!(e.g.!CD56+!cells!vs.!fibroblasts).!
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Figure	  1.	  Differential	  footprints	  reveal	  links	  between	  TF	  binding	  and	  gene	  
expression.	  (a)	  Differential	  gene	  expression	  (p<0.005,	  Mann-­‐Whitney	  U	  test)	  of	  all	  genes	  that	  have	  a	  differential	  CD4	  footprint	  containing	  a	  match	  for	  the	  T-­‐box	  motif	  in	  their	  promoter.	  (b)	  Average	  bias-­‐corrected	  DNase-­‐seq	  cleavage	  profiles	  (red:	   positive	   strand	   reads,	   green:	   negative	   strand	   reads)	   for	   T-­‐box	   sites	   in	  promoters	  of	  genes	  from	  (a)	  show	  evidence	  for	  binding	  of	  T-­‐box	  motifs	  in	  CD4+	  cells,	   but	   not	   in	   spine.	   Genes	   over-­‐footprinted	   for	  T-­‐box	   in	   CD4+	   cells	   are	   also	  over-­‐expressed,	   confirming	   a	   known	   lineage-­‐determining	   link.	   (c)	   Differential	  gene	   expression	   of	   all	   genes	   that	   have	   a	   differential	   CD4+	   DHS	   containing	   a	  match	  for	  the	  T-­‐box	  motif	  in	  their	  promoter.	  (d)	  Average	  bias-­‐corrected	  DNase-­‐seq	  cleavage	  profiles	  for	  T-­‐box	  sites	  in	  promoters	  of	  genes	  from	  (c)	  do	  not	  show	  evidence	  for	  binding	   in	  either	  cell	   type.	  The	  differential	  expression	  observed	   in	  (c)	  cannot	  be	  linked	  to	  TF	  binding	  using	  differential	  DHS	  scores	  alone.	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Figure	   2.	   Analysis	   of	   differential	   footprints	   in	   the	   haematopoietic	   system	  
reveals	   cell-­‐type	   specific	   transcription	   factor	   networks.	   Differential	  footprints	   in	   42	   pairs	   of	   cell	   types	   and	   matches	   to	   known	   motifs	   inside	  differential	   footprints	   were	   determined	   using	   DNase-­‐seq	   data	   from	   the	   NIH	  Roadmap	  Epigenomics	  project.	   Coloured	  boxes	   represent	  motif	   frequency	  with	  red	   indicating	   higher	   than	   average	   frequency.	   Hierarchical	   clustering	   was	  applied	  to	  rows	  and	  columns.	  The	  result	  correctly	  groups	  cell	  types	  and	  reveals	  known	  and	  likely	  regulatory	  factors.	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Supplementary	  Figure	  1.	  Wellington-­‐bootstrap	  scores	  differential	  footprint	  
occupancy	  between	  DNase-­‐seq	  datasets.	  Wellington-­‐bootstrap	  was	  applied	  at	  footprint	  loci	  in	  CD8+	  cells	  to	  detect	  over-­‐footprinted	  sites	  relative	  to	  CD19+	  cells.	  	  (a)	  53,539	  loci	  were	  sorted	  by	  increasing	  Wellington-­‐bootstrap	  score	  comparing	  CD8	  vs	  CD19.	  8,780	  loci	  were	  deemed	  to	  be	  DFPs.	  Red	  indicates	  an	  excess	  of	  positive	  strand	  cuts	  over	  negative	  strand	  cuts	  per	  nucleotide	  position,	  and	  green	  indicates	  an	  excess	  of	  negative	  strand	  cuts.	  Common	  footprints	  at	  the	  top	  of	  the	  heatmap	  share	  similar	  DNase	  activity	  as	  exemplified	  in	  (b)	  whereas	  footprints	  with	  increasing	  differential	  score	  towards	  the	  bottom	  of	  the	  heatmap	  show	  increasingly	  differential	  footprints	  (c,d).	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Supplementary	   Figure	   2.	  Differential	   footprints	   reveal	   links	   between	   TF	  
binding	  and	  gene	  expression.	  (a)	  Differential	  gene	  expression	  (p<0.005,	  Mann-­‐Whitney	  U	  test)	  of	  all	  genes	  that	  have	  a	  differential	  spine	  footprint	  containing	  a	  match	   for	   the	  MAZ	  motif	   in	   their	  promoter.	   (b)	  Average	  bias-­‐corrected	  DNase-­‐seq	   cleavage	  profiles	   (red:	  positive	   strand	   reads,	   green:	  negative	   strand	   reads)	  for	  MAZ	  sites	  in	  promoters	  of	  genes	  from	  (a)	  show	  evidence	  for	  binding	  of	  MAZ	  motifs	   in	   spine	   cells,	   but	   not	   in	   CD4+	   cells.	   Genes	   over-­‐footprinted	   for	  MAZ	   in	  spine	   cells	   are	   also	   over-­‐expressed,	   confirming	   a	   known	   lineage-­‐determining	  link.	   (c)	   Differential	  MAZ	   expression	   of	   all	   genes	   that	   have	   a	   differential	   spine	  DHS	  containing	  a	  match	  for	  the	  MAZ	  motif	   in	  their	  promoter.	  (d)	  Average	  bias-­‐corrected	  DNase-­‐seq	  cleavage	  profiles	  for	  MAZ	  sites	  in	  promoters	  of	  genes	  from	  (c)	   show	   evidence	   for	   binding	   in	   both	   cell	   types.	   The	   differential	   expression	  observed	   in	   (c)	   cannot	  be	   linked	   to	  differences	   in	  TF	  binding	  using	  differential	  DHS	  scores	  alone.	  
	  
	  
102
	  
	  
Supplementary	  Figure	  3.	  Bias	  correction	  refines	  profiles	  of	  average	  cutting.	  For	   T-­‐box-­‐containing	   loci	   of	   differential	   footprints	   used	   in	   Figure	   1b	   average	  DNaseI	  cleavage	  profiles	  are	  shown	  before	  (a,	   c)	  and	  after	  (b,	  d)	  correcting	  for	  the	  sequence	  specificity	  of	  DNaseI	  cleavage	  using	  a	  6-­‐mer	  model	  (He	  et	  al.,	  2013).	  Plots	  (b)	  and	  (d)	  are	  the	  ones	  shown	  in	  Figure	  1b.	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Supplementary	  Figure	  4.	  Example	  of	  a	  footprint	  deemed	  non-­‐differential.	  (a)	  Red	  (green)	  bars	  represent	  numbers	  of	  5’	  ends	  of	  reads	  aligning	  to	  the	  positive	  (negative)	  reference	  strand.	  Vertical	  black	  lines	  indicate	  footprint	  region.	  (b)	  Bootstrap	  distribution	  for	  data	  shown	  in	  (a).	  Nucleotide	  positions	  in	  CD19	  data	  were	  randomly	  shuffled	  and	  the	  distribution	  of	  Wellington	  footprint	  scores	  after	  pooling	  the	  shuffled	  CD19	  data	  and	  the	  fibroblast	  data	  was	  determined.	  Blue	  vertical	  bar	  shows	  the	  Wellington	  score	  after	  pooling	  data	  without	  shuffling.	  Green:	  Wellington	  footprint	  score	  in	  fibroblast	  data.	  Red:	  footprint	  score	  in	  CD19	  data.	  As	  pooling	  without	  shuffling	  yields	  a	  better	  footprint	  score	  than	  pooling	  with	  shuffling	  the	  footprint	  is	  considered	  non-­‐differential.	  	  	  	  
a	  
b	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Differential	  DNase-­‐seq	  footprinting	  identifies	  cell-­‐type	  determining	  
transcription	  factors	  	  Jason	  Piper,	  Salam	  A.	  Assi,	  Pierre	  Cauchy,	  Christophe	  Ladroue,	  Peter	  N.	  Cockerill,	  Constanze	  Bonifer,	  Sascha	  Ott	  
	  
Online	  Methods	  	  
DNase-­‐seq	  data	  and	  peak-­‐finding	  	  DNase-­‐seq	  data	  from	  the	  NIH	  Roadmap	  Epigenomics	  project1	  were	  downloaded	  from	   the	   Short	   Read	   Archive	   (accessions	   CD4:	   SRX214041,	   CD8:	   SRX204403,	  CD19:	   SRX342324,	   CD14:	   SRX252602,	   CD56:	   SRX204402,	   spinal	   column:	  SRX121287,	   fibroblasts:	   SRX135564)	   and	   were	   aligned	   to	   hg19	   using	   Bowtie	  2.2.0	   using	   the	   default	   parameters.	   DNase	   hypersensitive	   site	   detection	   for	   all	  DNase-­‐seq	   data	   was	   performed	   using	   HOMER’s	   findPeaks.pl	   tool2	   with	   the	  parameters	  “findPeaks	  -­‐region	  -­‐size	  500	  -­‐minDist	  50	  -­‐o	  auto	  -­‐tbp	  0”.	  
	  
	  
Differential	  footprinting	  –	  Wellington-­‐bootstrap	  	  Wellington-­‐bootstrap	   first	   determines	   Wellington	   footprints	   in	   the	   primary	  dataset.	  At	  each	   footprint	   locus	   the	  data	   from	   the	  comparator	  dataset	   is	  added	  and	   the	  Wellington	   footprint	   score	   for	   the	   pooled	   data	   evaluated.	  Wellington-­‐bootstrap	  then	  assesses	  if	  the	  change	  in	  footprint	  score	  is	  a	  consequence	  of	  the	  increase	  in	  read	  numbers	  after	  pooling	  reads	  or	  if	  the	  data	  from	  the	  comparator	  dataset	   makes	   a	   contribution	   to	   the	   footprint	   structure.	   To	   do	   this,	   the	  comparator	   data	   is	   randomly	   shuffled	   1000	   times,	   pooled,	   and	   the	  Wellington	  footprint	   score	   evaluated	   (see	   example	   in	  Supplementary	   Fig.	   4).	   Shuffling	   is	  done	  in	  a	  strand	  independent	  manner,	  randomising	  the	  positions	  of	  the	  counts	  of	  5’	   DNase	   cuts	   per	   base	   pair	   on	   the	   positive	   and	   negative	   strand.	   The	   score	   of	  pooled	  data	  without	  shuffling	  is	  assessed	  against	  the	  bootstrap	  distribution	  and	  the	   percentile	   used	   as	   the	   differential	   footprinting	   score.	   Low	   scores	   indicate	  non-­‐differential	   footprints,	   high	   scores	   differential	   footprints.	   Supplementary	  
Fig.	  1	  shows	  that	  sorting	  by	  this	  score	  orders	  pairs	  of	  footprints	  in	  an	  intuitive	  manner	   enabling	   the	   user	   to	   retrieve	   the	   most	   differential	   footprints	   while	  choosing	  the	  stringency.	  10	  was	  used	  as	  the	  threshold	  in	  this	  work.	  The	  role	  of	  the	  two	  datasets	  is	  reversed	  and	  the	  computation	  repeated	  to	  obtain	  both	  over-­‐	  and	  under-­‐footprinted	  sites.	  	  Initially	  it	  was	  thought	  that	  a	  measure	  of	  flexibility	  would	  be	  required	  regarding	  the	   width	   of	   the	   footprint	   and	   its	   position	   in	   the	   two	   datasets.	   Whilst	   initial	  methods	   were	   developed	   to	   take	   this	   into	   consideration,	   we	   found	   that	   this	  provided	   no	   improvement	   to	   the	   method,	   yet	   yielded	   a	   significant	   speed	  decrease.	  	  This	  analysis	  has	  been	  implemented	  in	  the	  wellington_bootstrap.py	  script	  as	  part	  of	  pyDNase	  0.2.0.	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Differential	  DHSs	  –	  Figure	  1	  and	  Supplementary	  Figure	  2	  	  Differential	   DHSs	   (∆DHS)	   scores	   were	   calculated	   according	   to	   the	   method	  proposed	   by	   He	   et	   al.3	   and	   the	   analysis	   script	   has	   been	   provided	   as	  
dnase_dshs_scores.py	   in	  pyDNase	  0.2.0.	  DHSs	  were	   then	   filtered	   to	   those	  that	   were	   within	   2kb	   of	   a	   single	   TSS	   using	   the	   hg19	   UCSC	   knownGene	   gene	  model,	   and	   the	   DHSs	   showing	   the	   top	   and	   bottom	   n=1000	   ∆DHS	   scores	   were	  chosen	   as	   the	   differential	   DHSs.	   Equivalent	   results	   were	   obtained	   using	   the	  following	   alternative	   choices	   for	   n:	   50	   (matching	   the	   number	   of	   DFPs	   used	   in	  
Figure	   1a,b),	   top	   476	   and	   bottom	   300	   (corresponding	   to	   two	   standard	  deviations	   difference	   to	   mean	   ∆DHS	   score),	   1403	   (corresponding	   to	   top	   and	  bottom	  10%).	  	  	  
RNA-­‐seq	  analysis	  	  RNA-­‐seq	  data	  were	  downloaded	   from	  the	  Short	  Read	  Archive	   (accessions	  CD4:	  SRR643766,	  spinal	  column:	  SRR980477)	  and	  FPKM	  was	  estimated	  using	  Tophat	  2.0.11	   and	   Cufflinks	   2.1.1	   with	   the	   Illumina	   iGenomes	   UCSC	   hg19	   knownGene	  GTF	  file.	  	  	  
Motif	  analysis	  –	  Figure	  2	  	  The	   annotatePeaks.pl	   script	   of	   the	   HOMER2	   package	   was	   used	   to	   find	  occurrences	   of	   known	   motifs	   in	   peaks.	   Wellington-­‐bootstrap	   was	   applied	   to	  compute	  42	  sets	  of	  differential	   footprints	   for	  all	  ordered	  pairs	  of	   the	  seven	  cell	  types	   used	   (CD4/CD8	   T-­‐cells,	   CD56	   NK	   cells,	   CD19+	   B	   cells,	   Spine	   (embryo),	  fibroblasts,	   CD14+	   monocytes).	   To	   analyse	   motif	   frequencies	   in	   differential	  footprints	   motif	   search	   was	   done	   within	   the	   differential	   footprint	   coordinates	  extended	  by	  10bp	  either	  side.	  Relative	  motif	  frequencies	  were	  calculated	  as	  	   Relative	  frequency	  motif	  i	  in	  comparison	  j	  =	  (!!" !!)× ! !!! !!"! ,	  	  where	  C	   is	  a	  scaling	  constant,	  nij	  is	   the	  number	  of	  differential	   footprints	   in	  set	   j	  
(j=1,2,…,42)	   that	   are	   occupied	   by	   motif	   i	   (i=1,	   2,….,I),	   I	   is	   the	   total	   number	   of	  motifs	   used,	   and	  Mj	   the	   total	   number	   of	   differential	   footprints	   in	   each	   subset	   j	  
(j=1,2,…,42).	  A	  matrix	  was	   generated	   and	  motif	   scores	   displayed	   as	   a	   heatmap	  after	  hierarchical	  clustering	  with	  Euclidean	  distance	  and	  complete	  linkage.	  Blue	  indicates	   low	   relative	   frequency;	   red/black	   indicates	   high	   relative	   frequency.	  	  Heatmaps	  were	  generated	  using	  Mev	  of	  the	  TM4	  microarray	  software	  suite4.	  	  	  	  	  
pyDNase	  0.2.0	  –	  cutting	  bias	  correction	  
	  In	  order	  to	  plot	  cut	  bias	  corrected	  average	  DNase	  cleavage	  plots,	   the	  DNaseI	  6-­‐mer	  cutting	  bias	  data	  from	  naked	  genomic	  data	  from	  the	  IMR90	  cell	  line	  and	  for	  each	   region	   an	   ‘expected	   count’	   was	   calculated	   using	   the	   ‘predicted	   count’	  formula	   from	  He	   et	   al.	   20133.	   The	   observed	   cuts	   at	   each	   base	   pairs	  were	   then	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divided	  by	   the	  expected	  counts.	  Bias	  correction	  modes	  have	  been	  added	   to	   the	  plotting	   scripts	   in	   pyDNase	   that	   can	   be	   invoked	  with	   the	   ‘-b <genome.fa>’	  option.	   The	   BAMHandlerWithBias	   class	   in	   pyDNase	   provides	   underlying	  access	   to	   the	   bias	   correction	   for	   power	   users.	   In	   this	  we	  have	   provisioned	   the	  ability	   for	   the	   user	   to	   supply	   a	   Variant	   Call	   Format	   (VCF)	   file	   so	   that	   the	  reference	   DNA	   sequence	   can	   be	   corrected	   using	   SNPs	   present	   in	   the	   sample	  being	  analysed	  if	  desired.	  	  	  
pyDNase	  0.2.0	  –	  other	  new	  features	  and	  improvements	  	  pyDNase	   0.2.0	   represents	   a	   major	   release	   for	   pyDNase,	   bringing	   several	  improvements.	  The	  core	  Wellington	  algorithm	  was	  reimplemented	  in	  C,	  and	  the	  underlying	  code	  structure	  was	  refactored	  in	  order	  to	  allow	  for	  parallelisation	  of	  Wellington	   score	   calculation.	   On	   a	   dual	   2.66Ghz	   i7	   Xeon	   workstation	   with	   8	  cores,	  footprinting	  a	  single	  dataset	  takes	  approximately	  30	  minutes,	  compared	  to	  up	   to	   20	   hours	   previously	   on	   a	   single	   core	   –	   this	   performance	   increase	   scales	  linearly	  with	  number	  of	  cores	  utilised.	  In	  addition,	  a	  number	  of	  analysis	  scripts	  have	  been	  added	  to	  the	  pyDNase	  library	  for	  calculating	  ∆DHS	  scores,	  calculating	  Wellington-­‐bootstrap	  scores,	  annotation	  of	  BED	   files	  with	  Footprint	  Occupancy	  Scores,	   and	   the	   annotation	   of	   a	   BED	   file	   with	   DNase	   cuts.	   A	   comprehensive	  DNase-­‐seq	   footprinting	   tutorial	   has	   also	   been	   added	   to	   assist	   those	   new	   to	  DNase-­‐seq	  analysis	  and	  DNase-­‐seq	  footprinting.	  Full	  details	  can	  be	  found	  at	  the	  pyDNase	  github	  repository	  (https://github.com/jpiper/pyDNase/).	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1 DNase I cleavage bias correction
pyDNase 0.2.0 comes with consideration for DNase-seq cutting bias. At the moment, this is a pre-
liminary implementation limited to just the visualisation functions dnase_average_profile.py and
dnase_to_javatreeview.py. Instead of DNase-seq read counts, this instead reports the fold change over a
theoretical background model using the bias values reported in the IMR90 naked genomic DNA reported in He et al.
2014
This is currently not a part of the core Wellington footprinting function, as a more thorough analysis of the impact of
introducing such a feature on the method is needed here.
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1.1 How is this useful?
Often, people use dnase_average_profile.py and dnase_to_javatreeview.py to visualise the foot-
prints of a specific transcription factor. When this is the case, the plot will be centred on a common motif, and sequence
specific cutting biases have the potential to become very apparent. As an example, footprinted E-box motifs have a
heightened cutting profile in the centre of the footprint. These were theorised by Neph et al. 2012 to be caused by
conformational changed to the DNA induced by the binding of the transcription factor. However, we can show here
that this is not that case, and by accounting for sequence bias these patterns dissapear.
1.2 Great! What’s the catch?
There are two catches here. The first is that this doesn’t work well on regions with low numbers of reads. If your read
depth is really low for the regions you are trying to plot, your data might not look good. Second, this is no longer
reporting read counts, but a “fold change”. This is more of an implementation issue as we felt proper methods for
accounting for DNase cleavage bias are best left for another study.
2 Frequently Asked Questions
Here are common questions we get. If there are any questions about pyDNase or general DNase-seq analysis, either
raise an issue on GitHub or email me on j.piper@warwick.ac.uk
2.1 How can I identify hypersensitive sites in DNase-seq data?
To identify DNase I hypersensitive sites in DNase-seq data, we recommend using HOMER‘s findPeakswith the pa-
rameters: findPeaks -region -size 500 -minDist 50 -o auto -tbp 0, converting the HOMER
peaks to a BED file using pos2bed.pl and then merging the overlapping regions with:
$ bedtools sort -i <input.bed> | bedtools merge -i - > <output.bed>
We find the results are almost exactly the same as the HOTSPOT method employed by ENCODE. See the HOMER
documentation for detailed information on how to carry out this procedure.
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2.2 pyDNase won’t install/import or gives weird errors
The most common issue here is that you have old versions of the dependencies - namely scipy, numpy, or pysam
installed - try updating these to their latest version. pyDNase is built against Python 2.6, 2.7 and 3.0 by the Travis
contious integration (CI) system, so we’re very confident in the deployability of the codebase.
2.3 These footprints from are too stringent for my liking
This is a common question - if you have low read depths you might need to adjust the -fdrlimit parameter to
something less stringent like "-10" or "-5", which sets the mimimum amounts of evidence required to support the
alternate hypothesis of there being a footprint. You can set this to 0 if you want to disable this feature altogether, and
then sort the footprints by their Wellington scores (e.g. sort -nk 5 <fp.bed> > <out.bed>) and choose
your threshold this way if you like.
3 DNase-seq footprinting Tutorial
This document gives you a brief outline on how to analyse DNase-seq data. It assumes knowledge of the unerlying
biological method, and is meant to help those that generally understand how to use the terminal to perform simple
bioinformatic analyses. If you want to brush up on your DNase-seq before continuing, the HOMER docs, the Welling-
ton Paper, the ENCODE DNase-seq paper, are good places to start.
3.1 Testing pyDNase installation
After installing pyDNase, go ahead and run:
$ example_footprint_scores.py
This script tests that everything has been installed and runs correctly. You should see the following window
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If so, congratulations! Everything has installed properly. The red and blue bars correspond to cuts on the positive and
negative strand, respectively, and the black line represents the raw Wellington footprint scores.
3.2 Getting data in the correct format
The first, and most important thing you need is the aligned reads from the DNase-seq experiment. If you are working
with ENCODE data, you can get the data pre-aligned in .bam format from here. Note that you must download
the corresponding .bam.bai file, which is the index file. You can find Dgf (digital genomic footprinting) reads
and hypersensitive sites from the wgEncodeUwDgf folder on the UCSC GoldenPath server. Note that these are
different thana those found in the wgEncodeOpenChromDnase and wgEncodeUwDnase folders, which are not
of sufficient sequencing depth to get a good number of footprints from.
Do note that there are two different DNase protocols - the single-hit method described by Boyle et al, and the double-
hit method described by Sabo et al. All of the data generated by ENCODE under the wgEncodeUwDgf label all uses
the double-hit method (the assay is easier to perform and the data is cleaner, so I don’t envisage the single-hit method
coming back). Do not that whilst Wellington can be run on the single-hit data, it hasn’t been designed to do so.
If you’re on the cutting edge, such as generating your own DNase-seq data or using some of the raw (unaligned) data
from the NIH roadmap epigenomics project, then you’ll need to align the FASTQ files from your sequencer yourself
(outlined below).
3.3 Aligning your reads
I used to use Bowtie 1 with the settings (this is basically how all the ENCODE data is aligned):
$ bowtie -t -p 8 -v 2 -m 1 --all --best --strata --sam hg19 -f -1 <input.fastq> > <output.sam>
But this has several limitations - the suppression of non-uniquely mapping reads angers Lior Pachter, bowtie doesn’t
do well with long reads, and bowtie can’t handle indels. So where possible, use bowtie2, which I usually use with
the default settings (example below):
$ bowtie2 -x hg19 -t -p 8 -q -U <input.fastq> -S <output.sam>
Indels can create ‘fake’ footprints as they lead to short regions where no sequences can align, so when comparing
different samples this becomes important!
3.3.1 Dealing with SRA
If you’re getting files from the SRA, you’ll need to convert the files from the propietry .sra format to .fastq
sratoolkit. Download and install sratoolkit from here and, and then use fastq-dump to convert to either
convert to FASTQ directly, or pipe directly to bowtie2 such as:
$ fastq-dump <reads.sra> -Z | bowtie2 -x hg19 -t -p 8 -q -U - -S <output.sam>
3.3.2 Sorting and Indexing
You must then convert these files to sorted, indexed, bam files:
$ samtools view -bS <in.sam> > <out.bam>
$ samtools sort <out.bam> <out.sorted>
$ samtools index <out.sorted.bam>
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At this point you will have <out.sorted.bam> and <out.sorted.bam.bai> - the BAM format is a very common format
used for the interchange of aligned sequence data, and lots of common tools like HOMER: and MACS can handle bam
files.
Tip: The more technical people will notice than you can pipe directly from fastq-dump to bowtie2 to
samtools view. The downside being it can be hard to debug problems when you chain a lot of programs to-
gether.
3.4 Peak calling
A prerequisite to footprinting the genome is the definition of DNase Hypersensitive Sites (DHSs) - these are regions
of the genome where nucleosomes have been displaced and the DNase is free to cut the DNA.
Many peak callers exist such as MACS, MACS2, F-seq, HOMER’s FindPeaks, HOTSPOTs (the list is practically
endless). There’s a good review of peak calling in DNase-seq data here, and identifying DNase hypersensitive sites is
outsite of the remit of this tutorial, so I emplore you to read around the area and use your own judgement here.
However, if you really want to be spoonfed (gimme the peaks now, I’m in a rush!) then I usually use HOMER‘s
findPeaks with the parameters:
$ findPeaks -region -size 500 -minDist 50 -o auto -tbp 0
converting the HOMER peaks to a BED file using HOMER’s builtin pos2bed.pl and then merging the overlapping
regions with:
$ bedtools sort -i <input.bed> | bedtools merge -i - > <output.bed>
I find the results are almost exactly the same as the HOTSPOT method employed by ENCODE. See the HOMER:
documentation for detailed information on how to carry out this procedure.
3.5 Quick and easy Footprinting
So this is what you’re waiting for - show me the money! as they say. Armed with your install of pyDNase and your
.bam, .bam.bai, and .bed files, you’re ready to go! You can go ahead and footprint your DHSs in order to identify
protein-DNA binding sites with the following command:
$ mkdir K562_footprints
$ wellington_footprints.py K562.DHSs.bed wgEncodeUwDgfK562Aln.bam K562_footprints/
By default this will use the number of threads that you have available, on a 16 core machine, this takes about 30
minutes.
You should really take some time to read through the settings in the documentation, you can get this by running:
$ wellington_footprints.py -h
I often get the comment that footprints from are too stringent. This is a common question - if you have low read depths
you might need to adjust the -fdrlimit parameter to something less stringent like "-10" or "-5" (the closer to
0, the more liberal), which sets the mimimum amount of evidence required to support the alternate hypothesis of there
being a footprint present.
Tip: You can set -fdrlimit to -0.01 if you want to disable this feature altogether, and then sort the footprints by
their Wellington scores (e.g. sort -nk 5 <fp.bed> > <out.bed>) and then visualise the footprints choose
your threshold this way if you are unsure.
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3.6 Interpreting Wellington’s Output
Explore the folder that you created above (K562_footprints) and you will notice three things.
wgEncodeUwDgfK562Aln.bam.K562.DHSs.bed.WellingtonFootprints.FDR.0.01.bed contains
the footprints at the FDR of 0.01 - this is a good place to start for your footprints. What is happening here is that
the data for each DHS is being randomised, and the p-value cutoff for each DHS is being raised from the baseline of
-fdrlimit according to how often the random data generate footprints. If you’re not happy with the footprints here
(i.e. they seem too stringent), then feel free to look at the p-value cutoffs (see below) or rerun with different parameters
such as a less stringent -fdrlimit (see above).
wgEncodeUwDgfK562Aln.bam.K562.DHSs.bed.WellingtonFootprints.wig contains the raw foot-
printing scores - have a look in IGV (you’ll need to convert to a bigWig track using UCSC’s wigToBigWig tool if
you’ve used all the DHSs)
p value cutoffs contains the footprints at varying different stringencies - some people prefer this approach to
the FDR approach, so these are saved here.
3.7 Visualising the data
You probably want to see what the data looks like. Well you can, with IGV! You can open up the BED files (and the
WIG file) from the output above, and also load up your .bam file and have a play around. Have a look at how the
different stringencies give you different results.
Often, we want to visualise the raw cut data (just the 5’ most ends of the cuts) from a DNase-seq experiment, so
visualising the pileups from the .bam file isn’t helpful here. Here’s the FMR1 promoter viewed as a .bam file in IGV
We can use the dnase_wig_tracks.py function to generate WIG files based on a BAM file a list of regions of
interest. Go ahead and look at the help options for dnase_wig_tracks.py and see if you can work out how to generate
the wig files and load them in IGV:
$ dnase_wig_tracks.py -h
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Note: By default, cuts on the reverse strand will be reported as negative numbers (for visualisation). If you want to
be using this data for something else, you can pass the -r flag, which will use the real number of cuts.
Once you do this, you can load the data into IGV and it should look like this
3.8 Visualising Footprints as average plots
So you have your set of footprints, or your set of footprinted motifs (E-box, CTCF, NFE2, etc...) and you want to see
what they look like. Average profile plots illustrating DNase activity surrounding a set of regions are frequently used
in papers, like this.
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Have a look at the help for dnase_average_profile.py and see if you can work out how to display the average
profiles for the supplied 3000 K562 CTCF footprinted motifs, K562_3000_CTCF_Footprints.bed (or the
footprints you discovered earlier). In order to get the locations of specific footprinted transcription factors, you’ll
need to perform motif finding. Have a play around with the parameters as well:
$ dnase_average_profile.py -h
Tip: This script uses matplotlib to generate the output, so it will write a filetype based on the file extension provided
(e.g. out.png or output.pdf). Use the file extension you want, and the plot will be generated as that type.
3.9 Visualising Footprints as heat maps
Lots of the time, people don’t want averages of the data (like above), but want a heatmap showing the raw data (ideally,
combine both in one plot!) like this
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Which illustrates footprints for the AP-1 complex in K562 cells. For this you’ll need JavaTreeView downloaded.
dnase_to_javatreeview.py will generate a CSV file that you can put straight into JavaTreeView to visualize
your data like above. Once again, go ahead and open up the help:
$ dnase_to_javatreeview.py -h
You’ll notice there are a lot of options here. Go ahead and use some data (e.g. the K562 CTCF footprints or the
footprints you calculated earlier) to make a CSV file using the script.
To actually view the data, load up javatreeview using:
$ java -Xmx4G -jar TreeView.jar
and then use File->Open, change the file format box to All Files and then chose the CSV file generated from
the script above. You’ll then want to go into Settings->Pixel Setting and check all the Fill boxes. Go
ahead and play around with the contrast! Play around with the parameters in the dnase_to_javatreeview.py
script and see how it affects the visualisation.
3.10 Motif Finding
Most of the things that people want to do with their footprints is look for enriched motifs, annotating the nearest TSS
to specific factors, etc. I usually use HOMER for this as it fits in with my workflow. We won’t have time to go into
how to do these analyses here, but HOMER has a really good tutorial on how to find motifs here and has generally
very good documentation on annotating genomic regions. I highly recommend you pour yourself a nice glass of wine
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and settle down in a fancy leather chair and read the website thoroughly. Don’t go running in, guns blazing, running
all the tools without understanding all the parameters!
Danger: Make sure when using HOMER‘s findMotifsGenome.pl script, make sure to use the -size
given parameter or it will just search for all motifs within several hundred basepairs of the footprint!
3.11 Leveraging pyDNase for fun and profit (mainly fun)
If you’ve survived this far, well done! Fire up the python terminal:
$ python
And head over to the advanced documentation here and here, which introduces you to how to load up data from a
BAM file directly. I don’t anticipate many people will get this far, but if you do, I will come and talk you through how
to proceed here if you’re having trouble following the API specification (although it is a fairly simple API).
Can you answer these questions? If you can’t think of how to approach the problem, come and ask me and I’ll give
you some pointers.
• For the set of 1000 DHSs provided in a bed file - can you work out me the mean number of DNase cuts per
DHS?
• Can you plot a histogram of the strand imbalance (the ratio of cuts on the +ve strand to -ve) for these 1000
DHSs?
• Can you write a BED file of these 1000 DHSs annotated with the number of DHS cuts they have in them?
117

Chapter 4
Discussion
4.1 Footprinting analysis of DNase-seq data
The Wellington paper describes the rst open-source software implementation of
a de novo algorithm for predicting transcription factor footprints using DNase-seq
data (Wellington). Wellington is designed to detect footprints based on the ob-
served strand imbalance that surrounds known protein-DNA interactions in the
double-hit protocol, which increased the predictive performance of DNase-seq foot-
printing over previous analysis methods [2, 80]. It was hypothesised that the strand
imbalance is a natural consequence of the size selection step of the double-hit pro-
tocol, which puries ca. 50-200 base pair DNA fragments produced by DNase
I digestion. This was later conrmed by two independent studies that assessed
the impact of various experimental parameters in the DNase-seq library prepara-
tion protocol [52, 64], highlighting the importance of understanding the biological
methods in detail before embarking on the design of analytical techniques.
Wellington was objectively validated against other footprinting and DNase-
seq analysis methods using a wide range of techniques, some of which were well-
established (i.e. Receiving Operating Characteristic (ROC) analysis using ChIP-
seq as a gold standard), along with other metrics such as motif content and phy-
logenetic conservation. In doing so, concerns were raised with previous validation
methods relying almost purely on ChIP-seq recapitulation. A major limitation of
validation of transcription factor binding site predictions is the belief that ChIP-
seq itself is an objective truth (as discussed in Chapter 1). By designing algorithms
to recapitulate ChIP-seq data, the risk of over-tting data to the small number of
ChIP-seq experiments becomes very real. Ny solely evaluating footprinting algo-
rithms on the ability to recapitulate ChIP-seq engenders a blind spot in DNase-seq
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footprinting due to reluctancy of predicting a transcription factor binding with-
out a corresponding ChIP-seq result, or vice versa, where there are results from
ChIP-seq but there is no corresponding footprint, which could be due to many
biological reasons such as transient or indirect binding. Whilst the performance of
Wellington has subsequently twice been independently validated ([53, 80]), these
authors still solely rely on area AUROC of ChIP-seq recapitulation as a perfor-
mance measure, which heavily favours the correct prediction of True Negatives
over False Positives in DNase-seq footprinting studies. Even though the AUROC
can be misleading with regards to the performance of a predictor, analysis of the
shape of the ROC curve can be informative to the performance characteristic over
the entire sensitivity range, i.e. the initial slope of the ROC curve is indicative of
the PPV of a footprinting algorithm.
It was suggested in this publication that ENCODE's claim that there are 0.4 to
2.3 million genomic footprints, dependent on the cell type [66], was exaggerated,
due to the large number of motif-less and low conservation scoring false positives
present in the ENCODE predictions. Others have also commented on the exag-
geration of ENCODE's claims of `functionality' in the human genome due to the
distinct lack of sequence conservation in `functional' elements [69], a nding which
recapitulates the discovery presented here e.g. a large set of the ENCODE foot-
prints are not conserved and have low motif content. However, it remains dicult
to determine exactly how many binding sites there may actually be in a given
DNase-seq dataset, and therefore the human genome, as DNase-seq footprinting
in humans is still limited by sequencing depth[2, 66]. As the cost of sequencing
continues to decrease, the predictive power of DNase-seq footprinting techniques
may eventually reach a limit.
Signicantly reducing the number of false-positive predictions and increasing
the positive predictive power gained from DNase-seq has the largest impact on
assays that have no technical or biological replicates, which is often the case with
primary tissues such as patient samples { even the ENCODE DNase-seq data
performed on cell lines lack biological or technical replicates. Ultimately, the
preference for high specicity over high sensitivity depends on the analysis being
performed, but by allowing the user of the tool to alter the stringency of the
parameters, this decision can be based on the performance characteristics of the
results that they nd acceptable for their downstream analyses.
The setting of default parameters for Wellington was challenging. Whilst
scripts to perform the analysis along with the parameters used in the paper were
provided, the reviewers insisted that the method should be a `point and click'
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exercise, without the need for the user to specify default parameters. Such a
philosophy all too easily leads to overtting, as all the data analysed here was
generated in one laboratory | and there was no evidence that the same param-
eters would be suitable for data generated by others. Because of the setting of
default parameters, a large number of users in other labs have commented on the
stringency of the default parameters. This issue is not too dissimilar to the prob-
lems that arose with the popular aligner, Bowtie [81]. In Bowtie 1, there were no
default parameters and the user had to read extensive documentation in order to
perform an alignment, which led to user confusion. In Bowtie 2 [82], the develop-
ers provide a default set of parameters so the tool can be run easily, but without
the user understanding the parameters behind the software. As such, many of
the emails from people would be easily answered if the users had read the paper
and documentation and understood the role of each parameter in the Wellington
algorithm.
In the remainder of the thesis, the underlying Wellington method remains
unchanged apart from implementation changes to increase computational speed.
It remains to be seen how footprinting algorithms can be further enhanced. Even
though it is known that the pattern of the DNase-seq signal surrounding protein-
DNA binding events is transcription factor-dependent [53, 66, 67], Wellington
outperforms CENTIPEDE, a method designed to use the transcription factor-
specic footprint patterns, even though a single model to search for all possible
transcription factor-binding events in a DNase-seq data set is used. Two further
footprinting methods have been published since the publication of the Wellington
paper: PIQ [83] and DNase2TF [53]. PIQ appears to have more false positives than
true positives, but because of the Area under the ROC (AUROC) statistic used
to validate this, the number of true negatives can create the impression that this
method performs adequately. DNase2TF, whilst using a much more complicated
model that incorporates corrections for the DNase I cutting bias (the data for
which were not available when Wellington was developed) only yields moderate
improvements over Wellington using the AUROC statistic (discussed further in
Section 4.4).
To encourage further investigations, pyDNase and Wellington were released
as a Python package for the fast and easy analysis of DNase-seq data. It was
hoped that this would accelerate both the analysis of DNase-seq data and the
development of further footprinting algorithms. It has been reassuring to observe
that in just over 1 year since publication, other research groups are benchmarking
new analyses against Wellington [53, 80], and applying the Wellington to biological
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data in a research article [84]. Additionally, several researchers have even taken
time to report bugs and provide code xes to the pyDNase github page.
4.2 Application of Wellington to clinical samples
Shortly after the development of Wellington, it was utilised in an integrative ge-
nomics project aimed (Appendix A) at identifying the core transcriptional network
regulating self-renewal and dierentiation block in t(8;21) acute myeloid leukaemia
(AML) [85]. The t(8;21) translocation is a common chromosomal rearrangement
that account for 10% of diagnosed AML [86, 87], giving rise to the RUNX1/ETO
fusion protein. Here the DNA binding domain of RUNX1, a transcriptional activa-
tor essential for haematopoietic identity [88] becomes fused to the transcriptional
repressor ETO. This fusion leads to the formation of an aberrant transcription
factor. The RUNX1/ETO fusion protein binds RUNX1 DNA motifs (TGYGGT)
in the genome, but leads to systemic transcriptional repression rather than tran-
scriptional activation [89].
Wellington was used to investigate the similarity of RUNX1/ETO binding
characteristics between the t(8;21) Kasumi-1 cell line and two patient-derived
samples in order to validate Kasumi-1 cells as a valid model system. This was
illustrated through the use of footprinting analysis of peaks found in the intersec-
tion of RUNX1/ETO, RUNX1, LMO2, and HEB ChIP-seq experiments from the
Kasumi-1 cell line. Motif searching was then performed for the ETS, RUNX1, and
HEB (E-box) motifs, where it was that Wellington was accurately predicting these
transcription factor binding sites in the clinical samples, and that all four motif
show footprints, illustrating that all proteins are directly in contact with the DNA
here, and that the clinical sample show similar binding characteristics to the cell
line. Footprinting DNase-seq data from the clinical sample within RUNX1/ETO
peaks from Kasumi-1 cells revealed co-localisation of PU.1, RUNX1, ERG, and
SCL motifs in these peaks via a co-occurrence analysis. Here, using one DNase-seq
experiment, we correctly identied RUNX1/ETO binding partners.
This study demonstrated the ability of DNase-seq footprinting analysis as re-
placement for ChIP-seq for the identication of transcription factor binding sites
by recapitulating the known transcriptional complex of PU.1, RUNX1, ERG, and
SCL through the complementary use of RUNX1/ETO ChIP-seq with DNase-seq
footprinting to identify binding partners. The validation of this method on clin-
ical samples is of great importance, where it is not feasible to perform multiple
ChIP-seq experiments due the large volumes of cellular material needed for sev-
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eral immunoprecipitations; this is the rst study to report successful DNase-seq
footprinting on clinical samples.
From a computational standpoint, it was reassuring that theWellington method
performed adequately on data generated externally of ENCODE. As the methods
had diering starting material of clinical samples (which are much more heteroge-
nous than the cell lines used in ENCODE), and a dierent DNase digestion proto-
col, with the removal of the nuclear isolation stage used in the ENCODE protocol.
Nevertheless, the default Wellington parameters used in Chapter 2 were adequate.
Unfortunately, dierential DNase-seq footprinting, as described in Chapter 3, was
not available for this paper, as this would have helped link the binding of specic
transcription factors to changes in gene expression. Overall, this study demon-
strated of the power of using footprinting in a functional genomics focussed anal-
ysis of a biological system, augmenting several other assays in order to provide
novel biological insights.
4.3 Dierential DNase-seq footprinting
The Dierential Footprinting paper introduces Wellington-bootstrap, an extension
to Wellington that allows for the identication of dierential footprints between
two datasets. This addresses the unmet need for a method that can identify dif-
ferences in DNase-seq footprints between two datasets beyond performing simple
present/absent footprinting comparisons. The method itself follows a conceptually
simple approach: Wellington was used to identify a footprint in a dataset, and it
was then determined whether the second dataset recapitulates this footprint by
comparing combined data from a second dataset to that where data from the
second dataset was randomly shued.
This assumes that the Wellington parameters (i.e. the footprint and shoulder
regions) between the two datasets are comparable. Whilst more complicated anal-
yses that accounted for the ability for footprints to either grow or shrink in size,
or even shift several basepairs, were considered, it was discovered that this did not
yield a dierence in the results, it led to a ca. 10 increase in the time taken to
perform an analysis due to the additional parameters in the resulting model. It
could be that events such as footprint size changes and footprint shifting are rare,
undetectable by DNase-seq, or do not occur in a large number within the datasets
that were analysed here.
Whilst the DNase I cutting bias has been thoroughly quantied since the pub-
lication of the Wellington paper [51{54] it was decided not to alter the Wellington
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method to account for the DNase I cutting bias when calculating Wellington scores.
Whilst there have since been two novel footprinting methods (DNase2TF [53], and
an unnamed method with no software implementation [54]) that accounts for the
DNase I cutting bias, the authors did not perform a comprehensive analysis of how
much the bias correction contributes to their footprinting performance indepen-
dent of their choice of statistical model. Because of this, a comprehensive analysis
of how bias correction aects footprinting performance is warranted before any
alteration of the underlying Wellington method.
A limitation of the Wellington-bootstrap method is that the method only per-
forms comparisons between two datasets, and the method had to be applied in a
pairwise fashion over 7 datasets in order to gain an understanding of the transcrip-
tion factor specicity. However, as this approach has time complexity of O(n2),
at roughly 192 CPU hours per comparison on a 2.66 Ghz Intel Xeon (Nehalem)
processor, the computational time required becomes prohibitive with an increase
in the number of datasets being analysed. Computational as well as analytical
challenges must be solved simultaneously in order to gain the most power out
of comparative DNase-seq footprinting studies. Considering the competitiveness
of the development of DNase-seq footprinting strategies (with at least 8 analysis
methods described in the last 5 years), there has been little focus on the speed of
the implementation compared to the scientic validation apart from speed bench-
marks released in the latest method, DNase2TF [53]. As part of the Dierential
Footprinting paper, signicant updates to the underlying pyDNase library were
released (pyDNase 0.2.0). Here, larger portions of the Wellington algorithm were
written in C (140 lines of code in C in the original Wellington vs 399 lines of code
in C in pyDNase 0.2.0). Additionally, the code was parallelised using python's
multiprocessing module | on a desktop machine with two 2.66 Ghz quad core
Intel Xeon (Nehalem) processors. This reduced the tine required to calculate the
Wellington scores on a single dataset from around 24 hours to about 30 minutes.
Footprinting multiple DHSs is an `embarrassingly parallel'1 problem, and there-
fore scales virtually linearly with the number of CPUs dedicated to the task. A
`proof of concept' version of Wellington that used OpenMPI for use on a cluster
environment allowed the computation of results in 5 minutes by leveraging hun-
dreds of cores at once. The OpenMPI implementation was not published alongside
this paper, though, as high-performance compute environments are usually highly
bespoke, and it would have been problematic to support an OpenMPI version. It
is envisaged that a parallelised iPython version will be released to make use of
1The job can easily be split into one task per DHS.
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cluster computer environments, as the underlying iPython parallelisation engine
provides a backend to interface with many popular job scheduling environments.
The Wellinton-bootstrap method opens the door to be able to build better
models for gene regulation by comparing changes in transcription factor occupancy
on a massively parallel level that is only possible with DNase-seq footprinting.
Attempting to use ChIP-seq based studies to perform a similar analysis would not
only be economically unfeasible at the current cost of high-throughput sequencing,
but would require knowledge of all the transcription factors of interest.
The results gained from the comparisons of the data from 7 clinical samples
from the NIH Roadmap epigenomics project [90] were only possible by DNase-seq
footprinting with Wellington. Our paper describes the rst DNase-seq footprinting
analysis on cells from healthy donor, and in addition to 5 haematopoietic cell
types that were isolated via Fluorescence Activated Cell Sorting (FACS) from the
same healthy donor. Using Wellington Bootstrap, it was possible to dierentiate
between the isolated populations purely based on transcription factor motif content
within dierential footprints, with minimal prior knowledge of the system.
It was also shown that changes in footprinting status in gene promoters can be
linked to changes in gene expression at neighbouring genes, where using dierential
DHS scores linked with a motif is unable to do so. This is most likely due to the
large size of the DNase hypersensitive regions (up to 2000bp) and the transcription
factor motif-rich landscape of gene promoters providing many false positives when
performing motif searches in promoters without the use of footprinting analyses.
Combined with chromatin conformation capture techniques, this method could
be used to link the binding of transcription factors at enhancers to gene expres-
sion without the need for antibodies. Alternatively, another approach that would
be interesting would be a similar analysis to the DNaseI sensitivity quantitative
trait locus (dsQTL) approach [33], but instead of linking DHS strength to gene
expression using a population study, linking footprint occupancy to gene expres-
sion across the genome. A weakness of this study was the lack of experimental
validation of the predicted dierential binding sites. ChIP-seq data for a set of
transcription factors across several of the clinical samples may allow the rigor-
ous validation of the predictions, providing better estimates of the sensitivity and
specicity of the method.
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4.4 Outlook
At the onset of this project, DNase-seq footprinting was a technique with only a
handful of documented analysis approaches, almost none of which had software im-
plementations, and those that did required considerable of data processing from the
raw sequencing data into non-standardised le formats in order to perform analy-
ses. Wellington was introduced as a leader in the DNase-seq footprinting eld. Not
only did it objectively perform better over a wide range of performance metrics,
which has subsequently been independently validated [80]. Wellington was dis-
tributed as an easy-to-use software package that did not rely on non-standardised
le formats, instead opting to use the industry standard BAM le format for se-
quence alignments [91]. Wellington was built on top of the pyDNase software
library, a Python library that allows for the easy interaction with DNase-seq data,
containing several convenience scripts that demonstrate the power of the pyDNase
library along with a DNase-seq footprinting tutorial.
The development of novel DNase-seq footprinting analysis methods has been
steadily increasing, with several unpublished (MOCCA, DNaseR) and published
(PIQ [83], DNase2TF [53]) methods that perform DNase-seq footprinting having
been released since the publication of theWellington paper. However, the develop-
ment of new footprinting methods has proven to be distinctly less competitive than
other functional genomic studies such as ChIP-seq and RNA-seq. This is probably
due to the relatively small number of groups able to perform the DNase-seq exper-
imental protocol, which is inherently more dicult to perform (and analyse) than
ChIP-seq [52, 92]. In addition to the technical challenges involved in performing
DNase-seq experiments, the cost of the method is also prohibitive, with samples
with read counts of up to 1.2 billion reads per sample still yielding increasing
numbers of footprints | it is hard to estimate at what read depth the number
of footprints detected will plateau. The risk inherent in performing DNase-seq is
therefore seen as relatively high, especially given that the analysis methods are
relatively immature compared to ChIP-seq.
There are two distinct approaches to footprinting present in the literature,
those that partition all occurrences of a motif in a genome into bound and un-
bound states, and those that operate directly on the data with no prior knowl-
edge. Both of these approaches seek to answer dierent questions, although the
partitioning approach is easier to validate due to being easily comparable to
ChIP-seq. However, not enough distinction is made in the literature between
true de novo footprinting algorithms (The Hesselberth method [61], the Neph
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Method [66], Wellington [2], DNaseR (unpublished: http://www.bioconductor.
org/packages/release/bioc/html/DNaseR.html) and DNase2TF [53]) and motif-
centric partitioning approaches (CENTIPEDE [67], MOCCA (unpublished: https:
//github.com/ajank/mocca), PIQ [83]).
Additionally, some of these footprinting methods were designed for and only
tested on the original single-hit protocol (CENTIPEDE, Hesselberth method),
whilst the others were designed around and only tested on the double-hit protocol
(Neph method, DNase2TF). It appears that only Wellington and MOCCA have
been comprehensively tested against both methods at the time of publication. A
recent study highlighted the eect of library preparation protocols on the quality
of sequencing data [52], illustrating the importance that analytical techniques need
to be developed alongside new experimental methods in order to gain the great-
est predictive accuracy power from DNase-seq footprinting. A potential avenue
of interest for further algorithmic development is the assessment of allelic dier-
ences in TF binding. Even though the ability to detect allelic transcription factor
footprints has been demonstrated by utilising the underlying sequence data from
DNase-seq to detect heterozygous SNPs and subsequently phase the the align-
ments [66], no footprinting models currently take allelic dierences into account
when performing footprinting. Where variants exist that disrupt transcription
factor binding, analysing the data on an allele-by-allele basis would prevent a false
negative prediction in the cases where combining the data from the alleles conceals
a footprint, and could provide an estimate to the number of allelic transcription
factor binding sites within the genome.
From the benchmarking performed in the Wellington paper, it appears that
for some transcription factors the performance of almost all analytic approaches
are reaching a common upper limit of predictive accuracy. This limit is also
seen in other benchmarking eorts [53, 80]. This saturation phenomenon could
highlight either the unsuitability of ChIP-seq data to be a `gold standard', or that
all analyses are reaching a upper bound on the predictive power of DNase-seq
data. It remains to be seen if further renements to the experimental protocol,
such as the use of novel nucleases such as benzonase and cyanase [64] will `unlock'
further predictive power of DNase-seq footprinting.
Another possible explanation for the discrepancies between DNase-seq foot-
printing and ChIP-seq data is the reduced ability for DNase-seq to recapitulate
more transient protein-DNA interactions due to the lack of the cross linking present
in the ChIP-seq protocol, which can capture much shorter interactions. It has
been suggested that shorter binding time of a transcription factor to DNA leads
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to `shallower' footprints, [53], but this study was limited to only select transcrip-
tion factors, and the cutting bias on DNase I was not taken into account when
making this observation, so it remains to be seen if this is true for all transcription
factors. Further time course assays would help shed light in this area, revealing
the time resolution of DNase-seq footprinting by capturing the dynamics of the
transcription factor binding site landscape over time.
With DNase-seq being a recent and relatively expensive assay, the lack of any
replicates in the ENCODE Digital Genomic Footprinting DNase-seq data makes
quantifying the reliability of the method dicult, has not allowed the quantica-
tion of technical and biological variation in the assays. However, the DNase-seq
data released as part of the NIH Roadmap Epigenomics Consortium [93] exists for
specic subpopulations of cells for a number of individuals. Analysis of the data
could assess the consistency of the chromatin and transcription factor landscape
for the same cell population between individuals (i.e. biological replicates).
A major limitation preventing the widespread adoption of DNase-seq is the
inability of the method to scale to a low (or even single) cell level, as with ChIP-
seq [94]. This is because a maximum of two fragments (for diploid cells) can be
generated per DHS per cell. It therefore becomes impossible to resolve the tissue
heterogeneity problem in DNase-seq footprinting | does a `weak' footprint in
DNase-seq data correspond to weak binding in the entire population of cells in
the assay, or to strong binding in a small subset? However, an improvement in
this area might be on the horizon through the use of another recently described
method used to map chromatin accessibility. The assay for transposase-accessible
chromatin by sequencing (ATAC-seq) that uses the ability of a tranposase to
integrate into DNA as a measure for DNA accessibility and can be performed on
as little as 500 cells [95]. Currently, it is uncertain whether it is possible to analyse
the resulting data to identify protein-DNA interactions at the same scale that can
be achieved with DNase-seq data.
Beyond the development of new analytical models for footprinting DNase-seq
data, other computational challenges, specically software engineering hurdles,
have the possibility of being a major limiting factor to further innovations in the
area. To allow for more comprehensive comparative analyses between large num-
bers of experiments to take place (i.e. to perform a similar analysis as undertaken
in the Dierential Footprinting paper for all 41 ENCODE samples), computational
eciency of the underlying methods becomes important. A recent integrative anal-
ysis of DNase-seq experiments in assessing the impact of DHSs on gene expression
[33] had to implement an entire custom pipeline for their analysis (and neglected to
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publish the code behind it), which illustrates the barrier of entry for these methods
to become mainstream. DNase2TF claims to be the fastest method for footprint-
ing, with a single dataset only taking around 30 minutes to analyse. The usefulness
of their method is somewhat detracted by their use of non open-source software
(MATLAB), the lack of software documentation, and the necessity to process les
into non-standardised le format. In the updates introduced to Wellington as part
of the Dierential Footprinting paper, Wellington's run time is now of comparable
magnitude.
4.5 Conclusions
The results presented in this thesis represent signicant advances in the prediction
of transcription factor binding sites from DNase-seq data, and provide free and
open source software tools and comprehensive documentation that facilitate the
application of the Wellington and Wellington-bootstrap methods. It is hoped that
through the increased specicity of DNase-seq footprinting alongside demonstra-
tions of the power of the method in clinical research scenarios inspire continued
research into the development of DNase-seq footprinting methods and stimulates
interest in the biological insights the data have to oer.
Because of the publication of the Wellington algorithm as an easy-to-use and
well-documented software tool, the ability for others to incorporate DNase-seq
footprinting analyses into their research is no longer limited to those that have
extensive expertise in DNase-seq signal processing. DNase-seq footprinting com-
plements other genomic assays in a number of ways: by providing information
about the transcriptional regulation landscape without having to specify interest
in a factor a priori [66, 84], by supplementing ChIP-seq experiments in order to
dierentiate direct from indirect binding[85], or as a direct surrogate for ChIP-seq
by integrating PWM data [67, 83].
Transcription factors remain attractive targets for drug design due their in-
volvement with almost all cellular processes [96], and understanding their be-
haviour is therefore pivotal in the ability to construct models that explain gene
expression. Even though transcriptional regulation becomes aberrant in a large
number of cancers [97, 98], only three transcription factor families are currently
targeted by cancer treatments | thiazolidinediones target the retinoid X recep-
tors (RXRs), tamoxifen targets the oestrogen receptor, and alitretinoin targets
the retinoic acid receptors (RARs) [99]. In the Dierential Footprinting paper,
dierential footprinting is used in order to reveal the transcription factors driving
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cell identities. However, interpreting dierential occupancy patterns will not only
allow for the identication of the transcription factor networks driving healthy
cell types, but also distinguish the events that dierentiate normal from diseased
cellular states. Moreover, these analyses will provide evidence for certain factors'
involvement in specic cancers, which in turn, will identify disease-specic tran-
scription factors and signalling pathways as targets for therapeutic interventions
in stratied approaches to treating cancer.
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SUMMARY
Oncogenic transcription factors such as RUNX1/
ETO, which is generated by the chromosomal
translocation t(8;21), subvert normal blood cell
development by impairing differentiation and driving
malignant self-renewal. Here, we use digital foot-
printing and chromatin immunoprecipitation se-
quencing (ChIP-seq) to identify the core RUNX1/
ETO-responsive transcriptional network of t(8;21)
cells. We show that the transcriptional program
underlying leukemic propagation is regulated by a
dynamic equilibrium between RUNX1/ETO and
RUNX1 complexes, which bind to identical DNA sites
in a mutually exclusive fashion. Perturbation of this
equilibrium in t(8;21) cells by RUNX1/ETO depletion
leads to a global redistribution of transcription factor
complexes within preexisting open chromatin, re-
sulting in the formation of a transcriptional network
that drives myeloid differentiation. Our work demon-
strates on a genome-wide level that the extent of
impaired myeloid differentiation in t(8;21) is con-
trolled by the dynamic balance between RUNX1/
ETO and RUNX1 activities through the repression of
transcription factors that drive differentiation.
INTRODUCTION
Lineage-specific cell differentiation is controlled by the estab-
lishment of specific gene-expression patterns in normal cells,
and interference with this process underpins oncogenesis.
Hematopoiesis is one of the best-understood developmental
pathways and involves dynamic alterations in transcriptional
programs, which regulate progression along the differentiation
hierarchy (Pimanda and Go¨ttgens, 2010). Individual cellular dif-
ferentiation states are defined by transcriptional networks
composed of combinations of transcription factors that bind to
specific sets of cis-regulatory elements (Davidson, 2010). There-
fore, experimental analysis of the binding activities of multiple
factors has served as a means of identifying crucial regulators
for a specific cell type (DeVilbiss et al., 2014; Tijssen et al.,
2011). However, normal differentiation is impaired in cancers,
leading cells to adopt a new malignant identity. Unique insights
into processes that control development toward both normal
and perturbed differentiation states can be gained from a
detailed examination of the mechanisms utilized by leukemic
transcription factors such as PML/RARA, MLL fusion proteins,
and RUNX1/ETO. These factors reprogram the epigenome and
thereby block the hierarchical succession of normal transcrip-
tional networks.
Leukemias are characterized by good experimental accessi-
bility and, compared with many carcinomas, relatively high
genetic stability, which makes them very amenable to investiga-
tions of general as well as specific mechanisms of oncogenesis.
Acute myeloid leukemia (AML) is the second most common leu-
kemia and is a heterogeneous disease with impaired myeloid
differentiation (Valk et al., 2004). The hallmarks of AML are mul-
tiple somatic mutations, including genetic rearrangements that
affect signal transduction and gene expression. This includes
mutations in genes encoding DNA methylases, chromatin mod-
ifiers, and transcription factors. Many such mutations affect
transcription factors that are crucial for the development of he-
matopoietic stem cells or for terminal myeloid differentiation,
such as RUNX1 and C/EBPa, respectively (Gaidzik et al.,
2011; Michaud et al., 2002; Pabst et al., 2001b; Snaddon
et al., 2003). However, the molecular details of how suchmutant
transcription factors cause alterations of the epigenome are still
insufficiently understood. In addition, so far no experiments
have defined the core transcriptional network of a specific
type of AML and dissected the role of mutated transcription fac-
tors within this network.
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One of the best-characterized chromosomal rearrangements
found in AML is the t(8;21) translocation, which accounts for
approximately 10% of all AMLs. This translocation fuses the
DNA-binding domain of the hematopoietic master regulator
RUNX1 to almost the entire ETO protein, which is an adaptor
protein for histone deacetylase (HDAC) complexes (Miyoshi
et al., 1993). The resulting RUNX1/ETO fusion protein lacks the
transactivation domain of RUNX1, resulting in major differences
in the biological activities of the two proteins. RUNX1 normally
recruits transcriptional activators and binds to DNA as a hetero-
dimer with core-binding factor b (CBFb). The RUNX1/ETO fusion
protein also interacts with CBFb but functions as a RUNX1/
ETO tetramer (Liu et al., 2006), and like ETO itself, it also inter-
acts with NCOR and SIN3A corepressors (Amann et al., 2001).
Consequently, this chromosomal rearrangement converts a
transcriptional activator into a repressor. However, there is evi-
dence that RUNX1 also interacts with HDACs via SIN3A and
can act as a repressor (Reed-Inderbitzin et al., 2006; Taniuchi
et al., 2002). Proteomic and chromatin immunoprecipitation
(ChIP) analyses in t(8;21) cell lines have demonstrated the asso-
ciation of RUNX1/ETO with multiple hematopoietic regulators
known to be involved in the regulation of hematopoietic stem
cell genes (Wilson et al., 2010). The RUNX1/ETO complex
consists of the E box binding transcription factors HEB and
LYL1 and the bridging factors LMO2 and LDB1. In chromatin,
this complex interacts with the ETS family members FLI1 and
ERG, and these interactions are required for the stability of the
complex and its leukemogenicity (Martens et al., 2012; Sun
et al., 2013).
Genome-wide analyses in t(8;21) cell lines and in patients via
ChIP sequencing (ChIP-seq) identified thousands of RUNX1/
ETO-binding sites (Ben-Ami et al., 2013; Martens et al., 2012;
Ptasinska et al., 2012; Saeed et al., 2012), but the role of specific
binding sites within the AML-specific transcriptional network is
unclear. All t(8;21) AML cells retain an intact copy of RUNX1,
which is required for cell survival—a feature that has also been
observed in other CBF leukemias (Ben-Ami et al., 2013; Goyama
et al., 2013). RUNX1 and RUNX1/ETO each drive the expression
of alternate subsets of genes (Ben-Ami et al., 2013). However,
60% of the RUNX1/ETO sites are shared with RUNX1 (Ptasinska
et al., 2012), and whether there is a direct dynamic competition
between RUNX1/ETO and RUNX1 for the same genomic sites
remains to be investigated.
The differentiation of t(8;21) cells is blocked at an early myeloid
progenitor stage and so far the core transcriptional program un-
derlying this block has been elusive. Changes in RUNX1/ETO
expression in t(8;21) AML cells are associated with both up-
and downregulated genes, and individual RUNX1/ETO-bound
genomic sites recruit both histone acetyltransferases (HATs)
and HDACs (Follows et al., 2003; Ptasinska et al., 2012; Sun
et al., 2013; Wang et al., 2011). However, we previously showed
that the genome-wide loss of RUNX1/ETO binding correlates
with increased histone H3 lysine 9 (H3K9) acetylation (Ptasinska
et al., 2012). In addition, RUNX1/ETO depletion is associated
with the upregulation of C/EBPa, a driver of myeloid and, in
particular, granulocytic differentiation (Zhang et al., 1997). More-
over, RUNX1/ETO has been shown to sequester C/EBPa from its
murine promoter, thereby interfering with C/EBPa expression
(Pabst et al., 2001a). RUNX1/ETO knockdown causes release
of the differentiation block, resulting in a gene-expression
pattern that resembles that of granulocytes andmonocytes (Pta-
sinska et al., 2012). Taken together, these results suggest that
RUNX1/ETO-mediated reprogramming of the epigenome in-
volves a complex and so far unexplored interplay of different
transcription-factor and chromatin-modifying cofactor activities.
To date, we have gained little insight into the nature of this
reprogrammed network and the sequential order of factors
required to restore normal myeloid cell functions.
In this study, we addressed these issues by investigating the
dynamic changes in global transcription-factor-binding patterns
that occur following depletion of RUNX1/ETO. To that end, we
combined ChIP-seq for multiple factors, DNaseI footprinting,
and transcriptome analysis to identify the core transcriptional
network of t(8;21) AML cells, and then characterized changes
in these networks upon RUNX1/ETO knockdown. These ana-
lyses revealed a dynamic equilibrium between RUNX1/ETO
and RUNX1 complexes competing for identical genomic sites.
Results from sequential ChIP (re-ChIP) show that the two com-
plexes have similar accessory-factor compositions but differ in
their preference for the recruitment of coactivators and core-
pressors. Using a digital DNaseI footprinting approach, we found
that both t(8;21)-positive cell lines (Kasumi-1 and SKNO-1) and
patient-derived primary AML cells with the t(8;21) translocation
(patient cells) share the same pattern of binding-site occupancy.
Within this core transcriptional network, RUNX1/ETO-bound loci
are predominantly associated with transcriptional repression.
Furthermore, loss of RUNX1/ETO establishes a differentiation-
associated transcriptional network dominated by de novo bind-
ing of C/EBPa resulting from the upregulation of CEBPA gene
expression. Our results demonstrate that the block in myeloid
differentiation in t(8;21) AML results from the dynamic interfer-
ence of RUNX1/ETO with cis-regulatory elements that normally
are destined to change transcription-factor assemblies during
myeloid differentiation, notably those that increase binding of
RUNX1 and C/EBPa.
RESULTS
Transcription-Factor Occupancy Patterns Are Highly
Comparable between t(8;21) Cell Lines and Patient Cells
To define the RUNX1/ETO-responsive core transcriptional
network and monitor dynamic changes associated with alter-
ations in RUNX1/ETO status, we utilized Kasumi-1 cells, which
represent a well characterized and widely used model system
for t(8;21) AML (Ben-Ami et al., 2013;Martens et al., 2012; Ptasin-
ska et al., 2012; Sun et al., 2013). We measured the binding of
multiple transcription factors in these cells using genome-wide
ChIP-seq and performed perturbation experiments by transiently
knocking down RUNX1/ETO expression. We then monitored the
consequences using ChIP-seq and RNA sequencing (RNA-seq)
analyses (Heidenreich et al., 2003; Ptasinska et al., 2012; Table
S1). We used antibodies against RUNX1, the ETO moiety of
RUNX1/ETO, LMO2 as a member of the RUNX1/ETO complex,
RNA-Polymerase II, and acetylated histone H3 for ChIP. To
obtain a more complete picture of the composition of RUNX1
and RUNX1/ETO-associated transcription-factor complexes
Cell Reports 8, 1974–1988, September 25, 2014 ª2014 The Authors 1975
149
without RUNX1/ETO knockdown, we also analyzed publicly
available data for the E box protein HEB (Martens et al., 2012;
Ptasinska et al., 2012). In order to follow additional alterations
in the epigenome after RUNX1/ETO knockdown, we also
measured the binding of PU.1 and C/EBPa, which are both
required for myeloid differentiation (Scott et al., 1994; Zhang
et al., 1997). We identified high-confidence transcription-factor
binding-site peaks by integrating ChIP data with DNaseI-seq
data before and after RUNX1/ETO depletion, and considered
only those peaks that were located within DNaseI hypersensitive
sites (DHSs).
RUNX1/ETO exists as a complex with other transcription
factors (Sun et al., 2013). Consistent with these findings, we
observed a colocalization of RUNX1/ETO, RUNX1, HEB,
LMO2, C/EBPa, and/or PU.1 binding at many DHSs in Kasumi-
1 cells, as exemplified by the LMO2 locus (Figure 1A). Closer ex-
amination of the genome-wide occupancy patterns of LMO2 and
HEB revealed that a substantial overlap existed among LMO2,
HEB, and RUNX1/ETO binding sites (Figure S1A). Although there
was some overlap with the other factors, the PU.1 and C/EBPa
binding sites did not closely cluster as a group with those for
the RUNX1/ETO complexes in Kasumi-1.
We next sought to determine whether the RUNX1/ETO and
RUNX1 binding patterns identified in Kasumi-1 cells were shared
with patient cells. First, we performed a DHS analysis on patient
cells and normal CD34+ hematopoietic stem and precursor cells
(CD34+ cells) derived from the peripheral blood of healthy do-
nors. This fraction is enriched for stem and multipotent progen-
itor cells. DHSmapping was complemented by RUNX1/ETO and
RUNX1 ChIP analysis. However, the large quantity of material
required for this approach precluded analysis of patient cells.
Therefore, to determine which subsets of DHSs from patient
cells overlap with sites that recruit RUNX1 and RUNX1/ETO in
the cell line and in CD34+ cells, we first generated a scatter dia-
gram of the joint DHS signal of patient cells (Ptasinska et al.,
2012) compared with normal CD34+ cells (Figure S1B). We
then projected the genomic coordinates from the RUNX1/ETO
and RUNX1 ChIP experiments onto these sequences. These di-
agrams clearly show that the RUNX1- and RUNX1/ETO-bound
sequences from Kasumi-1 cells projected onto the DHS peaks
from patient cells, whereas RUNX1-bound sequences from
CD34+ cells projected onto the DHS peaks from the CD34+
cells.
To further confirm the similarity between t(8;21) cell lines and
patient cells, and to test whether we could overcome the need
to conduct multiple ChIP-seq experiments, we generated addi-
tional higher-read-depth DNaseI data from two t(8;21) patients
and developed a digital footprinting algorithm (Wellington). This
high-resolution approach takes the chromatin structure sur-
rounding transcription-factor motifs that are protected from
DNaseI digestion into account and thus evaluates the genome-
wide transcription-factor occupancy with high accuracy (Piper
et al., 2013). DNaseI footprinting data obtained from one t(8;21)
patient were compared with ChIP data for regions bound by
RUNX1/ETO, RUNX1, HEB, and LMO2 in Kasumi-1 cells
(13,584 peaks in total). This comparison demonstrated a high
concordance between transcription-factor binding in Kasumi-1
cells and motif occupancy in patient cells, as defined by prefer-
ential protection against DNaseI digestion (Figure S1C). This is
exemplified by the DNaseI footprints found at the NFE2 locus
(Figure 1B, gray areas), which in both patient samples reflect
the pattern of binding of RUNX1/ETO, HEB, LMO2, PU.1, and
RUNX1 in Kasumi-1 cells. These sites also form a DHS in normal
CD34+ cells and are bound by RUNX1 in these cells, as deter-
mined by ChIP (Figure 1B, top).
In contrast to RUNX1, which interacts with a multiplicity of fac-
tors in different cell types (Scheitz and Tumbar, 2013; van Riel
et al., 2012), RUNX1/ETO preferentially binds to DNA elements
containing RUNX, ETS, and E box motifs, thus reflecting the
composition of the RUNX1/ETO complex (Sun et al., 2013). To
examine whether our footprinting analysis was able to confirm
this preference of colocalizing motifs in patient cells, we con-
ducted an unbiased pairwise clustering analysis of footprinted
motifs in regions bound by RUNX1/ETO. This analysis demon-
strated that motifs bound by RUNX1/ETO in Kasumi-1 cells
strongly clustered with ETS (PU.1 and ERG) and E box (SCL,
LYL, and HEB) motifs that are footprinted in patient cells (Fig-
ure 1C). We found a similar clustering pattern using sequences
from the Kasumi-1 ChIP-seq experiments (Figure S1D), although
it was less defined due to the larger peak sizes in this experi-
mental context. In conclusion, RUNX1/ETO-positive Kasumi-1
cells show similar transcription-factor motif occupancy patterns,
confirming that at this level of accuracy, digital footprinting
provides a viable method for investigating transcription-factor
binding-site occupancy and preferential interaction in patient
cells.
RUNX1/ETO and RUNX1-Containing Complexes
Compete for the Same Genomic Sites
We previously showed that more than 60% of RUNX1/ETO bind-
ing sites are shared with RUNX1 in the bulk population of cells
(Ptasinska et al., 2012), with many of the footprinted sites con-
tainingmultiple TGYGGTRUNX1-bindingmotifs (e.g., Figure 1B).
Therefore, we conducted re-ChIP experiments in Kasumi-1 cells
to test at known RUNX1/ETO binding sites whether the two fac-
tors co-occupy single sites or whether binding is mutually exclu-
sive at such sites. In addition, we examined which other factors
were shared between RUNX1 and RUNX1/ETO complexes.
RUNX1 and RUNX1/ETO both colocalize with LMO2, HEB, and
LYL1 in the Kasumi-1 cell population (Figures 1A, 2A, and
S2A). However, binding of RUNX1 and RUNX1/ETO to their
target sites was mutually exclusive, even at elements containing
multiple RUNX motifs, such as the NFE2 locus (Figures 1B, 2B,
2C, and S2B).
BothRUNX1/ETOandRUNX1havebeen shown to interactwith
HDACs and the HAT p300 (also known as EP300) (Amann et al.,
2001; Kitabayashi et al., 1998; Levanon et al., 1998; Reed-Inder-
bitzin et al., 2006; Wang et al., 2011). Using paralled re-ChIP
experiments,we show that RUNX1-bound elements had a prefer-
ence for binding the coactivator p300, whereas RUNX1/ETO-
occupied elements preferentially bound the corepressor HDAC2
(Figures 2D–2F). We further confirmed this preferential binding
and the strong association between RUNX1 and p300 by per-
forming manual ChIP and ChIP-sequencing experiments after
knockdown of RUNX1/ETO (Figure 3). These experiments
demonstrated (1) that the loss of RUNX1/ETO binding led to an
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Figure 1. Transcription-Factor Occupancy Patterns Are Similar between RUNX1/ETO-Expressing Cell Lines and Patient Cells
(A) UCSC genome browser screenshot showing the binding patterns of RUNX1/ETO, RUNX1, HEB, LMO2, C/EBPa, PU.1, DHS, H3K9Ac, andRNA-Polymerase II
(POLII), as well as input reads and conservation among vertebrates at the LMO2 locus as aligned reads.
(B) UCSC genome browser screenshot of ChIP-seq and DHS data aligned with digital footprints at the NFE2 locus within a DHS shared between two t(8;21)
patients and purified normal CD34+ cells (top). It also shows the binding pattern of RUNX1 in CD34+ cells and RUNX1/ETO, RUNX1, HEB, LMO2, and PU.1 in
Kasumi-1 cells as determined by ChIP. Footprint probabilities as calculated byWellington are indicated as gray columns below the lines. The bottom indicates the
location of occupied RUNX, ETS, and C/EBP motifs.
(C) Occupied RUNX, E box, and ETS motifs in patient cells cluster within DHS sites that colocalize with RUNX1/ETO binding in Kasumi-1 cells. The heatmap
shows hierarchical clustering of footprinted motif co-occurrences by Z score within RUNX1/ETO peaks, indicating transcription factor co-occupancy. Footprint
probabilities within RUNX1/ETO-bound peaks were calculated using DNaseI-seq data from t(8;21) patient 1. The motif search was done within RUNX1/ETO
footprint coordinates. Red and blue colors indicate statistically over- and underrepresented motif co-occurrences, respectively. For a more detailed explanation,
see the legend of Figure S1 and the Supplemental Experimental Procedures.
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increase in RUNX1 binding at the same sites, and (2) there was an
increased recruitment of p300 without a concomitant increase in
the expression of these factors (Figures 3 and S3A), providing
an explanation for the increased histone H3 lysine 9 acetylation
at such sites that we observed previously (Figure S3B; Ptasinska
et al., 2012). In contrast, knockdown of RUNX1/ETO led to a
reduction of HDAC2 binding to these target sites (Figure 3C).
Taken together, these data show that RUNX1/ETO and RUNX1
(1) compete for the same genomic sites and (2) colocalize with
the same transcription factors but have distinct preferences for
histone-modifying cofactors, with RUNX1 associated complexes
preferring to interact with p300 and RUNX1/ETO complexes
preferring to recruit HDACs, including HDAC2.
The Core Transcriptional Network Bound by RUNX1/
ETO Is Predominantly AssociatedwithRepressedGenes
We next analyzed our ChIP-seq data sets to identify the core
transcriptional network that characterizes the cellular identity
of t(8;21) cells by determining overrepresented combinatorial
binding patterns for the transcription factors RUNX1/ETO,
C/EBPa, HEB, LMO2, PU.1, and RUNX1 (Tijssen et al., 2011).
ChIP sequences in RUNX1/ETO-positive cells were enriched
for just 11 of the 63 possible different binding patterns, which
included six significantly enriched combinatorial patterns con-
taining RUNX1/ETO and five patterns that did not (Figure 4A,
marked by asterisks). Two possible binding patterns (111010
and 110011) were not observed. We then associated such
Figure 2. RUNX1 and RUNX1/ETO Complexes Differentially Interact with Coactivator and Corepressor Complexes, and Binding to the Same
Sites Is Mutually Exclusive
(A–E) Multiple RUNX1/ETO binding sequences and control sequences (IVL, Chr18) were selected and validated for factor binding by a first round of ChIP followed
by a second round with a different antibody or with just beads as indicated. All of the chosen binding sites contain several RUNX1 motifs (data not shown).
(A) LMO2 associates with both RUNX1 and RUNX1/ETO.
(B and C) RUNX1 and RUNX1/ETO binding is mutually exclusive. Control ChIPs were performed with the same antibody.
(D) EP300 associates with RUNX1, but not RUNX1/ETO.
(E and F) RUNX1 preferentially binds p300, whereas RUNX1/ETO preferentially associates with HDAC2. For additional amplicons, see Figure S2B. qPCR data
represent the mean ± SD of at least three independent experiments.
1978 Cell Reports 8, 1974–1988, September 25, 2014 ª2014 The Authors
152
elements with the nearest genes and performed a gene set
enrichment analysis (GSEA) using gene-expression data sets
derived from a time course of RUNX1/ETO knockdown in two
different t(8;21) cell lines (Figures S4A and S4B; Ptasinska
et al., 2012). In addition, we compared these gene signatures
with a RNA-seq-based gene-expression data set derived from
a 4-day RUNX1/ETO knockdown in Kasumi-1 cells (Figures 4B
and S4C). This analysis demonstrated that all overrepresented
RUNX1/ETO-containing binding patterns were associated with
the upregulation of gene expression upon knockdown (Figure 4B,
red asterisks), whereas loci that do not bind RUNX1/ETO were
enriched in genes that were downregulated after RUNX1/ETO
knockdown (green asterisks). The very same genes behaved
similarly when assayed after knockdown of RUNX1/ETO in
patient cells, confirming the similarity between cell lines and pri-
mary cells (Figure 4C).
Figure 3. Dynamic Alterations in Cofactor Binding upon RUNX1/ETO Knockdown
(A) Western blot detecting RUNX1/ETO, RUNX1, C/EBPa, LMO2, PU.1, p300, HDAC2, LYL1, LDB1, and HEB protein in Kasumi-1 cells treated for 48 hr with
mismatch control siRNA (siMM) and with RUNX1/ETO siRNA (siRE). GAPDH served as the loading control.
(B) UCSC genome browser screenshot of the NFE2 locus showing changes in the RNA expression and binding pattern of p300, RUNX1/ETO (R/E), RUNX1, and
DHS upon RUNX/ETO knockdown in Kasumi-1 cells.
(C) Increase of p300 binding and decrease of HDAC2 binding upon RUNX1/ETO knockdown.
(D) Global changes of p300 binding peaks shared between RUNX1/ETO and RUNX, peaks exclusively bound by RUNX1, and PU.1 peaks not associated with
RUNX1/ETO or RUNX1 binding. qPCR data represent the mean ± SD of three to five independent experiments. For other control analyses, see Figure S3B.
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Figure 4. Specific Transcription-Factor Binding Patterns in t(8;21) Cells Correlate with the Response to RUNX1/ETO Knockdown
Genes bound by RUNX1/ETO are preferentially upregulated, whereas genes not bound by RUNX1/ETO are preferentially downregulated.
(A) Analysis of combinatorial binding identifies prevalent patterns in Kasumi-1 cells. The numbers of peaks are shown on the left of the heatmap for 61 factor-
binding combinations (red: bound, scored as 1; blue: not bound, scored as 0 with the order of factors as depicted on top of the heatmap). Z scores on the right
indicate the significance of deviation between observed and expected instances for all 61 combinatorial binding patterns. We identified 11 overrepresented
binding patterns, which we analyzed further when each was associated with more than 100 genes. GSEA of selected large groups of genes (indicated by arrows)
shows a highly significant enrichment of genes upregulated (upper left) or downregulated (lower left) after 4 days of RUNX1/ETO knockdown.
(B) Heatmap showing the RNA-seq overall fold change in Kasumi-1 cells 4 days after RUNX1/ETO knockdown.
(C) GSEA plots showing enrichment for up- or downregulated genes associated with dominant binding patterns in patient cells subjected to RUNX1/ETO
knockdown, demonstrating that changes in gene expression were concordant between Kasumi-1 and patient cells after RUNX1/ETO knockdown. Note that in
patient cells, RUNX1/ETO was only depleted for 48 hr and it takes about 4 days for the majority of genes to be downregulated (Ptasinska et al., 2012), thus
explaining the lower p value seen with downregulated genes.
See also Figure S4.
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Using the different overrepresented binding patterns, we con-
structed an interacting transcriptional network (Figure S4D).
Most genes were regulated by a single binding pattern (node),
and only some of these genes were associated with cis elements
that bound different factor combinations (depicted as located
between nodes). This specific binding pattern is of biological
relevance because the genes that occupied the different
network nodes clustered by overlapping but distinct Gene
Ontology (GO) terms and KEGG pathways (Figures S4D and
S4F; Table S2), indicating that they perform different functions.
For example, cis-regulatory elements that bind RUNX1/ETO
and all other factors (pattern 111111) are associated with genes
involved in myeloid differentiation and hematopoiesis (Fig-
ure S4E; Table S2). Among the genes without RUNX1/ETO bind-
ing (pattern 011111) that were downregulated after RUNX1/ETO
knockdown, we found the transcription factor genes ERG and
ETV6 (TEL1) (Figure S4F; Table S2), both of which are important
for stem cell function and maintenance (Taoudi et al., 2011;
Wang et al., 1998) but also have been implicated in AML (Diffner
et al., 2013). ERG has also been shown to be important for sta-
bilization of the RUNX1/ETO complex (Martens et al., 2012).
Another downregulated transcription factor gene was MEF2C,
which encodes a transcription factor that modulates myeloid
fate and has oncogenic activity when overexpressed (Schwieger
et al., 2009).
In summary, our analysis of the RUNX1/ETO-responsive core
transcriptional network in t(8;21) cells highlights the predomi-
nantly repressive role of RUNX1/ETO within this network. More-
over, our analysis identified distinct classes of genes, with
repressed genes involved in myeloid differentiation and active
genes forming part of the stem cell signature.
Knockdown of RUNX1/ETO Leads to a Dynamic
Reorganization of Transcription-Factor Binding
We next examined how the t(8;21) core transcriptional network
changed 2 days after RUNX1/ETO depletion. Depletion had no
immediate influence on the expression levels of any of the other
factors studied above, with the notable exception of C/EBPa
(Figure 3A). Nevertheless, loss of RUNX1/ETO had a profound
effect on the binding of these transcription factors (Figure S5A).
As exemplified by the CEBPE locus, depletion led to increased
RUNX1 occupancy at several thousand sites, confirming that
RUNX1/ETO and RUNX1 binding are in equilibrium (Figures 5A,
top left, 5B, S5B, and S5C). Furthermore, increased RUNX1 oc-
cupancy, including RUNX1 sites that were not previously bound
by RUNX1/ETO, was associated with a strong increase in p300
binding (Figure 3D). In contrast, more than 3,000 LMO2 binding
sites were lost, mainly outside the regions bound by RUNX1/
ETO and RUNX1 (Figures 5A, bottom-right panel, and S5C).
Furthermore, whereas 80% of all PU.1 binding sites remained
unchanged, the number of sites bound by C/EBPa increased
4-fold. Interestingly, 65%of all C/EBPa de novo sites colocalized
with PU.1 (Figures 5A, top left, S5B, and S5D). In agreement with
these results, C/EBPa binding sites clustered more strongly with
both RUNX1 and PU.1 sites upon depletion of RUNX1/ETO
(Figure S5E).
The changes in RUNX1 and C/EBPa binding, however, were
not reflected by major global changes in DHS patterns. The
comparison of DHS profiles before and after 2 days of RUNX1/
ETO knockdown revealed that the majority of DHSs were un-
changed (Figure 5C). Both C/EBPa and RUNX1 mainly associ-
ated with DHSs that were already present before RUNX1/ETO
depletion. Only 20% of sites showed increased DNaseI sensi-
tivity or arose de novo following RUNX1/ETO knockdown coin-
ciding with de novo RUNX1 and C/EBPa binding (Figures S5F
and S5G).
In summary, knockdown of RUNX1/ETO led to immediate
genome-wide alterations in transcription-factor binding after
48 hr. Although a small fraction of binding sites arose de novo,
this reprogramming occurred predominantly within preexisting
transcription-factor assemblies.
The Dynamic Reorganization of the Leukemic
Transcriptional Network after RUNX1/ETO Depletion
Is Driven by C/EBPa
Many transcription factors upregulate the expression of their
own gene, with PU.1 (SPI1) being a prominent example (Leddin
et al., 2011; Staber et al., 2013). However, of all the transcription
factors examined, only C/EBPa was found to be significantly
increased after RUNX1/ETO depletion (Figure 3A). Similarly to
PU.1, C/EBPa upregulates its own expression in murine cells,
and it was previously suggested that RUNX1/ETO interferes
with C/EBPa expression by sequestering it from its promoter
and thereby suppressing autoactivation (Pabst et al., 2001a).
Our data demonstrate binding of C/EBPa to an element about
40 kb downstream of its own gene, a site that is also occupied
by RUNX1/ETO, suggesting a more direct mechanism of repres-
sion (Ptasinska et al., 2012). C/EBPa is absolutely essential for
terminal myeloid differentiation (Zhang et al., 1997) and occupies
a large number of binding sites in mature macrophages (Heinz
et al., 2010). However, CEBPA is not the only direct target
gene of the CEBP family that responds to RUNX1/ETO: CEBPE
and CEBPD are upregulated as well (Ptasinska et al., 2012),
indicating that these factors may be part of a wider network of
C/EBP proteins that control myeloid gene expression.
To test whether increased expression of C/EBPawas crucially
involved in shifting the transcriptional network after RUNX1/ETO
depletion, we defined overrepresented binding patterns for
C/EBPa, PU.1, RUNX1, and LMO2 after RUNX1/ETO knock-
down. Loss of RUNX1/ETO resulted in the formation of a tran-
scriptional network dominated by C/EBPa-containing binding
patterns, all of which were predominantly associated with upre-
gulated genes in RUNX1/ETO-depleted Kasumi-1 and patient
cells (Figures 6A–6C, S6A, and S6B; Table S3). Different patterns
were again indicative of different classes of genes in terms of
both GO and pathway analyses, with differentiation and signal
transduction pathways being prominently featured (Figures
S6C, S6D, and S7A). However, increased C/EBPa binding was
also observed with a subset of genes that were downregulated
(Figure 6D). Previous studies have shown that in addition to
C/EBPa’s role in driving myeloid differentiation, low levels of
C/EBPa are required for stem cell maintenance, as upregulation
of C/EBPa represses genes required for stem-cell self-renewal
(Zhang et al., 2004, 2013). Therefore, we identified genes that
(1) were downregulated after RUNX1/ETO knockdown and (2)
showed increased C/EBPa binding (a total of 145 genes met
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the latter criterion; Figure 6D). This category included stem cell
genes such as ERG and CD34 (Figures S6F and S6G), as well
as a large number of genes encoding for signaling molecules
that are involved in regulating proliferation and differentiation,
such as DUSP6 or PTK2 (Figure S6G).
We next evaluated whether C/EBPawas required for the upre-
gulation of repressed RUNX1/ETO target genes. For this pur-
pose, we depleted RUNX1/ETO with and without a concomitant
C/EBPa knockdown. Knockdown of RUNX1/ETO led to a 2-fold
increase in C/EBPa expression (Figures 3A, 7A, and 7B) and in-
creases in expression of the direct RUNX1/ETO target genes,
includingMS4A3,NKG7, andRNASE2, which all show increased
C/EBPa binding upon RUNX1/ETO depletion (Figures 7C and
7D; data not shown). Codepletion of C/EBPa diminished the in-
duction of the three target genes in both Kasumi-1 and SKNO-1
cells (Figures 7D and S7B–S7D). These data indicate that
Figure 5. Knockdown of RUNX1/ETO Leads to a Reorganization of Transcription-Factor Assemblies within Preexisting Open Chromatin
Regions
(A) Three-way Venn diagrams showing the overlap between RUNX1/ETO and RUNX1 (top left), CEBPa (top right), LMO2 (bottom left), and PU.1 (bottom right) in
Kasumi-1 cells treated for 48 hr with control (siMM) and with RUNX1/ETO siRNA (siRE).
(B) UCSC genome browser screenshot showing the binding pattern of the indicated factors at the CEBPE locus in Kasumi-1 cells treated for 48 hr with control
siRNA (siMM) and with RUNX1/ETO siRNA (siRE).
(C) Binding of de novo (siRE unique), common, and lost (siMM unique) transcription factors (C/EBPa (top) and RUNX1 (bottom) to regions of increased (DHS up),
unchanged (DHS invariant), or reduced DNaseI hypersensitivity.
See also Figure S5.
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derepression of C/EBPa caused by RUNX1/ETO depletion is
required for the full upregulation of a number of RUNX1/ETO
target genes. However, we cannot rule out a similar function
for other C/EBP members and in particular C/EBPd and C/
EBPε, which are both upregulated upon RUNX1/ETO knock-
down (Figure 5B and data not shown). Nevertheless, our data
confirm that C/EBPa plays an important role in orchestrating a
transcriptional network that drives myeloid differentiation down-
stream of the original RUNX1/ETO network (Figure 7E).
DISCUSSION
The study presented here shows that expression of the on-
cogenic transcription factor RUNX1/ETO interferes with the hier-
archical succession of transcriptional networks required for
myeloid differentiation. Binding of RUNX1/ETO to key regulatory
elements inhibits the expression of genes that drive differentia-
tion. Moreover, we show that the establishment of a stable
leukemic state not only depends on a static interaction of tran-
scription factor complexes but also contains a dynamic com-
petitive component as its key feature. We demonstrate that the
transcriptional network controlled by RUNX1/ETO depends on
a dynamic equilibrium between RUNX1/ETO and RUNX1 com-
plexes, whose binding to their target sites is mutually exclusive.
Although these complexes share the factors LMO2, HEB, and
LYL1, they differ in their preferences for histone modifiers.
RUNX1 can also act as a repressor (Levanon et al., 1998;
Reed-Inderbitzin et al., 2006; Taniuchi et al., 2002), but in this
factor context it preferentially recruits the HAT p300, whereas
RUNX1/ETO recruits histone deacetylases, including HDAC2.
RUNX1/ETO shares almost three-quarters of its binding sites
with RUNX1, suggesting that the equilibrium between these
two complexes results in a finely tunedmodulation of expression
for a wide range of genes. Thus, the leukemic phenotype re-
quires the downmodulation of genes associated with differen-
tiation, but may not tolerate their complete suppression.
Figure 6. Transcriptional Network after RUNX1/ETO Depletion Is Enriched for C/EBPa Target Genes
(A) The transcription-factor binding state for CEBPa, LMO2, PU.1, and RUNX1 after RUNX1/ETO knockdown is characterized by an overrepresentation of four
dominant occupancy patterns. The number of peaks for all 15 factor combinations is shown on the left of the heatmap (red: bound, scored as 1; blue: not bound,
scored as 0). Z scores on the right indicate the significance of deviation between observed and expected instances for all 15 binding patterns. Left: GSEAs of
genes associated with the two most enriched dominant occupancy patterns (indicated by arrows) show highly significant enrichment of upregulated genes after
RUNX1/ETO knockdown.
(B) Genes associated with specific occupancy patterns that significantly change expression asmeasured by RNA-seq 4 days after RUNX1/ETO knockdown. The
heatmap shows the RNA-seq overall fold change in Kasumi-1 cells 4 days after RUNX1/ETO knockdown.
(C) GSEAs showing that genes associated with dominant occupancy patterns that are upregulated in Kasumi-1 cells behave similarly in patient cells.
(D) Venn diagram depicting the number of genes bound by C/EBPa that are downregulated after RUNX1/ETO knockdown and show increased C/EBPa binding.
See also Figure S6.
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Figure 7. Loss of RUNX1/ETO Triggers C/EBPa-Driven Reorganization of the Leukemic Transcriptional Network
(A)RUNX1/ETO andCEBPAmRNA expression levels in Kasumi-1 cells 72 hr after electroporation with the indicated siRNAs. siRE, RUNX1/ETO siRNA; siCEBPA,
C/EBPa siRNA; siMM, mismatch control siRNA. Results represent the mean ± SEM of five independent experiments. *p < 0.05; ns, not significant by paired
Student’s t test.
(B) Western blot indicating RUNX1/ETO and C/EBPa protein expression levels in single- and double-knockdown cells as indicated. An antibody against H3 was
used as control. Mock, no siRNA.
(C) mRNA levels of MS4A3, NKG7, and RNASE2 72 hr after electroporation with the indicated siRNAs. Results represent the mean ± SEM of five independent
experiments. *p < 0.05, **p < 0.01 by paired Student’s t test.
(D) UCSC genome browser screenshot showing the binding pattern of RUNX1/ETO, C/EBPa, and DHSs at theMS4A3 locus in Kasumi-1 cells treated for 48 hr
with mismatch control siRNA (siMM) and with RUNX1/ETO siRNA (siRE).
(E) Model of RUNX1/ETO-mediated control of leukemic transcription. The competitive equilibrium in locus occupation between RUNX1/ETO and RUNX1
complexes drives leukemic self-renewal. Depletion of RUNX1/ETO increases the levels and DNA binding of its direct target gene, C/EBPa, which together with
other differentiation genes reinstalls a transcriptional program that promotes myeloid differentiation.
See also Figure S7.
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Consequently, perturbation of this equilibrium by depletion of
RUNX1/ETO leads to loss of self-renewal, whereas knockdown
of RUNX1 severely impairs viability (Ben-Ami et al., 2013; Dunne
et al., 2006; Martinez et al., 2004; Martinez Soria et al., 2009).
Currently, we do not know whether the different complexes exist
independently or are in a rapid exchange. Evidence for both
mechanisms exists; for example, in a previous study (Sun
et al., 2013), neither p300 nor HDACs could be purified together
with the RUNX1/ETO complex from t(8;21) cells using high strin-
gency conditions. However, immunohistochemistry has demon-
strated that RUNX1 and RUNX1/ETO are targeted to different
subnuclear compartments (McNeil et al., 1999), a scenario that
would be difficult to reconcile with a rapid exchange of factors
binding to the same region of chromatin. Whatever the mecha-
nism, it is likely that a mutually exclusive binding pattern can
be found in other CBF leukemias. A similar colocalization with
RUNX1 and its mutated counterpart has also been seen in
AML with inversion 16 carrying the CBFB-MYH11 fusion protein
(Mandoli et al., 2014), and furthermore, this type of AML is also
dependent on the presence of an active copy of RUNX1 (Ben-
Ami et al., 2013).
It was recently shown that aberrant RUNX1 expression is
required for the maintenance of epithelial cancers (Scheitz
et al., 2012). Moreover, RUNX1 plays a tumor-suppressive role
by interacting with estrogen receptor a, and ERa-positive breast
cancer patients carry mutations that disrupt these interactions
(Chimge and Frenkel, 2013; Stender et al., 2010), highlighting
increasing evidence that this factor and its deregulation or
mutation are at the heart of multiple pathological processes.
Moreover, alternative splicing of RUNX1 leads to a C-terminally
truncated isoform known as AML1a, which lacks the transactiva-
tion domain and promotes self-renewal of hematopoietic stem
cells (Tsuzuki and Seto, 2012).We previously showed that during
blood cell development, RUNX1 binding reshapes the epigenetic
landscape by attracting other factors to its binding sites, and that
this factor relocation is reversible (Lichtinger et al., 2012). There-
fore, a dynamic equilibrium between different RUNX1 isoforms
and other factors may also be relevant for cancers outside of
the hematopoietic system.
A second important finding of our study is that the destruction
of the RUNX1/ETO network establishes a transcription network
dominated by the combinatorial binding of PU.1, RUNX1, and,
in particular, C/EBPa (Figure 7E). Once RUNX1/ETO is depleted,
C/EBPa expression levels increase and this factor then occupies
a large number of binding sites, demonstrating at the genome-
wide level that (1) C/EBPa is a major driver of myeloid differenti-
ation and (2) the differentiation block in AML is partly caused by
C/EBPa downregulation. The latter observation is consistent
with the fact that a large number of AMLs involve mutations of
C/EBPa (Preudhomme et al., 2002). However, the majority of
binding sites are found in regions of previously accessible chro-
matin, indicating that (1) RUNX1/ETO targets binding sites that
are destined for differentiation-driven factor exchange, and (2)
shortly after its upregulation, C/EBPa resumes its original bind-
ing behavior and reorganizes existing transcription factor as-
semblies to drive myelopoiesis. These results tie in with the
finding that PU.1 binding was largely invariant before and after
RUNX1/ETO depletion. Although previous overexpression ex-
periments indicated that RUNX1/ETO inactivated PU.1 (Vangala
et al., 2003), our data indicate that, at least during the time win-
dow of 2 days, the PU.1 cistrome is largely unperturbed by the
presence or absence of RUNX1/ETO and forms a platform
upon which other factors dynamically assemble (Natoli et al.,
2011).
In summary, our work sheds light on global mechanisms of the
differentiation block in t(8;21) AML, which is of conceptual rele-
vance for other types of AML and even other cancers. Many
AML types are characterized by mutations in C/EBPa and
RUNX1, which would impact many of the binding sites described
here. The dynamic equilibrium between a mutated transcription
factor and its wild-type counterpart allows a rapid reversion from
a transcriptional program promoting malignant self-renewal to a
differentiation program. Such dynamic behavior is likely to be the
molecular cause of the good prognosis of t(8;21) AML and may
also be a major angle for therapeutic intervention in other types
of AML without mutations in other hematopoietic regulators.
EXPERIMENTAL PROCEDURES
More detailed descriptions of the materials and methods used in this work can
be found in the Supplemental Experimental Procedures.
Human Patient Cells and Cell Lines
Patient material was obtained with approval from the NHS Research Ethics
Committees (Leeds Teaching Hospitals NHS Trust and Newcastle upon
Tyne Hospitals NHS Foundation Trust). Kasumi-1 cells were obtained from
the DSMZ cell line repository (http://www.dsmz.de/) and were cultured in
RPMI1640 containing 10% fetal calf serum (FCS). SKNO-1 cells were main-
tained in RPMI1640 supplemented with 20% FCS and 7 ng/ml granulocyte-
macrophage colony-stimulating factor.
siRNA Transfections
Kasumi-1 and SKNO-1 cells were transfected with 200 nM siRNA using a
Fischer EPI 3500 electroporator (Fischer) as described previously (Ptasinska
et al., 2012). The following siRNAs were used: RUNX1/ETO siRNA (sense,
CCUCGAAAUCGUACUGAGAAG; antisense, UCUCAGUACGAUUUCGAGG
UU), mismatch control siRNA (sense, CCUCGAAUUCGUUCUGAGAAG; anti-
sense, UC UCAGAACGAAUUCGAGGUU); and C/EBPa siRNA (sense, CCG
GAGUUAUGACAAGCUUUC; antisense, AAGCUUGUCAUAACUCCGGUC).
Real-Time RT-PCR
RNA extraction and quantitative real-time RT-PCR were performed as
described previously (Ptasinska et al., 2012). Primers are listed in Table S4.
Western Blotting
Kasumi-1 cells were lysed in RIPA buffer 2 days after electroporation. The
following antibodies were used for western blot analysis: C/EBPa, ab15048
(Abcam); ETO, SC-9737 (Santa Cruz Biotechnology); GAPDH, ab8245
(Abcam); HDAC2, ab7029 (Abcam); HEB, SC-357 (Santa Cruz); LDB1, SC-
11198 (Santa Cruz); LMO2, AF2726 (R&D Systems); LYL1, SC-374164 (Santa
Cruz); PU.1, SC-352 (Santa Cruz); p300, SC-585 (Santa Cruz); and RUNX1,
PC285 (Millipore).
ChIP
ChIP assays were performed as described previously (Ptasinska et al., 2012).
Nuclei were essentially prepared as described previously (Lefevre et al., 2003).
The following antibodies were used: C/EBPa, SC-61 (Santa Cruz Biotech-
nology); ETO (C terminus specific), SC-9737 (Santa Cruz); HDAC2, SC-6296
(Santa Cruz); HEB, SC-357 (Santa Cruz); LMO2, AF2726 (R&D Systems);
LYL1, SC-374164 (Santa Cruz); PU.1, SC-352 (Santa Cruz); p300, SC-585
(Santa Cruz); RUNX1 (C terminus specific), ab23980 (Abcam) or IgG rabbit
12-370 (Millipore); IgG goat, SC-2346 (Santa Cruz); and IgG mouse,
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SC-2025 (Santa Cruz). Precipitated material was subjected to library prepara-
tion and run on an Illumina Hiseq 2000 sequencer.
RNA-Seq
RNA samples from three independent biological replicates were pro-
cessed using the Tru-seq RNA Sample Prep Kit v2 (Illumina) according
to the manufacturer’s protocol. Libraries were run in 43 multiplex on an
Illumina Hiseq 2000 sequencer generating !90 million paired-end reads
per sample.
Re-ChIP
Re-ChIP was carried out as described above with minor modifications.
Following the final ChIP wash, chromatin complexes were eluted twice in
50 ml of ChIP elution buffer (100 mM NaHCO3, 1% SDS, PIC) for 15 min at
room temperature with shaking. Eluates were combined and diluted 20 times
with ChIP dilution buffer, followed by a 5 hr incubation with the second primary
antibody or IgG. After elution with 100 mM NaHCO3, 1% SDS for 30 min at
room temperature, the re-ChIP products were analyzed by quantitative PCR
(qPCR). Fold-enrichment values were calculated relative to a negative control
region of the genome. Primers are listed in Table S4.
DHS Mapping
Genome-wide DHSs were mapped as described previously (Leddin et al.,
2011).
Library Generation and Sequencing
Libraries of DNA fragments from ChIP or DNase I treatment were prepared
from 10 ng of DNA according to standard procedures. ETO, RUNX1, C/
EBPa, PU.1, LMO2 ChIP, and Kasumi-1 DNase I libraries were sequenced
on an Illumina Genome Analyzer GAIIx using 36 bp single-end reads. For
patients 1 and 2, DNase I (491 and 342 million reads, respectively) and control
patient libraries (Table S1) were sequenced on an Illumina HiSeq using 50 bp
single-end reads.
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